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Abstract
Quantitation of Fentanyl and Metabolites from Blow Fly Tissue and Development
Effects of Fentanyl on Lucilia sericata
Joseph Cox
Death investigations often involve collaborative work between different forensic disciplines,
especially with regards to pathology, toxicology, and entomology. In death cases consisting of individuals
who have no apparent trauma, a routine postmortem toxicology analysis is performed. Here, coroners
and medical examiners traditionally rely upon matrices such as blood, urine, gastric content and vitreous
to provide toxicological interpretation of drug concentrations. However, in absence of these tissue
samples in decedents with advanced decomposition or skeletonized, insects have proven resourceful in
supporting valuable analytical information. In fact, beyond 72 hours, entomology evidence is considered
the most reliable source to estimate the minimum postmortem interval (minPMI). The minPMI is the
minimum amount of time that it would take for an insect to reach a physical character such as length or
life stage and, therefore, is the minimum time that an individual has been deceased.
The succession that occurs on a corpse after death is a relatively confined and closely packed
ecosystem that is typically restricted to the remains and environment proximity. The incorporation of
drugs into the insects is possible and open an opportunity for assessing drug presence and developmental
effects in insect tissue. Various drugs accelerate insect growth, like codeine, cocaine, diazepam, and
methamphetamine. In contrast, others like tramadol, methadone, methylphenidate, and morphine have
been shown to slow the development of forensically relevant insects. The significance of these changes is
the impact on the minPMI calculation that can be incorrectly determined based on the insect’s size or stage
of growth if drugs are present when the insects are actively feeding.
This dissertation investigates the effects of designer opioids on the development of blow fly
(Lucilia sericata) larvae and the ability to detect and quantify the drugs and/or metabolites present in each
stage of the fly’s life cycle. Therefore, we evaluated human tissue fortified with fentanyl at four treatment
concentrations, and blow fly larvae were placed to feed on the drug infused tissue. A quick, easy, cheap,
effective, rugged, and safe (QuEChERS) extraction method was developed, validated, and applied to
extract fentanyl and metabolites from the larva, pupa, pupa casings, adults of Lucilia sericata. Additionally,
since liver tissue was utilized as feeding media, a complete validation extraction was also developed,
followed by the quantitative analysis of target drugs and metabolites via liquid-chromatography-tandem
mass spectrometry (LC-MS/MS).
This research represents an advancement in the combat of the opioid epidemic by offering a fully
validated protocol that complements the analytical toolkit in forensic toxicology laboratories and medical
examiners offices for complex biological matrices by 1) providing a protocol to extract and quantify
fentanyl and metabolites from complex matrices using QuEChERS to aid in forensic investigations, 2) an
evaluation any growth effects fentanyl has on the development of the insects and the potential
implications on the impact of minPMI estimations, 3) conclusions on the ability to correlate the
concentration of fentanyl and metabolites from the insect tissue to the initial concentration of the feeding
media.

Funding Statement
This study was funded by the National Institute of Justice, Award #2019-R2-CX-037, NIJ- STEM
Graduate Fellowship. The title of the NIJ fellowship was “Extraction and Quantification of Fentanyl and
Metabolites from Complex Biological Matrices to Support Medicolegal Death Investigations” (Jan 2020Dec 2021).

iii

Acknowledgements
Through this adventure of earning my Ph.D, I am proud to say that I have learned from the best in
the field of forensic science. Accomplishing this has been challenging and a great experience that I will cherish
forever. I could not have reached the end of this mission without my great team to support me along the way
and I thank y’all for being there for me.
Most importantly I would like to thank my mentor and committee chair, Dr. Luis Arroyo. He was
always there for me when I needed support and provided countless opportunities to advance my professional
and personal life. I will never be able to thank you enough and will be eternally grateful for my time at WVU.
I would also like to thank my other committee members; without your guidance I would not be at this
point today. Dr. Rachel Mohr, your help and guidance in terms of forensic entomology will remain with me
forever. You were always helpful when I needed you and your knowledge of entomology was vital to my project,
thank you. Dr. Tatiana Trejos, without your help with my project design and statistical models I would not have
been able to produce this project. You were always there when I need professional or personal guidance and I
thank you for making my time at WVU memorable. Dr. Joseph DelTondo, your assistance with pathology and
opening of doors for connections that I would not have obtain on my own was invaluable. You were always
willing to assist in any way you could, and I appreciate your willingness to help. Dr. Suzanne Bell, though your
time on my committee was limited, your guidance during my project proposal provided a large impact on my
project and your guidance as a mentor was greatly appreciated. I would like to thank Dr. James Kraner for his
support from the medical examiner’s office and for his guidance.
I would also like to thank my research group, without y’all life would have been boring and dull. We
always found ways to entertain ourselves while still accomplishing so much. I would like to specifically thank
Colby Ott, Kylea Mathison (Morris), Kourtney Dalzell, Sara Kuberski, Travon Cooman, Bill Feeney, and
Katherine Davis for their help in making this journey memorable. Colby, you are a great friend and an awesome
roommate.
Finally, I would like to thank my family: my mother Ruth Cox, my grandmother Betty Cox, and my
brother Brandon Cox, for their support during this time. I am sure they felt like this journey had no end, but
the mountain has been climbed. During this climb, I was lucky enough to meet a colleague that I hope will be
with me for a lifetime, Roberta Gorziza. You started as a visiting scholar and I am proud to call you my fiancé.
Without you this journey would have been insurmountable, I am so lucky to have found you. I love you.
There are no such thing as applied sciences, only application of science.
-Louis Pasteur

iv

Table of Contents
List of Figures ....................................................................................................................... xi
List of Tables ...................................................................................................................... xiii
List of Abbreviations ............................................................................................................ xv
Chapter 1: Overview and Study Objectives ............................................................................. 1
1.1. Project Overview .................................................................................................................................... 2
1.2. Project Design and Objectives ............................................................................................................... 5
1.2.1. Overall Project Goals ............................................................................................................. 5
1.2.2. Objectives and Tasks.............................................................................................................. 6

Chapter 2: Introduction and Literature Review ..................................................................... 10
2.1 Introduction...........................................................................................................................................11
2.2 Forensic Entomology.............................................................................................................................11
2.2.1. Biological Factors .................................................................................................................11
2.2.2. Insect Age Estimation ..........................................................................................................16
2.3. Forensic Entomotoxicology .................................................................................................................17
2.3.1. Impact on minPMI ..................................................................................................................17
2.3.2. Toxicology Specimens ..........................................................................................................19
2.4. Insects of Interest.................................................................................................................................20
2.5. Establishment of Colony ......................................................................................................................21
2.6. Postmortem Toxicology .......................................................................................................................22
2.7. Extraction Techniques..........................................................................................................................22
2.7.1. Liquid-Liquid Extraction .......................................................................................................23
2.7.2. Solid-Phase Extraction .........................................................................................................23
2.7.3. QuEChERS Extraction ...........................................................................................................24
2.8. Drug Overdose Deaths .........................................................................................................................25
2.9. Fentanyl ................................................................................................................................................26
2.10. Metabolism ........................................................................................................................................29
2.11. Validation ...........................................................................................................................................30
2.11.1. Calibration model ..............................................................................................................31
2.11.2. Interference studies ...........................................................................................................31
2.11.3. Ionization suppression/enhancement ..............................................................................32
2.11.4. Bias and Precision ..............................................................................................................32
2.11.5. Limits ..................................................................................................................................32
2.11.6. Carryover and Dilution Integrity .......................................................................................33
2.11.7. Processed Sample Stability................................................................................................33
2.11.8. Recovery and Process Efficiency .......................................................................................33
2.12. Critiques and Current Challenges ......................................................................................................35

v

2.13. Critical Need .......................................................................................................................................37

Chapter 3: Development and Application of QuEChERS Extraction Method for the
Quantitation of Fentanyl and Metabolites from Liver Tissue ................................................. 39
3.1. Section 1: Method Development and Application .............................................................................40
3.1.1. Introduction .........................................................................................................................40
3.1.2. Methods ...............................................................................................................................43
3.1.2.1. Chemicals and Materials .....................................................................................43
3.1.2.2. LC-MS/MS ............................................................................................................44
3.1.2.3. Extraction Techniques .........................................................................................47
3.1.2.3.1. QuEChERS..........................................................................................................47
3.1.2.3.2. SPE .....................................................................................................................48
3.1.2.3.3. LLE .....................................................................................................................49
3.1.2.4. Extraction Validation ...........................................................................................50
3.1.2.4.1. Selectivity ..........................................................................................................50
3.1.2.4.2. Ionization Suppression/Enhancement.............................................................51
3.1.2.4.3. Bias and Precision .............................................................................................52
3.1.2.4.4. Linearity of Calibration .....................................................................................52
3.1.2.4.5. Processed Sample Stability ..............................................................................52
3.1.2.4.6. Limits .................................................................................................................53
3.1.2.4.7. Proof of Applicability ........................................................................................53
3.1.2.4.8. Comparison of Extraction Techniques (Recovery, Matrix Effects, and Process
Efficiency) ..........................................................................................................................53
3.1.3. Results and Discussion.........................................................................................................54
3.1.3.1. Selectivity .............................................................................................................54
3.1.3.2. Ionization Suppression/Enhancement ................................................................54
3.1.3.3. Bias and Precision ................................................................................................55
3.1.3.4. Linearity of Calibration ........................................................................................56
3.1.3.5. Processed Sample Stability .................................................................................56
3.1.3.6. Limits ....................................................................................................................57
3.1.3.7. Proof of Applicability ...........................................................................................58
3.1.3.8. Comparison of Extraction Techniques ................................................................61
3.1.3.9. Conclusions ..........................................................................................................63
3.2. Section 2: Expansion of Method to 34 Fentanyl Analogs ...................................................................64
3.2.1. Overview ..............................................................................................................................64
3.2.2. Introduction .........................................................................................................................65
3.2.3. Methods ...............................................................................................................................66
3.2.3.1. Chemicals and Materials .....................................................................................66
3.2.3.2. LC-MS/MS ............................................................................................................68
3.2.3.3. Sample Preparation .............................................................................................71
3.2.3.4. Validation .............................................................................................................71
3.2.3.4.1. Calibration model .............................................................................................71
3.2.3.4.2. Interference studies .........................................................................................73
3.2.3.4.3. Ionization suppression/enhancement .............................................................74
3.2.3.4.4. Bias and precision .............................................................................................75

vi

3.2.3.4.5. Calibration model .............................................................................................75
3.2.3.4.6. Limits .................................................................................................................76
3.2.3.4.7. Carryover and dilution integrity ......................................................................76
3.2.3.4.8. Processed sample stability ...............................................................................77
3.2.3.4.9. Recovery, matrix effects and process efficiency .............................................77
3.2.3.4.10. Proof of applicability ......................................................................................78
3.2.4. Results and Discussion .........................................................................................................78
3.2.4.1. Calibration model ................................................................................................78
3.2.4.2. Interference studies.............................................................................................78
3.2.4.3. Ionization suppression/enhancement ................................................................79
3.2.4.4. Bias and precision ................................................................................................80
3.2.4.5. Limits ....................................................................................................................80
3.2.4.6. Carryover and dilution integrity..........................................................................80
3.2.4.7. Processed sample stability ..................................................................................85
3.2.4.8. Recovery, matrix effects and process efficiency ................................................87
3.2.4.9. Proof of applicability ...........................................................................................87
3.2.5. Conclusions ..........................................................................................................................91

Chapter 4: Evaluation of the Effects of Fentanyl on Blowfly Larva and Application of
QuEChERS Extraction Method for the Quantitation of Fentanyl and Metabolites from Larva
and Pupa (Lucilia sericata) ................................................................................................... 93
4.1. Chapter Overview ................................................................................................................................94
4.2. Section 1: Validation of QuEChERS Extraction for Larva and Pupa ....................................................94
4.2.1. Introduction .........................................................................................................................94
4.2.2. Methods ...............................................................................................................................97
4.2.2.1. Adult Colony ........................................................................................................97
4.2.2.2. Experimental Design ............................................................................................97
4.2.2.3. Chemicals and Materials .....................................................................................99
4.2.2.4. LC-MS/MS ............................................................................................................99
4.2.2.5. Sample preparation ...........................................................................................101
4.2.2.6. Validation parameters .......................................................................................102
4.2.2.6.1. Calibration model ...........................................................................................102
4.2.2.6.2. Interference studies .......................................................................................102
4.2.2.6.3. Ionization suppression/enhancement ...........................................................103
4.3.3.6.4. Bias and Precision ...........................................................................................104
4.2.2.6.5. Limits ...............................................................................................................104
4.2.2.6.6. Carryover and Dilution Integrity ....................................................................104
4.2.2.6.7. Processed Sample Stability ............................................................................105
4.2.2.6.8. Recovery and Process Efficiency ....................................................................105
4.2.3. Results ................................................................................................................................106
4.2.3.1. Validation ...........................................................................................................106
4.2.3.2. Ionization suppression/enhancement ..............................................................107
4.2.3.3. Bias and precision ..............................................................................................108
4.2.3.4. Limits ..................................................................................................................109
4.2.3.5. Carryover and dilution integrity........................................................................109

vii

4.2.3.6. Processed sample stability ................................................................................110
4.2.3.7. Recovery and process efficiency .......................................................................111
4.2.3.8. Entomotoxicology Results .................................................................................112
4.2.3.9. Insect measurements .........................................................................................113
4.2.4. Discussion ...........................................................................................................................114
4.2.4.1. Validation ...........................................................................................................114
4.2.4.2. Entomotoxicology ..............................................................................................115
4.2.4.3. Insect development ...........................................................................................118
4.2.5. Conclusion ..........................................................................................................................119
4.3. Section 2: Physical Effects of Fentanyl on Larva and Pupa (Lucilia sericata)...................................120
4.3.1. Overview ............................................................................................................................120
4.3.2. Morphometrics ..................................................................................................................121
4.3.3. Methods .............................................................................................................................122
4.3.3.1. Design .................................................................................................................122
4.3.4. Results ................................................................................................................................124
4.3.4.1 Mixed Effects Model ...........................................................................................125
4.3.4.2. Mean Lengths Day 2 ..........................................................................................127
4.3.4.3. Mean Lengths Day 3 ..........................................................................................127
4.3.4.4. Mean Lengths Day 4 ..........................................................................................128
4.3.4.5. Mean Lengths Day 5 ..........................................................................................129
4.3.4.6. Mean Lengths Day 6 ..........................................................................................129
4.3.4.7. Mean Lengths Day 10 ........................................................................................130
4.3.4.8. Growth Curves ...................................................................................................131
4.3.4.8.1. Replicate #1 ....................................................................................................131
4.3.4.8.2. Replicate #2 ....................................................................................................132
4.3.4.8.3. Replicate #3 ....................................................................................................133
4.3.4.8.4. Total ................................................................................................................134
4.3.5. Discussion ...........................................................................................................................138
4.3.6. Conclusion ..........................................................................................................................141
4.4. Section 3: Quantitation of Fentanyl and Metabolites from Larva and Pupa (Lucilia sericata).......142
4.4.1. Overview ............................................................................................................................142
4.4.2. Toxicology Matrix and Correlations ..................................................................................142
4.4.3. Methods .............................................................................................................................144
4.4.4. Results ................................................................................................................................145
4.4.4.1. Survey of Drugs ..................................................................................................145
4.4.4.2. Regression Plots.................................................................................................155
4.4.5. Discussion ...........................................................................................................................159
4.4.6. Conclusion ..........................................................................................................................162

Chapter 5: Evaluation of the Effects of Fentanyl on Blowfly Adults and Application of
QuEChERS Extraction Method for the Quantitation of Fentanyl and Metabolites from Empty
Puparium and Adult Flies (Lucilia sericata) ......................................................................... 164
5.1. Chapter 5 Overview ...........................................................................................................................165
5.2. Section 1: Validation of QuEChERS Extraction for Empty Puparia and Adult Flies .........................165
5.2.1. Late Insect Stage Overview ...............................................................................................165

viii

5.2.2. Introduction .......................................................................................................................166
5.2.3. Methods .............................................................................................................................167
5.2.3.1. Adult colony .......................................................................................................167
5.2.3.2. Chemicals and materials ...................................................................................167
5.2.3.3. Design for Authentic Insect Samples ................................................................168
5.2.3.4. Comparison of Extraction Techniques ..............................................................169
5.2.3.4.1. Micropulverized QuEChERS Extraction ..........................................................169
5.2.3.4.2. Acidic Digestion QuEChERS Extraction ..........................................................170
5.2.3.4.3. Basic Digestion and LLE ..................................................................................170
5.2.3.5. Validation parameters .......................................................................................171
5.2.3.5.1. Calibration model ...........................................................................................171
5.2.3.5.2. Interference studies .......................................................................................171
5.2.3.5.3. Ionization suppression/enhancement ...........................................................172
5.2.3.5.4. Bias and Precision ...........................................................................................172
5.2.3.5.5. Limits ...............................................................................................................172
5.2.3.5.6. Carryover and Dilution Integrity ....................................................................173
5.2.3.5.7. Processed Sample Stability ............................................................................173
5.2.3.5.8. Recovery and Process Efficiency ....................................................................173
5.2.4. Results ................................................................................................................................174
5.2.4.1. Comparison of Extraction Techniques ..............................................................174
5.2.4.2. Validation ...........................................................................................................176
5.2.4.3. Ionization suppression/enhancement ..............................................................177
5.2.4.4. Bias and precision ..............................................................................................178
5.2.4.5. Limits ..................................................................................................................179
5.2.4.6. Carryover and dilution integrity........................................................................179
5.2.4.7. Processed sample stability ................................................................................180
5.2.4.8. Recovery and process efficiency .......................................................................181
5.2.4.9. Entomotoxicology Results .................................................................................182
5.2.5. Conclusion ..........................................................................................................................184
5.3. Section 2: Morphometric Comparisons of Adult Flies ......................................................................184
5.3.1. Overview ............................................................................................................................184
5.3.2. Morphometrics ..................................................................................................................185
5.3.3. Methods .............................................................................................................................185
5.3.3.1. Design .................................................................................................................185
5.3.4. Results ................................................................................................................................187
5.3.4.1. Day 21.................................................................................................................187
5.3.4.1.1. Wing Vein ........................................................................................................187
5.3.4.1.2. Tibia Length.....................................................................................................187
5.3.4.1.3. Mass ................................................................................................................188
5.3.4.2. Estimated Survivor Rates ..................................................................................188
5.3.5. Discussion ...........................................................................................................................189
5.3.6. Conclusion ..........................................................................................................................190
5.4. Section 3: Application of QuEChERS Extraction to Empty Puparia and Adult Flies .........................191
5.4.1. Overview ............................................................................................................................191

ix

5.4.2. Toxicology Matrix and Correlations ..................................................................................191
5.4.3. Methods .............................................................................................................................192
5.4.4. Results ................................................................................................................................192
5.4.5. Conclusion ..........................................................................................................................197

Chapter 6: General Conclusions.......................................................................................... 199
6.1. Chapter 3: Development and Application of QuEChERS Extraction Method for the Quantitation of
Fentanyl and Metabolites from Liver Tissue ............................................................................................200
6.2. Chapter 4: Evaluation of the Effects of Fentanyl on Blowfly Larva and Application of QuEChERS
Extraction Method for the Quantitation of Fentanyl and Metabolites from Larva and Pupa (Lucilia
sericata) .....................................................................................................................................................201
6.3. Chapter 5: Evaluation of the Effects of Fentanyl on Blowfly Adults and Application of QuEChERS
Extraction Method for the Quantitation of Fentanyl and Metabolites from Empty Puparium and Adult
Flies (Lucilia sericata) ................................................................................................................................203

Future Work ...................................................................................................................... 207
References ........................................................................................................................ 210
Appendix A........................................................................................................................ 226

x

List of Figures
Chapter 2
Figure 2.1: Life cycle of the Green Bottle Fly Lucilia sericata. .....................................................................13
Figure 2.2: Third instar larvae with posterior respiratory slits magnified. .................................................13
Figure 2.3: Image of a wandering third instar. Absence of feeding substrate in the crop is a clear
indication of a wandering third instar larvae. .............................................................................................14
Figure 2.4: Diagram of the alimentary canal of a larval blow fly (25). ........................................................15
Figure 2.5: Diagram of a Malpighian tubule (29). .......................................................................................15
Chapter 3
Figure 3.1: Fragmentation predictions from ChemDraw for fentanyl quant transition (left) and the
qualifier transitions. .....................................................................................................................................46
Figure 3.2: Images for the adapted homemade reaction chambers for the QuEChERS extraction. ..........48
Figure 3.3: Visual workflow for the QuEChERS extraction. .........................................................................48
Figure 3.4: Workflows for the LLE, SPE, and QuEChERS extraction protocols. ...........................................50
Figure 3.5: LC-MS/MS chromatogram for the MRM transitions of the three target analytes. ..................54
Figure 3.6: Graphical representation of the stability of the high concentration for processed samples
stored in the autosampler (4°C). .................................................................................................................57
Figure 3.7: Box plot of quantitative results for the OCME case samples. ...................................................60
Figure 3.8: Chromatogram of the 11 isobaric fentanyl analogs with norfentanyl and carfentanil for
reference. Numbers 1-13 in the figure correspond to Table 1. ..................................................................79
Chapter 4
Figure 4.1: Larvae (day 4) and pupae (day 12) measurements of length and width (mm). .......................98
Figure 4.2: Chromatographic separation of norfentanyl, β-hydroxy fentanyl, 4-ANPP, and fentanyl at the
LLOQ. Quantifier transitions are displayed above. ....................................................................................100
Figure 4.3: Fortified liver (25 g) aliquot (A) with 70-90 eggs placed (B). ..................................................123
Figure 4.4: Schematic of the design workflow. .........................................................................................124
Figure 4.5: Plot of predicted means via the mixed effects model. ...........................................................126
Figure 4.6: Comparison of mean lengths for insects collected on day 2 in replicates #1-3. ....................127
Figure 4.7: Comparison of mean lengths for insects collected on day 3 for replicates #1-3. ...................128
Figure 4.8: Comparison of mean lengths for insects collected on day 4 for replicates #1-3. ...................128
Figure 4.9: Comparison of mean lengths for insects collected on day 5 for replicates #1-3. ...................129
Figure 4.10: Comparison of mean lengths for insects collected on day 6 for replicates #1-3. .................130
Figure 4.11: Comparison of mean lengths for insects collected on day 10 for replicates #1-3................130
Figure 4.12: Growth curves for the four treatments for replicate #1. ......................................................131
Figure 4.13: Growth curves for the four treatments for replicate #2. ......................................................132
Figure 4.14: Growth curves for the five treatments for replicate #3. .......................................................134
Figure 4.15: Growth curves for the five treatments for all three replicates combined............................135
Figure 4.16: The maximum length measured from the larva collected on each day. ..............................136

xi

Figure 4.17: Box plot for the concentration of fentanyl quantitated for the single and pooled larva
specimens collected from the high treatment liver on day 3 for all three replicates (n=15). ..................148
Figure 4.18: Box plot for the concentration of fentanyl quantitated for the single and pooled larva
specimens collected from the medium treatment liver on day 3 for all three replicates (n=15).............148
Figure 4.19: Box plot for the concentration of fentanyl quantitated for the single and pooled larva
specimens collected from the medium treatment liver on day 3 for all three replicates (n=15).............149
Figure 4.20: Box plot for the concentration of fentanyl quantitated for the single and pooled larva
specimens collected from the low treatment liver on day 3 for all three replicates (n=15). ...................149
Figure 4.21: Box plot for the concentration of norfentanyl quantitated for the single and pooled larva
specimens collected from the high treatment liver on day 3 for all three replicates (n=15). ..................150
Figure 4.22: Box plot for the concentration of norfentanyl and 4-ANPP quantitated for the single and
pooled larva specimens collected from the authentic treatment liver on day 3 for all three replicates
(n=5). ..........................................................................................................................................................150
Figure 4.23: Regression plots for liver concentrations to larva concentrations for the single and pooled
extractions collected on day 3 in replicate #1. ..........................................................................................155
Figure 4.24: Regression plots for liver concentrations to larva concentrations for the single and pooled
extractions collected on day 3 in replicate #2. ..........................................................................................155
Figure 4.25: Regression plots for liver concentrations to larva concentrations for the single and pooled
extractions collected on day 3 in replicate #3. ..........................................................................................156
Figure 4.26: Correlation plots for liver concentrations to larva concentrations for the single and pooled
extractions collected on day 3 for all three replicates. .............................................................................158

Chapter 5
Figure 5.1: Regression plot data for the liver to empty puparia fentanyl concentrations (left) and for liver
to adult fentanyl concentrations (right). ...................................................................................................183
Figure 5.2: Measurements for the costa vein in the fly wing and the tibia length. ..................................186
Figure 5.3: Comparison of mean wing vein length for insects collected on day 21 for replicates #1-3. ..187
Figure 5.4: Comparison of mean tibia length (mm) for insects collected on day 21 for replicates #1-3. 188
Figure 5.5: Comparison of mean mass for insects collected on day 21 for replicates #1-3. ....................188
Figure 5.6: Box plot for the concentration of fentanyl quantitated for the pooled empty puparia
specimens collected from the authentic, medium, and high treatments on day 21 for all three replicates
(n=6). ..........................................................................................................................................................194
Figure 5.7: Box plot for the concentration of norfentanyl quantitated for the pooled empty puparia
specimens collected from the authentic, medium, and high treatments on day 21 for all three replicates
(n=6). ..........................................................................................................................................................195
Figure 5.8: Box plot for the concentration of β-hydroxyfentanyl quantitated for the pooled empty
puparia specimens collected from the low, medium, and high treatments on day 21 for all three
replicates (n=6). .........................................................................................................................................195
Figure 5.9: Box plot for the concentration of fentanyl quantitated for the pooled adult fly specimens
collected from the low, medium, and high treatments on day 21 for all three replicates (n=6). ............196
Figure 5.10: Box plot for the concentration of norfentanyl quantitated for the pooled adult fly specimens
collected from the low, medium, and high treatments on day 21 for all three replicates (n=6). ............197

xii

List of Tables
Chapter 2
Table 2.1: Fentanyl and metabolites ...........................................................................................................27
Chapter 3
Table 3.1: MRM MS method parameters....................................................................................................45
Table 3.2: List of 31 compounds evaluated for potential interferences .....................................................51
Table 3.3: Ionization Suppression/Enhancement. ......................................................................................55
Table 3.4: Bias and Precision .......................................................................................................................56
Table 3.5: Linearity of calibration. ...............................................................................................................56
Table 3.6: Processed stability for samples stored in autosampler (4°C). ....................................................57
Table 3.7: Review of fentanyl liver concentrations (µg/kg). .......................................................................59
Table 3.8: Comparison of beef and human liver extractions at low, med, and high concentrations (n=5).
.....................................................................................................................................................................61
Table 3.9: Matrix effects, recovery, and process efficiency for the 3 extraction techniques (n=5). ...........62
Table 3.10: MS parameters for the 6470 Agilent system............................................................................70
Table 3. 11: List of 31 compounds evaluated for potential interferences. .................................................74
Table 3.12: Ionization suppression/enhancement. .....................................................................................82
Table 3.13:: Bias and precision data for the 34 fentanyl analogs. ..............................................................83
Table 3.14: LOD, LLOQ, and AMR. ...............................................................................................................84
Table 3.15: Dilution integrity of post extraction dilution at a 1:5 dilution (n=15). .....................................85
Table 3.16: Stability at a low and high concentration for the 34 analytes for processed samples stored in
the autosampler (25 °C) ...............................................................................................................................86
Table 3.17: Matrix effects, recovery, and process efficiency. .....................................................................88
Table 3. 18: Authentic postmortem liver results. .......................................................................................90
Chapter 4
Table 4.1: MRM MS method parameters..................................................................................................101
Table 4.2: List of 31 compounds evaluated for potential interferences. ..................................................103
Table 4.3: LOD, LLOQ, and AMR for larvae and pupae extractions. .........................................................106
Table 4.4: Ionization suppression/enhancement, recovery, and process efficiency for the larval and
pupal tissue (n=10). ...................................................................................................................................108
Table 4.5: The bias and precision validation data for larvae and pupae extractions (n=15). ...................109
Table 4.6: Dilution integrity for the larvae and pupae extractions at a 1:5 dilution. ...............................110
Table 4.7: Stability at a low and high concentration for the larvae and pupae extractions for processed
samples stored in the autosampler (25 °C). ...............................................................................................111
Table 4.8: Larvae and pupae fentanyl concentrations from day four and day twelve collections. ..........113
Table 4.9: Survivor rates for the day four and day twelve insect collections............................................114
Table 4.10: Percent stage over time for each life stage (2nd instar larva, 3rd instar larva feeding, 3rd instar
larva wandering, pupa, and adult flies). ....................................................................................................125
Table 4.11: Equations for the growth curve of the control group for each replicate and as a total. .......136

xiii

Table 4. 12: Age estimations generated using the equations from Table 4.11. Estimated ages were
compared to the actual day of collection to calculate a difference () age (d). .......................................137
Table 4.13: Larval drug concentrations from day three collections for all three replicates.....................147
Table 4.14: Larval drug concentrations from day six collections for all three replicates. ........................152
Table 4.15: Pupal drug concentrations from day 10 collections for all three replicates. ..........................154
Table 4.16: The linear regression equations for the regression plots with R2 values. ..............................157
Table 4.17: Liver concentration estimation using larval concentration by linear regression. ..................158
Chapter 5
Table 5.1: Ionization suppression/enhancement, recovery, and process efficiency for the empty
puparium tissue (n=10). .............................................................................................................................175
Table 5.2: Comparison for the three extraction techniques micropulverized QuEChERS extraction (MP),
acidic digestion QuEChERS (acidic), and basic digestion LLE for the ability to extract fentanyl and
metabolites from pooled (n=16) authentic empty puparia specimens. ...................................................176
Table 5.3: LOD, LLOQ, and AMR for empty puparia and adult fly extractions. ........................................177
Table 5. 4: Ionization suppression/enhancement, recovery, and process efficiency for the adults and
empty puparium tissue (n=10). .................................................................................................................178
Table 5.5: The bias and precision validation data for adults and empty puparium extractions (n=15). ..179
Table 5.6: Dilution integrity for the adult and empty puparium extractions at a 1:5 dilution. ................180
Table 5. 7: Stability at a low and high concentration for the adult and empty puparium extractions for
processed samples stored in the autosampler (25 °C). .............................................................................181
Table 5.8: Concentrations of fentanyl and norfentanyl detected in the empty puparia and adult flies. .183
Table 5.9: Percent estimated survivor rates for all the treatments and replicates combined. ................189
Table 5.10: Gender distribution for the adult flies....................................................................................189
Table 5.11: Empty puparia and adult drug concentrations from day 21 collections for all three replicates.
...................................................................................................................................................................193

xiv

List of Abbreviations
%CV – Percent relative standard deviation
4-ANPP – Despropionyl fentanyl
AAFS – American Academy of Forensic Science
ACN – Acetonitrile
AMR – Analytical measurement range
ASB - Academy Standard Board
CNS – Central nervous system
CYP450 – Hepatic cytochrome P450
dMRM – Dynamic multiple reaction monitoring
d-SPE – Dispersive solid-phase extraction
EDDP – 2-Ethylidene-1, 5-Dimethyl-3, 3-Diphenylpyrrolidine
GC/MS – Gas chromatograph mass spectrometry
HCl – Hydrochloric acid
HPLC – High performance mass spectrometry
IMF – Illicitly manufactured fentanyl
IRB – Institutional Review Board
IS – Internal standard
IWS – Intermediate working solution
LC-MS – Liquid chromatography mass spectroscopy
LC-MS/MS - Liquid chromatography tandem mass spectrometry
LLE – Liquid-liquid extraction
LLOQ – Lower limit of quantitation
LOD – Limit of detection
ME – Matrix effects
MgSO4 – Magnesium sulfate
MRM – Multiple reaction monitoring
MTBE – Methyl-tertbutyl ether

xv

NaCl – Sodium chloride
NaOH – Sodium chloride
NSO - Novel synthetic opioids
NSOs – Novel synthetic opioids
NVSS - National Vital Statistics System
OCME – Office of the Chief Medical Examiner
PE – Process efficiency
minPMI – Minimum PMI
PMR – Postmortem redistribution
PSA – Primary secondary amine
QuEChERS - Quick, Easy, Cheap, Effective, Rugged, and Safe
RE – Recovery of the extraction
REML – Restricted maximum likelihood
RIA – Radioimmunoassay
s/n – Signal to noise
SPE – Solid phase extraction
SWGTOX – The Scientiﬁc Working Group for Forensic Toxicology
TLC – Thin layer chromatography
Vd – Volume of distribution
WVU – West Virginia University

xvi

Chapter 1: Overview and Study Objectives
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1.1. Project Overview
In medico-legal death investigations, postmortem toxicology interpretations can be a crucial
component in determining the cause of death. In a forensic postmortem toxicological workflow, typically
various specimens are submitted for testing including: urine, blood, liver, kidney, and other complex
biological tissues (1). Often, concentrations from one or more of the above specimen types are used to
corroborate one another. Interpretation of these results generally depend on previously published work
from the field. By investigating concentrations of drugs in various matrices in postmortem cases, the
strength of toxicological interpretation increases especially involving cases with advanced decomposition.
Insect tissue, usually larva or pupa, is widely accepted as a qualitative toxicology matrix with quantitative
value being extremely limited. Insects, when there is open access to a cadaver, arrive shortly after death
to colonize the body with eggs and persist through the entire decomposition process. This allows insect
tissue to have a larger window of detection compared to most biological fluid or tissue samples. Another
result of this natural association is that insects can be used for estimating the minimum postmortem
interval (minPMI). Entomological estimation of minPMI is rooted in the assumption that insects arrive shortly
after death and that their development is primarily governed by temperature (2). Based on the physical
size or stage of the insect and the thermal history, the age of an insect can be calculated at which the
insect was collected (2, 3). The minPMI can be a vital tool in death investigations by determining a minimum
time that a cadaver has been exposed to insect development.
Under this scope, this research is focused on evaluating the developmental effects of fentanyl on
immature stages of the blow fly Lucilia sericata (Meigen)) and the prevalence of fentanyl and metabolites
from larval and pupal tissue after feeding on liver tissue with the presence of fentanyl.
This dissertation is presented in five main chapters, an overall conclusion section, and future work.
Chapter 1 is a general overview with project objectives. In chapter 2 the biological elements of Lucilia
sericata and forensic significance are presented including life cycle, distribution, and fundamentally how
forensic entomology calculates minPMI. Toxicology background and significance presented in this chapter
2

include extraction types, drugs of abuse, metabolism, and applications to insect tissues. General topics
are presented in this chapter and are expanded in subsequent chapters.
Chapter 3 describes the evaluation and selection of the extraction protocol chosen to be utilized
for the analysis of fentanyl and metabolites from complex biological matrices. Fentanyl is a potent µopioid agonist with a high potential for abuse, addiction, and overdose. The detection and quantitation of
fentanyl and metabolites from traditional matrices of blood, urine, vitreous, and liver tissue can be of vital
importance in postmortem toxicology investigations. Blood can be susceptible to postmortem
redistribution and often liver tissue is used to corroborate the blood concentrations. When blood or other
fluids are no longer available or suitable for analysis, liver tissue is often the tissue selected by toxicologists
due to its function in metabolism as well as its relative resistance to postmortem redistribution when
compared to blood. As the decomposition process progresses, the complexity of the matrix and the
condition of the sample can present a challenge for a toxicologist. This chapter focuses of the complexity
of the liver matrix then later expansion to larva, pupa, empty puparium, and adult flies presented in
chapters 4 and 5. Liver was selected as the matrix for comparison testing of liquid-liquid extraction (LLE),
solid phase extraction (SPE), and a quick, easy, cheap, effective, rugged, and safe (QuEChERS) extraction
with analysis by LC-MS/MS. The QuEChERS extraction was chosen for validation by the American Academy
of Forensic Science Standard Board (ASB) Standard 036. After validation, the extraction was applied to 12
livers from authentic fentanyl intoxication investigations. The first part of this chapter was published in
the Journal of Analytical Toxicology (4). The analysis of liver tissue was expanded to include a total of 34
fentanyl analogs and metabolites. This expansion was to help the field by providing an extraction
technique coupled with LC-MS/MS analysis for the emerging synthetic opioids. A survey of the target
analytes in 22 authentic samples was also completed. This chapter was published in the Journal of
Analytical Toxicology (5).
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Chapter 4 describes the validation of a QuEChERS extraction of fentanyl and metabolites from
larval and pupal tissue via LC-MS/MS. The analysis was validated under the ASB Standard 036. The overall
design of the study is explained in this chapter including variable such as fortifying the liver tissue,
concentrations, egg placement, collection times, physical characteristic observations, and toxicology
analysis. The experimental design consisted of four treatment groups (0, 10, 100, and 350 µg/kg) of
fortified liver samples as the insect feeding media and insects were collected over seven time periods (2,
3, 4, 5, 6, 10, and 21 days) for three replicates. The statistical analysis of the physical characters of length,
width, and mass are presented in this chapter as well as the correlation plots for the concentration of the
liver tissue to the concentration of the insect tissue for the early stages of larvae and pupae. The later
insect stages of empty puparia and adult flies are presented in chapter 5. Fentanyl and metabolites were
detected in insects collected from the treatment groups and correlations for the insects collected on day
3 to liver concentrations were generated. Metabolism of fentanyl by the insect were observed with
norfentanyl observed in the early feeding larva and β-hydroxyfentanyl observed in the later stages.
Validation data from this chapter has been submitted to the Journal of Forensic Sciences.
Chapter 5 describes the ASB Standard 036 validation of a QuEChERS extraction of fentanyl and
metabolites from empty puparium and adult tissue via LC-MS/MS. This chapter explores the later insect
stages of the design presented in chapter 4. With the matrix of empty puparium being highly keratinized,
multiple extraction techniques were evaluated to establish the best extraction for the analysis of the
empty puparium. The statistical analysis of the physical characters of wing vein length, tibia length, and
mass are presented in this chapter as well as the correlation plots for the concentration of the liver tissue
to the concentration of the insect tissue for the later stages of empty puparium and adult flies.
Metabolism of fentanyl by the insect was observed in the later stages with β-hydroxyfentanyl observed in
the empty puparia but not observed in the adult flies. Norfentanyl was detected in both the empty puparia
and the adult flies.
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Overall, this study provided a methodology for detecting fentanyl and metabolites from all stage
of the life cycle of L. sericata. In the feeding larva, a high correlation of insect fentanyl concentrations to
liver concentrations was observed. Evidence of metabolism of fentanyl to β-hydroxyfentanyl and
norfentanyl was observed as well as a trend of β-hydroxyfentanyl being observed in the later stages of
the insect and norfentanyl observed throughout the insect’s life cycle. An overall trend was not observed
but the treatment of fentanyl in the liver had an impact on the growth of the insects that needs to be
considered by entomologists when estimating PMI on individuals with fentanyl present. Major
conclusions include the ability to extract and quantitate fentanyl and metabolites from all the insect life
stages (larva, pupa, empty puparia, and adult flies), an observable correlation in the feeding larva fentanyl
concentrations to liver concentrations, evidence of metabolism of fentanyl by L. sericata with persistence
in all the insect life stages, and an impact of the presence of fentanyl in the feeding media even without
a discernable trend.

1.2. Project Design and Objectives
1.2.1. Overall Project Goals
The overall aim of this study was to develop a comprehensive strategy to facilitate the extraction of
novel synthetic opioids (NSO) including fentanyl and its major metabolites from highly complex biological
specimens and to evaluate the effects fentanyl has on the growth and development of L. sericata. The
isolation of fentanyl, metabolites, and analogs from liver tissue using modified QuEChERS is presented as
a cheaper, cleaner, more efficient, and faster way to allow their detection via liquid chromatography
tandem mass spectrometry (LC-MS-MS). Additionally, this novel procedure demonstrated supplementary
capabilities to evaluate the effects of fentanyl on insect stages and provide assistance to interpretation
on PMI when drugs are present in a cadaver. The informative power obtained throughout this research
will have an impact in law enforcement investigations specially in those cases involving fentanyl where
highly decomposed human remains are present by providing a technique to use insects as a toxicology
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matrix, a potential for a correlation of the quantitative concentration in the insects, and a word of caution
for estimation of the postmortem interval when fentanyl is present in the corpse.
The specific aims of this project were to: 1) extract and quantify fentanyl and metabolites from
complex matrices using QuEChERS to aid in forensic toxicology and medicolegal death investigations, 2)
evaluate any growth effects fentanyl has on the development of the insects and the potential implications
on the impact of PMI estimations, 3) draw conclusions on the ability to correlate the concentration of
fentanyl and metabolites from the insect tissue to the initial concentration of the feeding media.
1.2.2. Objectives and Tasks
Objective 1: Development and validation of a QuEChERS extraction and LC-MS/MS quantitation method
for fentanyl and metabolites from human liver tissue, larvae, pupae, empty puparium, and adult insects.
Task 1.a: Optimization of LC-MS/MS parameters for selected analytes (fentanyl, norfentanyl, 4-ANPP,
and β-hydroxyfentanyl) including optimization of precursor ions, product ions, fragmentor power and
collision energy. An Agilent 1290 Infinity II LC system coupled with an Agilent 6470 tandem mass
spectrometer was used in this study.
Task 1.b: QuEChERS extraction and LC-MS/MS analysis method validation following ASB standard
guidelines for accuracy, precision, and reproducibility. Recoveries and matrix effects for each media were
evaluated to ensure the extraction of the target compounds is effective.
Task 1.c: Comparison of extraction efficiencies for tissue analysis between liquid-liquid extraction
(LLE), solid phase extraction (SPE), and QuEChERS. The extraction methods were evaluated at two
concentrations (high and low) with a minimum of 5 replicates at each concentration for each method (30
spiked-liver samples and 15 control liver samples).
Task 1.d: Fortified tissue treatment regime. For the fortified tissue, a control (no drugs added) and
three treatments were chosen to be performed in triplicate. The treatments consisted of a low
concentration (10 μg/kg), a medium (100 μg/kg) and a high (350 μg/kg) based on casework review.
Treatments were chosen to simulate the various types of potential death and resulting decomposition of
6

a person from non-fentanyl related death, mixed drug fentanyl related death and fentanyl related death.
A mass of 70-90 eggs were added to each treatment. On the day that eggs are added to the treatment,
approximately 2 g of tissue was taken for LC-MS/MS analysis and recorded as Day 0.
Task 1.e: Sampling insect tissue for the quantitation of fentanyl and metabolites. Sampling was
performed at four times: at 96 hours (feeding larvae), 144 hours (wandering larvae), 192 hours (pupae),
and emergence into adult for four treatments (each at 0, 10, 100, 350 μg/kg). Figure 2.9 displays the
design flow. In each treatment 70-90 eggs of Lucilia sericata were placed and the treatments were
replicated in triplicate. For each day that insects were sampled, 2 g of tissue from the feeding media was
taken for analysis. A modified QuEChERS extraction was used for feeding liver and insect tissue. Insect
tissues were extracted as single samples (5 individual insects) and as pooled specimens (5 sets, each of 4
pooled insects), each in triplicate. The same samples were used for tasks 2a, 2b and 3a.
Task 1.f: Extraction of fentanyl and metabolites from casework liver tissue from authentic fentanyl
related overdose victims. Samples were provided as part of our collaboration with the Office of the Chief
Medical Examiner (OCME), to serve as our validation set.

Objective 2: Determination of any significant effects of fentanyl on athe growth and development of the
insects.
Task 2.a: Evaluation of the effects of rearing the insects on fentanyl infused liver tissue.
For the development effects, each of seven factors had a treatment of fentanyl concentration in the
liver tissue the insects were reared on consisting of one of the four levels: 0, 10, 100, 350 μg/kg with 0
μg/kg as the control group. Seven sampling times (factors) at 48 hours, 72 hours, 96 hours, 120 hours, 144
hours, pupa (192 hours), and emergence were evaluated (figure 2.9). In each treatment 70-90 eggs of
Lucilia sericata were placed and the treatments were replicated in triplicate.
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Figure 2.1: Design workflow.

Task 2.b:

Recording of physical characteristics of insects: For all the insect stages, physical

characteristics were recorded to evaluate the effects each treatment had on growth. To determine the
effects of fentanyl on the growth and development of the blow flies, the mass, and percent stage (first
instar, second instar, third instar, pupa, or adult) of the insect were collected including: the feeding instar
(48 hours, 72 hours, and 96 hours), wandering third instar (120 hours and 144 hours), and pupae (240
hours). The percent stage of the insects was monitored at seven timings to evaluate the effects of fentanyl
of the growth rate of the insects. Measurements for mass were recorded for the larval and pupa, empty
puparium, and adult fly specimens. For each treatment and time sampling, the entire group of insects
were culled and collected.
Task 2.c: Statistical analysis for evaluation of growth and development effects of fentanyl on the
insects. A nested ANOVA test was utilized to determine if the control and treatment groups differ. Further
Tukey-HSD tests determined which treatments were significantly different and due to sample size
differences, restricted maximum likelihood (REML) was applied. Also, a mixed effect model to incorporate
the length, width, and mass as a complete model was applied (equation below). These statistical tests
determined if the drug treatments have any significant effects on the insect’s development.
̃=𝝁
𝒀
̃ + 𝛿𝑗 + 𝜏𝑖 + (𝛿𝜏)𝑗:𝑖

1
+ (0
0

𝛿𝑗:𝐿
(𝛿𝜏)𝑗:𝑖:𝐿
𝜏𝑖:𝐿
0 0
1 0 0
1 0 0
̃𝝆 + 𝚬
̃𝒖
1 0) ( 𝜏𝑖:𝑀 ) + (0 1 0) ( 𝛿𝑗:𝑀 ) + (0 1 0) ( (𝛿𝜏)𝑗:𝑖:𝑀 ) + 𝚬
0 1 𝜏𝑖:𝑊
0 0 1 𝛿𝑗:𝑊
0 0 1 (𝛿𝜏)𝑗:𝑖:𝑊
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Figure 2.2: Nested ANOVA design for a single replicate (n=3).

Task 2.d: Comparison of a subset of insects reared on authentic overdose liver specimens. For
replicate #3, a liver specimen with an authentic fentanyl concentration (non-fortified liver) was
homogenized and added as fifth treatment group. The number of eggs, insects collected, morphometric
observations, and toxicology extractions were the same as the other treatment groups. Concentrations of
the authentic livers were determined before the eggs were placed.

Objective 3: Determination of fentanyl and metabolites concentration correlation found in the insect
tissue to fentanyl concentrations in human tissue the insects reared on.
Task 3.a: Comparisons of concentrations extracted from the insect to the initial infused
concentrations of the liver tissue. Using the concentrations extracted from each insect life stage of the
various treatments (task 2a), a correlation analysis will be conducted to determine if there was consistent
insect to human tissue ratios.
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Chapter 2: Introduction and Literature Review
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2.1 Introduction
This chapter provides a review of the current literature on forensic entomology and forensic
entomotoxicology including the biological factors, life cycle of the investigated insect, estimation of
minimum postmortem interval, insects as toxicology specimen, and the impact drugs can have on the
growth of insects. Background information of the drugs, metabolism, and matrices of interest are
presented here. The fundamentals of toxicology extraction and analysis methods are also presented in
this chapter.

2.2 Forensic Entomology
The term forensic entomology describes the study of insects and other arthropods in the course
of a criminal investigation (6, 7). Once algor mortis (the cooling of the body to ambient temperature after
death) has reached completion, the estimation of the time since death or postmortem interval (PMI) is
attributed to the field of forensic entomology (7, 8). Specifically, medicolegal entomology is the branch of
forensic entomology that focuses on the estimation of the minimal postmortem interval (minPMI) for
decomposing remains of humans or animals in which a criminal case is pending or if the death is under
suspicious circumstances (7, 9). It should be noted that insect age estimation of minPMI and PMI are not
perfectly interchangeable, as PMI includes the potential for a lag time for insect colonization that

minPMI

using insect age cannot account for.
2.2.1. Biological Factors
Arthropods are the largest biological group and are found in environments all around the globe
(10, 11). Arthropods are poikilothermic, meaning they do not regulate their body temperature and are
regulated by the environmental temperature (12, 13). This reliance on the environment for thermal
regulation creates a predictable growth pattern for arthropods (12, 14). The arthropod of most
significance to forensic investigation are from the orders of Diptera and Coleoptera (10, 15).
Necrophagous insects that are attracted to human decomposition are commonly the focus for
entomological death investigations (10, 14, 15). Necrophagous flies (Diptera) are common insects to first
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arrive and beetles (Coleoptera) often arrive later to feed on fly larva or in the later stages to feed on dried
remains (10, 15).
Blow flies (Diptera: Calliphoridae) and Flesh flies (Diptera: Sarcophagidae) are typical first insect
colonizers for decomposition with blow flies often the initial insects to arrive (16, 17). Initial colonization
is a key component to calculating minPMI and complete PMI. The sooner an insect arrives, the shorter the
lag time between colonization and the time a person dies. Blow flies lay eggs in aggregation and the larva
develop as an aggregation (18, 19). Feeding as an aggregation facilitates exodigestion, food intake, and
assists with thermal regulation (18–20). The holometabolous life stages of blow flies begin with
oviposition of an egg and progress to first instar, second instar, feeding third instar, wandering or
migrating third instar, pupation, and finally emergence as adults (Figure 2.1) (2, 21, 22). Through the blow
fly’s life cycle, behavioral and physical changes occur to the insect (23). The life of the blow fly begins with
oviposition of the egg directly on or near the cadaver (17, 23, 24). Once an egg hatches, the larva begins
feeding and progresses through three stages of first, second, and third instar (17, 21). The progression
through the larva instars is distinguished by molting events and an increase in posterior respiratory slits
(Figure 2.2) (21, 23). Once a third instar larvae feeds enough, a behavioral change in the insect occurs as
the larvae stops feeding and begins to leave the feeding substrate to begin pupation. This developmental
stage is called a wandering or migrating third instar larvae (21, 23, 24). Once the larvae stops feeding and
begins to migrate, there is a decrease in length of the insect as it begins the process of pupation (21, 23).
After pupation, the insect will emerge for the pupa casing as an adult fly while leaving behind an empty
puparium.
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Figure 2.3: Life cycle of the Green Bottle Fly Lucilia sericata.

Figure 2.4: Third instar larvae with posterior respiratory slits magnified.
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Figure 2.5: Image of a wandering third instar. Absence of feeding substrate in the crop is a clear indication of a wandering third
instar larvae.

The larva of the blow fly will feed in an aggregation, which helps with digestion and thermal
regulation. The anatomy of the blow fly larva contains a complete alimentary canal starting with a mouth
and mouth hooks with completion to hindgut and anus (25). The mouth of the larvae has no teeth
however it does contain mouth hooks (19, 20, 26). These mouth hooks help the larvae with locomotion,
to pierce soft tissue, and to help the insect burrow deeper into the feeding substrate (18–20). The larva
lack the ability to truly masticate and therefore the need to ingest the feeding media as liquefied substrate
or in semi solid form (18, 19). To aid in the liquification of the tissues, the larva secrete enzymes, typically
proteases or carbohydrases to facilitate the breakdown of the tissues (18, 19, 26, 27). The aggregation of
the larva increases the breakdown of the tissue as more larva secrete enzymes, the faster the tissue
liquefies and the faster the larva can feed (18, 19). As the larvae feeds, the liquefied tissue is sucked in
through the mouth, and passes through the esophagus to the crop (19). After passing the crop, the next
segment is the foregut, midgut, hindgut, ileum, colon, rectum, and finally anus (Figure 2.4) (19). At the
junction of the midgut and hindgut is where the Malpighian tubules diverge (19). Malpighian tubules
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function to remove waste, exogenous materials, and any other ions from the insect (19, 28).

Figure 2.6: Diagram of the alimentary canal of a larval blow fly (25).

Figure 2.7: Diagram of a Malpighian tubule (29).
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2.2.2. Insect Age Estimation
Insects serve an important ecological function as the major driver of mechanical breakdown of
human and animal corpses in the natural world. Assuming that the cadaver is accessible to them, insects
typically arrive shortly after death, colonize the cadaver with their eggs, and persist through the
decomposition process until the cadaver is skeletonized (30, 31). As a result of this natural association,
forensic entomology techniques can be the most accurate method for estimating the
hours after death (32–35). Entomological estimation of

minPMI

minPMI

beyond 72

is rooted in the assumption that insects

arrive shortly after death and that their development is primarily governed by temperature (2). To
calculate this, two general factors are considered: the time it takes for the necrophagous insects to arrive
at the remains and the temperature-dependent rate that is needed for the insects to progress through
their life cycles (8, 21, 32, 33). A series of factors are required to be accounted for when employing
entomological methods of PMI calculation including the process of colonization, the development time of
the insect, decomposition of the corpse, as well as the distribution, biology, ecology, and behavior of the
insects (8, 33). With the knowledge of the species of the insect, the stage of development, the weather
conditions including temperature and humidity, and the growth rate of the insect, a reliable time since
death can be determined (7, 22, 33). Using the relationship of insect development and temperature, the
age of an insect can be calculated based on the physical size or stage of the insect and the thermal history
at which the insect developed (2, 7, 21, 22). Common approaches for

minPMI

estimation are thermal

summation models, curvilinear models, isomorphen, and isomegalen diagrams (2, 22, 31, 32, 36). Each of
these approaches uses either physical characters of length, width, mass, or current developmental stage
of the collected insect to estimate its temporal age, which in turn serves as a proxy for the minPMI (2, 22).
Of these, larval length and developmental stage of the insect are the most utilized technique currently
(37).
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Once a corpse is discovered, estimating a minimum time since death is still one of the most
fundamental questions to be answered and the application of the developmental rates of necrophagous
insects located on the body is crucial for calculating the PMI in these legal cases (7, 21, 22).

2.3. Forensic Entomotoxicology
The term entomotoxicology was first coined in 1994 to describe the combination of entomology,
forensic science, and toxicology in regards to the detection of drugs in insects feeding on tissue with drugs
or toxins present and the effects caused by these xenobiotics on the insects’ life cycles (22, 38–40).
Depending on the research orientation, we can identify 2 major subclasses: (1) the detection of drugs or
toxins in insects after feeding on media with drugs or toxins present and (2) the effects caused by the
ingestion of drugs or toxins on the growth and development of the insects (39, 41, 42).
2.3.1. Impact on minPMI
Even though entomology can be used to estimate the

minPMI

due to the predictable nature of

insect growth, the base assumption of predictable growth in a given environment is violated when insects
are affected by xenobiotic influences if drugs or poisons present in the cadaver they have colonized (43–
45). Since 2004, entomotoxicology research has slowly shifted focus from correlation of larvae to blood
concentrations and towards drug detection in later life stages or the effect drugs have on the insect
growth and development. In general, drugs that are stimulants in humans have been shown to speed up
development times for insects and drugs that are depressants have been shown to slow down the
development time. For instance, recent reports including methamphetamine, cocaine, ketamine,
morphine, and tramadol have shown contrasting effects on insect development (45–49). Stimulant drugs
such as methamphetamine and cocaine, appeared to have an increasing effect on the physical
development rate and body size of the blow flies (46, 48). It was found that the overall developmental
time was shorter in the presence of cocaine, and the general insect growth being larger for both cocaine
(Chrysomya albiceps (Wiedemann) (Diptera: Calliphoridae) and Chrysomya putoria (Wiedmann) (Diptera:
Calliphoridae)) and methamphetamine laced diets (Calliphora stygia (Fabricius) (Diptera: Calliphoridae))
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(46, 48). Among depressant-type drugs, morphine was shown to have no significant effect on size or
development rates of C. stygia (47); however, ketamine and tramadol appeared to increase body size for
the larvae of Lucilia sericata (Meigen) (Diptera: Calliphoridae) (45, 49). Changes in physical characters or
developmental rates of insects due to the presence of xenobiotics can significantly impact

minPMI

estimations, leading to either under- or overestimation of time since death (46). Understanding the effects
that drugs can have on insect growth and development is important in terms of estimating minPMI in cases
that involve toxins or overdose deaths (50).
Previous case studies have shown that insects feeding directly from tissues containing drugs or
illicit substances will incorporate the xenobiotics into the insect’s tissue (22, 39). When feeding on tissue
with drugs present, the effects on insect growth vary by the drug and the concentration (39, 42, 51).
Changes in growth and development of the insect caused by exposure to xenobiotics can create
discrepancies in PMI estimations. The effects of heroin on Boettcherisca peregrina (Robineau-Desvoidy )
(Diptera: Sarcophagidae) created PMI discrepancies of 29 hours with similar results for Lucilia sericata at
24 hour discrepancies (51). Cocaine and methamphetamine appeared to accelerate the rate of
necrophagous fly development while barbiturates were found to lengthen the larval stage and in turn
slow down development into the pupal stage (51). Chrysomya megacephala (Fabricius) (Diptera:
Calliphoridae) larvae reared on tissue containing malthalion developed slower than the control group and
the time required to emerge as adults from pupa was delayed to 10 days compared to 7 days in the control
group (51).
Studies have shown that drugs ingested by the deceased can affect the growth of insects feeding
on the body (39, 52). Some drugs have suggested to speed up growth, like codeine, cocaine, diazepam,
and methamphetamine, while others, tramadol, methadone, methylphenidate, or phenobarbital have
indicated to slow the development of forensically relevant insects. Tramadol was reported as increasing
the size of larvae but increased the total development time (45). The effect of methadone was limited but
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a high concentration (4 µg/g) the rate of development was decreased (44). Methylphenidate and
phenobarbital when present in the media larvae were reared on, increased the total development time
by 24 hours and 12 hours respectively (53). Codeine was reported as decreasing the time of larval
development to pupa by 24 hours and decreased the time for emergence from pupa to adult by 48 hours
(54). Carvalho et al. reported larvae treated with cocaine containing feed stock emerged 60 hours before
the non-treated control group (48). Diazepam was reported to decrease the overall development time of
Chrysomya putoria by over 90 hours (55). Mullany et al. investigated the effects of methamphetamine on
Calliphora stygia and reported a decrease in larval development time of 44 hours and a decrease of pupal
emergence to adult time of 78 hours (46). The significance of this data is a PMI calculation can be
incorrectly determined based on the size or stage of growth of the insect if drugs are present when the
insects are actively feeding (46). From a forensic toxicology perspective, in decomposed corpses suspected
of opioid fatality, insect life stages can provide valuable information currently unexplored. Indeed, no
entomotoxicological studies have been observed for the extraction and quantitation of fentanyl from
insect tissue or the effects of fentanyl on insect growth. As a result, there is a need to assess the value of
entomotoxicology on forensic investigations of opioids like fentanyl and analogs.
2.3.2. Toxicology Specimens
The succession that occurs on a corpse after death is a relatively confined and closely packed
ecosystem that is typically restricted to the remains and proximity. If xenobiotics are present in the body,
they will be ingested by the organisms feeding on the corpse. For postmortem toxicological analysis,
depending on the stage of decomposition and availability, matrices like blood, urine, liver or heart tissue
are often specimens that are analyzed. However, under certain conditions, the stages of decomposition
can progress quickly leaving traditional toxicological matrices unavailable (39, 56). Fly larvae has been
used as a toxicological analysis matrix in these instances (38, 39, 57). In some cases, larvae matrices can
produce less endogenous interferences compared to advanced decomposed tissues (56). Detection of
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drugs in insects can be vital in corroborating traditional toxicology matrices or as the only matrix available
in cases with advanced decomposition, exsanguination, or burn victims (39, 58, 59).
A case where only fly larvae were used to determine drug use was presented by Beyer et al. when
a deceased individual was found with no fluids or organs to test for drugs and only fragments of skin
present (58). The deceased had been last seen 14 days prior to discovery and the remains were badly
decomposed with the head, thorax, and abdomen completely skeletonized (58). The decedent had a
history of suicide attempts, a recent prescription for 100 tablets of phenobarbital, and the bottle was
found empty in her purse (58). Analysis and detection of phenobarbital in the larva collected from the
cadaver was the only toxicology results available for corroborating the physical evidence found on the
deceased (58).
In a case presented by Bugelli et al., benzodiazepines and metabolites were detected in the burnt
cadavers of a maternal filicide-suicide by fire (59). In this case, the detection of drugs in the insects was
used to corroborate the findings of drugs in the fluids and tissues collected (59). When there is a death
with a delayed recovery like suicide or drug overdose, advanced decomposition of the body can occur to
the point where insect tissue is the only matrix available or can corroborate the findings of any more
traditional matrix available (39).

2.4. Insects of Interest
Lucilia sericata was chosen as the target species for this study because it is common to many
regions of the US (including West Virginia) and the rest of the world. L. sericata is considered as a Holarctic
species but has been documented as an invasive species in many parts of the southern hemisphere
including Colombia and Australia (8, 60). Due to it being a widely distributed blow fly species, Lucilia
sericata has also been the most used species in entomotoxicological research with at least 13 papers being
published since 1980 (61). The species is a first wave colonizer and reproduces quickly making it a prime
choice for in colony decomposition research (21). As one of the first organisms to reach a body after death,
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L. sericata is often collected by entomologist and used in PMI estimations (61). The blow fly L. sericata can
be found over a broad range of landscapes and is considered one of the most common blow fly species
making it a candidate for many biological and development studies (21). Multiple studies on the
development of L. sericata have been performed monitoring growth from egg to adult at different
temperatures, evaluation of feeding diets, size distributions, developmental plasticity, and testing of PMI
estimation models (8, 17, 21, 23, 24, 60). Of the necrophagous insects studied for entomotoxicology
purposes, L. sericata is the most prevalent (61). A desired model species should be associated with
forensic casework with a direct relationship with decomposing corpses, be geographically widespread and
common or abundant, and their husbandry should be easy enough to facilitate research (61). The blow fly
Lucilia sericata fulfills this criteria and was chosen as the target species (61).

2.5. Establishment of Colony
Adult colonies of L. sericata were established in May 2018 from field collected specimens from
Morgantown, West Virginia. The collected insects were allowed to grow to adulthood and adults were
identified as L. sericata by physical morphological characters (62). The adult colony at the time of the
study was at generation 30 without the addition of new flies to reduce genetic variation within the colony
(21). The colony was housed in BugDorm1 (MegaView Co., Ltd., Taiwan) screen cages (30 cm x 30 cm x 30
cm) stored in a Percival I36LLVLC8 incubator (Percival Scientific, Inc., Perry, Iowa, USA) at 25 °C (± 0.5 °C)
at 65% relative humidity (± 10%) with a 12:12 (L:D) photoperiod. Adults were given honey and water ad
libitum and raw beef liver was provided for oviposition. New generations were separated from adults after
oviposition to signal the beginning of the next generation and were moved to a new screen cage during
emergence.
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2.6. Postmortem Toxicology
When a death is sudden or unexpected, investigation into causes or contributing factors
generates the need for toxicology testing (63). Interpretation of analytical postmortem toxicology results
can be a challenge with often two or more matrices being utilized with preference to peripheral blood
and another specimen to corroborate the findings (63, 64). Challenges include autolysis, putrefaction,
drug degradation, and postmortem redistribution (63, 65). Postmortem redistribution (PMR) is described
as the passive diffusion of drugs in higher concentrations moving to areas of lower concentration after
death (63–66). With lipophilic drugs, the gradient is usually moving from higher concentrations in tissues
to the lower concentrations in blood, thereby artificially increasing the blood drug concentration (63, 64).
A tissue specimen, usually liver, is selected for quantitation in combination to blood specimens to
corroborate and adjust for PMR in postmortem testing (63, 64). In cases with advanced decomposition or
with drugs with higher tendencies for PMR, tissue concentrations can be more reliable for interpretation
compared to cavity or decomposed blood specimens (64). Putrefaction and autolysis during
decomposition can create challenges for a toxicologist as the sample extraction and clean-up can be
affected (63). The need for further sample clean up or different extraction techniques may need to be
employed to counteract the effects of decomposed specimens (1, 63, 67).

2.7. Extraction Techniques
Toxicology analysis consists of two main components, the ability to liberate or extract a drug or
toxin from a matrix and the instrumental analysis of the extracted drugs. Though these components can
be optimized independently, toxicology analysis cannot be successful if one of the components is not
effective. Depending on the desired concentration range and the complexity of the sample matrix,
extensive sample preparation or extraction can be necessary. The effects of the matrix can cause
ionization suppression or enhancement, especially for LC-MS/MS analysis. When trying to quantitate low
concentrations, the reduction of interfering endogenous components of the matrix can be crucial.
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2.7.1. Liquid-Liquid Extraction
A traditional extraction technique is liquid-liquid extraction (LLE). This technique involves an
aqueous phase and an organic solvent phase with a partitioning of the desired compounds to one phase
or the other (68). To partition a drug into the organic or aqueous phase, the pH of the extraction is
manipulated to allow for the drug to partition. A style of LLE that uses a miscible solvent is often referred
to as dilute and shoot, as the aliquot of the specimen is diluted by the solvent which merely crashes out
the proteins of the sample leaving a less than optimal sample (67). Samples extracted by dilute and shoot
are often harsher on instrumentation and can lead to more drastic matrix effects, especially in LC-MS/MS
analysis (67). The more widely used version of LLE involves an aqueous sample and an immiscible solvent.
For extraction of drugs of abuse, the pKa of the target analyte and chemistry are necessary as that will
determine how the pH needs to be manipulated to partition the drugs into the organic or aqueous layers.
Typically, the pH is manipulated to drive the drug into the organic layer of the extraction with a pH
manipulation of lower for acidic drugs and higher for basic drugs. Once the drug partitions to the organic
layer, the layer is removed, dried, and reconstituted in a phase suitable for instrumental analysis (69, 70).
LLE is considered a cheaper extraction process but has disadvantages of harsh organic solvents, a higher
volume of organic solvent use, and is generates a generally less clean sample. LLE is often used for blood,
urine, and other liquid matrices but has been applied to more complicated matrices such as bile, stomach
contents, liver, kidney, and brain tissues (69, 70).
2.7.2. Solid-Phase Extraction
An often-used extraction technique that provides a more robust sample clean-up is solid-phase
extraction (SPE) (71). SPE can be used in analytical procedures for sample clean-up, compound extraction,
class fractionization, or for preconcentration for trace analytes (71, 72). Compared to traditional LLE
procedures, SPE generally uses less organic solvent and removes more co-eluting matrix components (71).
In simple terms, SPE consists of a solid phase or sorbent, typically in a cartridge, that has a form of affinity
for the target analytes (71, 72). Common sorbents include reverse-phase, normal-phase, ion-exchange,
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mixed-mode (ion exchange and reverse-phase), adsorption, size exclusion, magnetic, and
immunosorbents (71). SPE procedure fundamentals consist of a preconditioning step, loading of a sample
on the solid phase sorbent housed in the cartridge that has an affinity for the target analytes, a wash step
to rinse the sample of any unwanted matrix components, and an elution of the target analyses from the
sorbent with a solvent selected to overcome the affinity of the target analytes to the sorbent (71). This
technique helps remove salts and other components of the matrix, however, components with similar
properties as the target analytes will still be coeluted. SPE has been applied to extraction for a wide range
of drugs in biological fluid and tissues including blood, urine, oral fluid, bovine milk, and liver tissue (73–
78).
There are advantages and disadvantages for LLE and SPE in comparison to each other between
cost, resource consumption, sample clean-up, and overall extraction ability. LLE is considered a cheaper
choice as there is no need for the single use SPE cartridge and does allow for direct extraction of a semisolid matrix however, the use of increased harsh organic solvents and potential for matrix effects by
coelution are strong disadvantages. SPE techniques reduce the use of organic solvents while providing a
more effective reduction in coeluting matrix components but does increase the cost of sample processing
and cannot directly extract from a semi-solid specimen such as tissue homogenate without further sample
preparation.
2.7.3. QuEChERS Extraction
For pesticide analysis, a quick, easy, cheap, effective, rugged, and safe (QuEChERS) extraction for
pesticide analysis in produce samples was presented by Anastassiades et al. (79). Since the application
was in agriculture, larger sample sizes of 10 g were used. A homogenized produce sample was extracted
with acetonitrile and a mixture of salts, magnesium sulfate (MgSO4) and NaCl (79). No pH adjustment was
performed. Acetonitrile (ACN) and water are miscible and the two are not typically chosen for LLE
extraction except for dilute and shoot techniques, however, with the addition of salts distinct partitioning
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phases are created much like nonpolar solvents with water (79). The salts will dissolve into any aqueous
layer but will not partition into the organic layer, creating distinct layers. Acetonitrile is considered to have
a low chronic toxicity compared to nonpolar organic solvents (79). An aliquot of the organic layer was
then transferred to a dispersive SPE vial containing primary secondary amine (PSA) sorbent and anhydrous
MgSO4 for further sample clean-up (79). The dispersive-SPE acts as a chemical filter to remove coeluted
matrix components such as fatty acids, lipids and pigments without the extensive process of traditional
SPE (79). QuEChERS can be considered a two-part process with the first part being a LLE with salting out
and a second part a SPE clean-up but all within a simplified workflow. Modifications to the protocol,
including a reduction of sample and extraction volumes, have been adapted to allow for QuEChERS
extractions to be applied to forensic casework (1). QuEChERS extraction protocols have been to forensic
biological matrices including blood, urine, and liver tissue (1, 4, 80–82). QuEChERS combines the best parts
of traditional LLE and the advantages of traditional SPE without sacrificing selectivity or robustness (80,
83).

2.8. Drug Overdose Deaths
Deaths caused by the abuse or poisoning from drugs continues to be a burden on the United
States health system with 70,630 drug overdose deaths in 2019 alone (84). The age-adjusted rate for drug
overdose deaths in the US is 21.6 per 100,000 which is elevated compared to 20.7 in 2018 (84). A class of
drugs that continues to increase in overdose deaths is the opioid class drugs.
The opioids crisis in the United States has a serious impact on our society. According to the
National Vital Statistics System (NVSS) in 2019, more than one hundred people died every day of opioid
overdose (84, 85). Of the 70,630 drug overdose deaths in 2019, 49,860 involved opioids (70%) (84, 85).
Even more concerning is the increase of overdose deaths involving synthetic opioids (e.g. fentanyl,
fentanyl analogs, and tramadol), with an increase from 3105 in 2013 to 36,359 in 2019, almost 12 times
higher (84, 85). Overdose deaths involving synthetic opioids accounted for over half (51%) of the total
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drug overdose deaths in 2019 (84, 85). The prevalence of synthetic opioid overdose deaths creates a need
for postmortem toxicological analysis and depending on the stage of decomposition and availability,
matrices like blood, urine, liver, or heart tissue are often specimens that are analyzed (63).

2.9. Fentanyl
Even though the US is experiencing an opioid epidemic currently, opium derivatives have been
used for thousands of years (86). Compounds with an affinity for one of the 7-transmembrane G proteincoupled opioid receptors are classified as opioids (87). Opioid receptors can be further separated into four
subgroups: mu (µ), kappa (κ), delta (δ), and nociceptin (88–90). Naturally occurring compounds that are
found in the opium poppy including morphine, codeine, and thebaine are a subset of opioids referred to
as opiates (87). Endogenous peptides, endorphins and enkephalins, also bind to these receptors (87). The
discovery of meperidine in 1939, led to more research into deriving drugs from this compound (87). This
led to the discovery of fentanyl by Dr. Paul Janssen in the late 1950s (86, 87). The improved analgesic and
anesthetic effects of fentanyl over opium derived opioids led to further research into the drug class (86).
Research was compiled in an attempt to create the most potent narcotic analgesic possible and the
structure to activity relationship of narcotic analgesics generated scientific interest in the area (86, 87).
The compounds discovered, including fentanyl, have strong central nervous system (CNS) action, high
potency and rapid brain entry that produces a rapid onset of action (86, 87). These same
pharmacodynamic and pharmacokinetic properties that are targeted for effectiveness as therapeutic
drugs also make them targets for abuse. Fentanyl is a highly effective µ-opioid agonist with a potency of
50-100 times that of morphine that is used clinically as a schedule II drug and, like other opioids, has
considerable addictive potential (91, 92). Fentanyl has a pKa of 8.43, a high volume of distribution (Vd) at
3-8 L/kg and is 84% protein bound at pH 7.4 (93–95).
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Table 2.1: Fentanyl and metabolites

#

Compound

Structure

Molecular Weight

Fentanyl
1

C22H28N2O

336.2

Norfentanyl
2

232.2
C14H20N2O

4-ANPP
3

280.2
C19H24N2

β-Hydroxyfentanyl
4

352.5
C22H28N2O2
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This research from the mid twentieth century lead the ground work for illicit manufacturing of
fentanyl and analogs in the early 2010s. Illicitly manufactured fentanyl (IMF) and analogs have been
abused individually and combined with other drugs like heroin often in counterfeit pill formulations (96–
99). The structural scaffold of fentanyl can be modified in numerous ways to generate various versions of
novel fentanyl analogs and this is exploited to produce IMF and analogs (Figure 2.6) (91, 92, 98).
Modifications are made to the core fentanyl scaffold in an attempt to avoid legislation or to modify
potency (100, 101). The four main regions include the amide region, the aniline ring, piperidine ring, and
the N-alkyl chain (Figure 2.6). Table 2.1 displays fentanyl and three common metabolites.

Figure 2.8: Fentanyl scaffold.
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2.10. Metabolism
The extensive metabolism of fentanyl in humans has been well documented with most
elimination driven by first pass hepatic metabolism (102). Primary metabolites generated by human
metabolism of fentanyl are norfentanyl and despropionyl fentanyl (4-ANPP) with norfentanyl being the
most abundant (102). Cytochrome P450, specifically CYP3A4, is highlighted as the primary actor in the
first pass metabolism for fentanyl in human metabolic pathways (91, 92, 102). Fentanyl is metabolized in
the liver to norfentanyl by CYP3A4 through oxidative N-dealkylation at the piperidine ring (Figure 2.7) (91,
102). β-hydroxyfentanyl is formed by hydroxylation on the N-alkyl chain (Figure 2.7). Fentanyl is
metabolized to 4-ANPP by carboxamide hydrolysis of the amide group (Figure 2.7). In human metabolism,
less than 10% of fentanyl is excreted as the parent drug and the rest are excreted as metabolites (91).

Figure 2.9: Metabolism pathway for major and minor metabolites of fentanyl in humans.
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The excretory system of an insect consists of Malpighian tubules (MT) and the hindgut (Figure 2.5)
(29). The Malpighian tubules are responsible for the transport of xenobiotics from within the insect’s
coelom to the hindgut for excretion (29). In general, water soluble molecules are filtered out of the
hemolymph by the MT and hydrophobic molecules would need to be bio transformed (44). The chemistry
of P450 enzyme has been exploited to produce bioactivated insecticides where metabolism via the P450
enzyme creates a more toxic compound once metabolized in the insect but these insects were not
necrophagous (29).
Metabolism mechanisms of drugs in blow fly species have not been thoroughly investigated and
broad metabolic assumptions are limited. For Calliphora stygia, Parry et al. reported when maintained on
meat containing morphine, the insects only contained morphine with no substantial metabolites detected
(28). Excretion reported as clearance rate of morphine was reported indicating even without significant
metabolism for the drug in the insect, elimination of the drug was still possible (28). Norcodeine and
morphine were detected in L. sericata raised on a diet of pig liver fortified with codeine (103). This could
be evidence of insect metabolism but toxicology analysis of the liver tissue detected norcodeine and
morphine so metabolism of the liver enzymes could not be ruled out as the source of the metabolites
(103). Gosselin et al. reared L. sericata on a diet of beef hearts fortified with methadone and were able to
detect EDDP in some of the high treatment specimens (44). The authors presented this data as evidence
that the insects biotransformed the methadone to EDDP to better excrete the drugs and the observation
of methadone and EDDP in only the high treatment specimens is further indication of the insects ability
to excrete the more hydrophobic metabolite (44).

2.11. Validation
Toxicology method validation guidelines from the Scientific Working Group for Forensic
Toxicology (SWGTOX) were replaced by the American Academy of Forensic Sciences (AAFS) Academy
Standards Board (ASB) 036 requirements (104, 105). Method validations were performed using this
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standard for the model and the evaluated parameters included calibration model, interference studies,
ionization suppression/enhancement, dilution integrity, processed sample stability, bias, precision, limits
of quantitation and detection (Figure 2.8).
2.11.1. Calibration model
For each validation presented in the subsequent chapters, calibration curves were evaluated using
at a minimum of six non-zero concentrations with a minimum of five replicates. This calibration curves
represented the analytical measurement range (AMR) for each target analyte. Calibration curves were
analyzed weighted (1/x) in MassHunter. These curves were performed in matrix matched extractions and
were performed simultaneously with the bias and precision extractions. Residual plots were examined for
constant variance. It is crucial to show that the calibration curve is linear throughout the curve for accurate
calculation of concentration. All of the ASB standard 036 procedures were followed unless stated
otherwise.
2.11.2. Interference studies
To evaluate interferences, the impact of any inference of the target analytes to the internal
standards, any interference of the internal standard to the target analytes, any interference of the matrix
to the target or internal standards, and any interference from commonly encountered analytes were
considered.
To evaluate interferences a high concentration (highest calibrator) of the target analytes was
injected with no IS to show any interference of the drug standards to the IS. Conversely, an aliquot of IS
with no target analytes was injected to observe any interference caused by the IS. Matrix interferences
were evaluated by extracting blank matrix sources (n=10) for the matrix of interest with no IS added. To
evaluate potential interferences from commonly encountered compounds, a mix of common drugs
encountered in toxicology was injected.
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2.11.3. Ionization suppression/enhancement
Ionization suppression or enhancement was evaluated at two concentrations, low and high, for
ten replicates at both concentrations. To be deemed acceptable, the percent ionization suppression or
enhancement shall not exceed ±25% with a percent relative standard deviation (%CV) not exceeding 20%
(104). A post-extraction addition approach was utilized by comparing neat standards (Set 1) to blank
matrix samples fortified with neat standard after extraction (Set 2). Set 1 consisted of neat standards
prepared at low (2 times the LLOQ) and high (50% of the highest calibrator) and were injected ten times
to establish the mean peak area for each target analyte. Set 2 consisted of ten individual blank matrix
sources in duplicate, for low (n=10) and high (n=10) concentration, extracted and spiked with the low and
high concentration, respectively, after extraction. The average area of each set (𝑋) was used to calculate
the suppression or enhancement effects at each concentration for each analyte is as follows:

𝐼𝑜𝑛𝑖𝑧𝑎𝑡𝑖𝑜𝑛 𝑠𝑢𝑝𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 𝑜𝑟 𝑒𝑛ℎ𝑎𝑛𝑐𝑒𝑚𝑒𝑛𝑡 (%) = (

𝑋 𝐴𝑟𝑒𝑎 𝑜𝑓 𝑠𝑒𝑡 2
𝑋 𝐴𝑟𝑒𝑎 𝑜𝑓 𝑠𝑒𝑡 1

− 1) ∗ 100

2.11.4. Bias and Precision
For bias and precision calculations, blank tissue samples were fortified and analyzed at low,
medium, and high concentrations for the target analytes in triplicate over five days (n=15). Bias was
calculated as a percent deviation of the extracted mean concentration from the theoretical concentration
with an acceptable bias not exceeding ±20%. Precision was evaluated by percent standard deviation (%CV)
of the mean at each concentration with the criteria of not exceeding 20%.
2.11.5. Limits
For the evaluation of the limit of detection (LOD) and the lower limit of quantitation (LLOQ), blank
matrix sources for each tissue were spiked with concentrations at the lowest non-zero calibrator.
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Triplicates of each blank matrix sources were spiked at the lowest non-zero calibrator and analyzed over
three days (n=9). The acceptable parameters were bias (±20%) and precision (%CV ≤ 20%). For LOD,
chromatographic acceptance was evaluated and deemed acceptable when signal to noise (s/n) ratios
were above 3.3 and qualifier ratios did not exceed ±20%.
2.11.6. Carryover and Dilution Integrity
Blank matrix samples were injected directly after injections of samples three times greater than
the highest calibrator in triplicate analysis to evaluate carryover. Carryover was not considered significant
if present below 10% of the lowest calibrator (LLOQ). For dilution integrity, blank matrix samples from
both sources were spiked at concentrations three times the highest calibrator in triplicate and extracted
simultaneously with blank matrix only spiked with internal standard in triplicate. The resulting extract was
diluted 1:5 (S:T) with the extracted blank matrix with internal standard (5, 106). The process was repeated
over a period of five runs (n=15) and the dilution integrity was deemed acceptable if bias did not exceed
±20% and the precision (%CV) did not exceed 20%.
2.11.7. Processed Sample Stability
To determine the stability of processed samples for each tissue type in the autosampler (25 °C),
blank matrix samples were fortified at low and high concentrations and extracted. Post extraction
reconstituted samples, for low and high respectively, were pooled and aliquoted to LC-MS/MS vials.
Triplicate analysis at time frames: 0, 12, 24, 36, 48, 60, and 72 hr were performed for each concentration.
Average peak area was calculated for each triplicate and compared to time zero. An acceptable bias
threshold was set at ±20%.
2.11.8. Recovery and Process Efficiency
To calculate recovery of the extraction (RE) and process efficiency (PE) two formulas were utilized.
Variables in the formulas represent the mean peak areas for the neat solution (A), the mean peak areas
for the standards spiked after extraction (B), and the mean peak areas for the standards spiked before
extraction (C) (107). Recovery and process efficiency were at low and high concentrations for ten
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replicates (n=10) for each matrix type. Ideally, a perfect recovery or process efficiency would be 100% and
±20% of this value is desired while not exceeding a %CV of 20%. The ASB Standard 036 does not have a
requirement for recovery or process efficiency and the ±20% while not exceeding a %CV of 20% is a selfimposed guideline.

𝑅𝐸(%) =

𝐶
∗ 100
𝐵

𝑃𝐸(%) =

𝐶
∗ 100
𝐴
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Figure 2.10: Overall design for validations following the ASB Standard 036.

2.12. Critiques and Current Challenges
In previous studies, toxicology correlations from insect concentrations to blood or liver
concentrations has been limited due to large standard deviations in measurements. Tracqui et al. found
large inter-larvae variations for meprobamate and nordiazepam as well as variations in inter-site pooled
larvae samples from 5 body locations for nordiazepam and cyamemazine (108). The anatomic sites
monitored were upper digestive tract, perioral area, trunk, upper limbs and lower limbs with
concentrations ranging from 24 ng/g (ppb) to 837 ng/g (ppb) (108). While these numbers are concerning,
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no indication was given for what stage the maggots sampled were in (first, second, third, or wandering)
or if the maggots sampled were from a single species or multiple species. Variations in life stages,
especially if oviposition occurred at a separate time, or if multiple species were sampled can contribute
to deviations in measured concentrations. A feeding third instar has the potential for drug infused tissue
to be present in the crop of the maggot that has yet to be incorporated in the insect tissue whereas a
wandering third instar are identified as having an empty crop and drug concentrations detected would be
from the insect tissue (46). This is important due to drug concentrations in the undigested food material
in the crop can create variations in the amount of drug extracted from the insects if feeding third instars
and wandering third instars were compared (46). Mullany et al. controlled for this variable by having the
feeding insects starved for 4 hours before culling (46). Tracqui et al. provided no indication of stage or
species that could be attributed to the measured deviations. No reference tissue concentrations were
measured at the 5 different locations that the larvae were pooled from. Williams and Pounder identified
that there is a site to site variability of drug concentrations in skeletal muscle (109). Without a reference
tissue sample from the sites of collection, it is unknown if the deviations in concentration are to be
attributed to the nature of the insect activity or normal site to site variation of skeletal muscle. Tracqui et
al. made a bold statement that the drugs detected in maggots can also be detected in the tissue as well,
however that is based on the assumption that tissue will be available for analysis (108). In warm arid
conditions it is possible for a corpse to desiccate leaving no soft tissue for analysis even if it is a rare
occurrence. Tracqui et al. also focused on the larvae and did not address the toxicological value of later
insect stages including pupa, adults and empty puparium that can persist longer than both tissue and
maggots.
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2.13. Critical Need
It is well documented that drugs and toxins in the media insects feed on affects their growth and
development, however the effects vary by the class of drug or toxicant, and the concentration (39, 42,
51). Wallace highlighted differences in rates of elimination, bioaccumulation, and pharmacokinetic
characteristics vary between arthropods and between drug classes; pointing to the need for more
entomotoxicological experiments to investigate these parameters (39, 110). Differences in drug
concentrations observed for feeding larvae and post feeding or wandering larvae as well as the later
stages of development (111). This suggest that there are differences in metabolism, bioaccumulation, and
elimination of the drug as it progresses through its life stages, not only variations caused by differences in
drug classes (111). Alterations in insect development caused by toxicants in the feeding material, also
alter the calculation of the postmortem interval (39, 110). The opioid epidemic has caused a sharp
increase in opioid deaths in the United States and observing the effects that opioids can have on insect
growth can provide useful information in calculating PMI in opioid related deaths. A review by Da Silva
identified 122 toxicants investigated by 63 entomotoxicology publications with none monitoring fentanyl
or its metabolites (61). As of this study, there have been no published entomotoxicology journal articles
with fentanyl or its metabolites as the drug of interest. With fentanyl abuse increasing along with
overdose rates, there is a critical need for evaluating the effects of fentanyl on the growth and
development of forensically relevant blow flies.
Recent studies have demonstrated the possibility of correlating concentrations of drugs extracted
from insects compared to concentrations of the feeding substrate, however interpretation of results has
remained a controversial issue (39, 111). Estimation to the cause of death or relationships of blood or liver
tissue concentrations to drug concentrations recovered from insects feeding on a corpse remain
unachieved and are subject to debate (39, 111). Identifying this quantitative relationship is difficult due
to complicated influencing factors (111). Variations in insect concentrations are affected by drug tropism
in the body, postmortem redistribution, and the extraction and detection efficiencies of the analytical
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techniques (39, 61). Sallawad et al. highlighted this need and lack of valuable research into the factors
limiting the assessment of correlating insect drug concentrations to tissue drug concentrations with the
conclusion that further research into entomotoxicology is necessary (42). The first step in achieving
correlation between blood/tissue and insect concentrations is to control or reduce the influencing factors
by identifying correlations from insect drug concentrations to single tissue type source drug
concentrations. To address this critical need, this study will evaluate liver tissue fortified with fentanyl as
the feeding media for the insects in this study. Concentrations were compared to determine any potential
correlation.
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Chapter 3: Development and Application of QuEChERS Extraction Method for the
Quantitation of Fentanyl and Metabolites from Liver Tissue
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3.1. Section 1: Method Development and Application
Reproduced in part with permission from Cox, J., Train, A., Field, A., Ott, C., DelTondo, J., Kraner,
J., et al, Journal of Analytical Toxicology, https://doi.org/10.1093/jat/bkaa006.
3.1.1. Introduction
In a forensic postmortem toxicological workflow, often various specimens are submitted for
testing including: urine, blood, liver, kidney, and other tissues (1). For medico-legal death investigations,
the interpretation of toxicological findings is a key component to establish the cause of death of an
individual (64). Due to its relevance and legal implications, the accurate measurement of drug
concentrations found in a forensic tissue sample is of utmost importance for forensic toxicologists (63).
Therefore, significant efforts are devoted to the development of analytical routes to efficiently extract
and isolate the target analytes, while simplifying the overall analytical scheme. When working with
biological specimens, the analyst is prone to deal with tissues that are in various stages of decomposition.
Natural processes like autolysis and putrefaction complicates the tissue sample integrity, this creates a
complex challenge for toxicologists.
To overcome the complexity of the matrix, a toxicologist relies on extraction strategies that help
to mitigate such challenges. Several outcomes are expected when performing a sample pretreatment:
first, the isolation of the analytes of interest from the matrix; second, the removal of proteins, lipids, salts,
and other interferent compounds that could obscure the analytical signal of interest and preconcentration of the drugs (67, 112).
Often, overdoses occur when fentanyl is unknowingly ingested due to a mixture of drugs or
fentanyl being distributed as another drug causing the user to be unaware of the potency of the drug they
are consuming, partly attributed to the introduction of illicitly manufactured fentanyl (IMF) into the heroin
trade (99, 113). Mixtures of illicit drugs such as heroin, cocaine and methamphetamine with IMF increases
the risk of overdose due to the user being exposed to varying potency of the product consumed,
potentially delivering an exponentially greater dose (113). Unintentional consumption of more potent
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IMF containing mixtures can cause severe unintended consequences including overdose and death.
Specifically, between July 2016 and December 2016, 50% of the opioid related overdose deaths in West
Virginia involved fentanyl (113). Analysis of synthetic opioids pose an analytical challenge due to the acute
lethal intoxication concentrations, continuous variations of analogs, and wide variations in chemical
structure (114).
Many sources provide references range information to aid in the interpretation of fentanyl blood
concentrations. However, numerous factors must be given consideration to estimate the likely effects of
a specific fentanyl concentration. The fentanyl blood concentration that results in a fatal overdose can
vary greatly from person to person depending on factors including but not limited to: age, body fat
percentage, fentanyl or opioid tolerance, alcohol consumption, liver health, and other drugs present
including prescribed medications (115, 116). As postmortem redistribution (PMR) occurs, blood drawn
from central cavities often have higher concentrations than blood drawn from peripheral area and is
attributed to the diffusion of drug from organs from surrounding tissues (117, 118). Fentanyl has a high
volume of distribution (Vd) at 3-8 L/kg and compounds with a large Vd are more prone to postmortem
redistribution (93, 94). Olson et al. presented findings of significant PMR for fentanyl when comparing two
blood draws; first close to the time of death (between 2.5 and 6 hr) followed by a second draw (between
7 and 53 hr) with a mean first draw concentration of 4.6 µg/L and a mean second draw of 17.3 µg/L (66).
Olson et al. also reported multiple first draw concentrations of none detected followed by positive
concentrations in the second draw in four cases (66). Based on the PMR tendencies of fentanyl, liver or
other organ tissue are needed to provide a medical examiner the proper data to make an informed
decision on the manner or cause of death when fentanyl is present and may provide a more adequate
indication of antemortem concentrations compared to blood (64).
In the body, fentanyl is metabolized mostly via hepatic cytochrome P450 (CYP450), primarily
CYP3A4, with norfentanyl and despropionyl fentanyl (4-ANPP) being the major and minor metabolites
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respectively (91, 102, 119). CYP3A4 has been reported to have metabolic pathways for multiple drugs in
the opioid and benzodiazepine classes (119). For investigations involving drug toxicity, medical examiners
often evaluate both parent and metabolite concentrations to improve the interpretation of the analytical
results (119, 120). The ratio of parent drug to metabolite can be useful in determining manner of death,
differentiate chronic abuse from acute overdose, misuse versus therapeutic usage or delayed death (119,
120).
Within the drug classes encountered in casework, opioids and specifically synthetic opioids are of
particular interest to current practitioners due to increase and prevalence of fentanyl overdoses. Some of
the sample preparation schemes for liver extraction in use in forensic toxicology labs include simple
procedures like dilute and shoot, protein precipitation, liquid-liquid extraction (LLE) and solid phase
extraction (SPE) (67). SPE methods often utilize some form of sample pretreatment to release the drugs
from the matrix and to allow the samples to pass through the SPE cartridges (75). Crum et al. and Shoff et
al. have presented SPE methods for synthetic opioids in blood and liver tissue (73, 121). Coopman et al.,
Rojkiewicz et al., and McIntyre et al. presented LLE methods for the quantification of synthetic opioids in
blood and tissues including liver in 2016 and 2017 (69, 70, 122).
By its nature, the liver contains many lipids that can contribute to matrix effects and be
problematic for instrumentation (1). In 2003, Anastassiades et al. presented a methodology for a quick,
easy, cheap, effective, rugged, and safe (QuEChERS) extraction for pesticide analysis in produce samples
(79). QuEChERS is ideal for tissue extractions due to its two-part process that allows for a direct extraction
with organic solvent in the first part followed by a dispersive-solid phase extraction step (81). QuEChERS
embraces the advantages of LLE, direct extraction from tissue with an organic solvent and cost
effectiveness, combined with the advantages of SPE, reduction of matrix effects and impurities, without
sacrificing selectivity or robustness (80, 83). Usui et al. demonstrated that a QuEChERS protocol could be
modified to test human liver tissue for benzodiazepines (1). A QuEChERS extraction was utilized to extract
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acetyl fentanyl from urine in a fatal poisoning and presented here is an application for a QuEChERS
extraction for the quantification of fentanyl in liver tissue (82).
The development and validation of a QuEChERS extraction protocol is presented in this study as
an alternative analytical method for efficient extraction and detection of fentanyl and its major
metabolites: norfentanyl and despropionyl fentanyl (4-ANPP).
3.1.2. Methods
3.1.2.1. Chemicals and Materials
Drug standards: fentanyl, norfentanyl, 4-ANPP, fentanyl-D5, and norfenanyl-D5 were obtained
from Cerilliant (Round Rock, Tx) at concentrations of 1 mg/mL or 100 µg/mL in methanol. Optima ® LC-MS
grade methanol, acetonitrile, methyl-tertbutyl ether (MTBE), formic acid, and ammonium formate were
purchased from Fisher Scientific (Fair Lawn, NJ). Analytical grade hydrochloric acid (HCl) was obtained
from Fisher Scientific (Fair Lawn, NJ). Analytical grade sodium hydroxide (NaOH) was purchased from
Sigma-Aldrich (St. Louis, MO). All water was purified using a Direct-Q® 3 UV Water Purification System
(Darmstadt, Germany). Cartridges for SPE analysis were Bond Elut Certify (130 mg; 3 mL) purchased from
Agilent Technologies (Santa Clara, CA). The QuEChERS original extraction salt packets, containing 6 g
magnesium sulfate and 1.5 g sodium chloride, and 2 mL dispersive-SPE tubes, containing 25 mg of primary
secondary amine (PSA), 25 mg end-capped octadecylsilane (C18EC), and 150 mg magnesium sulfate, were
purchased from Agilent Technologies (Santa Clara, CA). A Mixer Mill MM 200 was utilized for
homogenization was obtained from Retsch® (Haan, Germany). Steel zinc plated BB balls (0.177 cal, 4.5
mm) were obtained from Daisy (Rogers, AR).
Pooled liver specimens used in method development and validation were generated from six
packages of beef liver purchased from a local retailer packaged by Rumba Meats (Del Rio, TX). Quantitative
analysis was performed on authentic human liver specimens submitted from suspected fentanyl-related
deaths investigated by the Office of the Chief Medical Examiner Office (OCME) in Charleston, West
Virginia. All samples were stored at -20°C prior to analysis.
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3.1.2.2. LC-MS/MS
The quantification method was performed on an Agilent 6470 Triple Quad LC-MS/MS system
coupled with an Agilent 1290 Infinity II LC system. Chromatographic separation was achieved on a Zorbax
Eclipse Plus C18 RRHD 3.0x100 mm, 1.8 μm column with 0.1% formic acid and 5 mM ammonium formate
in water (mobile phase A) and 0.1% formic acid in methanol (mobile phase B). Data acquisition was
performed in multiple reaction monitoring (MRM) mode with positive ESI with a principal MRM transition
for quantitation and a minimum of one qualifier MRM transition for each analyte. A gradient elution at a
flow rate of 0.5 mL/min was run as follows: initial hold for 1 min at 5% mobile phase B with a ramp to 40%
mobile phase B for 1 min, followed by a ramp to 80% B in 3 mins with a hold of 30 s, and finally a 2.5 min
post run for re-equilibrium at 5% B.
The MS source parameters were performed as follows: gas temperature 325°C; gas flow 10 L/min;
nebulizer 45 psi; sheath gas flow 11 L/min; capillary voltage 3500 V; and a charging voltage 500 V.
Optimization of the data acquisition parameters was performed utilizing Agilent MassHunter Optimization
software in MRM mode to select the optimal precursor ions with corresponding fragmentor voltage and
selection of product ions with associated collision energies for each transition. The optimized parameters
are listed in Table 3.1.
The quantitation of analytes was performed using Agilent MassHunter Quantitative software
version B.08.00. Relative responses were calculated using the absolute response of the drug in relation to
response of the IS and plotted against drug concentrations.
The LC-MS/MS analysis was validated following the American Academy of Forensic Sciences
Standards Board (ASB) standard 036 requirements (104). Evaluated parameter include selectivity, matrix
effects, linearity, processed sample stability, bias, and precision.
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Table 3.1: MRM MS method parameters.
Compound

Transitiona

Fragmentor (V)

337.2→188.0
Fentanyl

337.2→105.0
337.2→77.0

146

281.2→188.0
4-ANPP
Norfentanyl
D5-Fentanyl
D5-Norfentanyl
a

281.2→105.0
281.2→77.0

233.2→84.0
233.2→55.1

342.3→188.0
342.3→105.0

238.2→84.0
238.2→55.1

122
117
141
107

CE (V)
24
48
100
16
36
84
20
44
24
48
20
48

Cell Acc (V)

Internal Standard

4

D5-Fentanyl

4

D5-Fentanyl

4

D5-Norfentanyl

4

-

4

-

Precursor ion followed by product ion, quantifier transition is bold

Individual stock solutions of each analyte standard were prepared in methanol and stored at 20°C. An intermediate working solution (IWS) mix of fentanyl (10 ng/µL), norfentanyl (10 ng/µL), and 4ANPP (8 ng/µL). Using the IWS, a serial dilution was performed to prepare stock solutions at
concentrations of 0.02, 0.04, 0.1, 0.4, 2, and 4 ng/µL (ppm) for fentanyl and norfentanyl with
concentrations of 0.016, 0.032, 0.08, 0.32, 1.6, and 3.2 ng/µL (ppm) for 4-ANPP. An internal standard
solution with fentanyl-D5 and norfentanyl-D5 was prepared at a concentration of 100 ng/mL. Separate
solutions were made of fentanyl (10 ng/µL), norfentanyl (10 ng/µL), and 4-ANPP (8 ng/µL) for further
dilutions for use in bias and precision samples. All solutions were prepared in methanol and stored at 20°C.
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Figure 3.1: Fragmentation predictions from ChemDraw for fentanyl quant transition (left) and the qualifier transitions.

Pooled beef liver specimens, as described above, were aliquoted out in 0.2 g portions and spiked
with 5 µL of 0.02, 0.04, 0.4, and 2 ng/µL for fentanyl and norfentanyl with corresponding concentrations
of 0.016, 0.032, 0.32, and 1.6 ng/µL (ppm) for 4-ANPP to create four concentrations of 0.5 µg/kg (LLOQ),
1.0 µg/kg (LOW), 10 µg/kg (MED), and 50 µg/kg (HIGH) for fentanyl and norfentanyl with corresponding
concentrations of 0.4 µg/kg (LLOQ), 0.8 µg/kg (LOW), 8 µg/kg (MED), and 40 µg/kg (HIGH) for 4-ANPP. QC
samples were created on the day of analysis.

46

3.1.2.3. Extraction Techniques
3.1.2.3.1. QuEChERS
The modified method proposed reduces the amount of sample required for extraction to 0.2 g
while reducing the risk of cross contamination by homogenizing the sample in a single reaction tube (1).
The apparatus utilized steel beads and a bead beater type homogenizer allowing for homogenization of
tissue while avoiding cross contamination risks associated with bladed devices (1). This process reduced
the amount of QuEChERS materials required for the extraction while reducing the pretreatment process.
Drug extraction from tissue requires a method that is sensitive, reduces the matrix effects, and allows for
direct extraction from the tissue. Liver tissue is often fatty in nature with many lipids. A modified
QuEChERS protocol meets all the requirements for liver extraction and reduces the risk of cross
contamination in the homogenization process. A reaction chamber for the mixer mill was created (Figure
3.2) to house the extraction microcentrifuge tubes.
Tissue samples weighing 0.2 g were placed in a 1.5 mL centrifuge tube, followed by 400 µL
deionized water, 100 µL IS, and 700 µL acetonitrile addition to the tube, along with 3 steel beads. The
tubes were vortexed, and 0.2 g QuEChERS original extraction salt was added to the tubes. The tubes were
modified for homogenization by cutting off the lid hinge and tip, then parafilm was wrapped around the
top of the tubes to avoid leakage. The samples were then vortexed, mixed with a mixer mill for 1 minute,
centrifuged for 5 minutes, and the supernatant was transferred to a QuEChERS dispersive tube. The tubes
were vortexed and centrifuged again for 5 minutes. The supernatant was transferred to a new 1.5 mL
centrifuge tube to dry down under a nitrogen stream, at 50°C, to dryness. The samples were reconstituted
with 100 µL of methanol and transferred to LC-MS/MS vials for analysis (Figure 3.3).
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Figure 3.2: Images for the adapted homemade reaction chambers for the QuEChERS extraction.

Figure 3.3: Visual workflow for the QuEChERS extraction.

3.1.2.3.2. SPE
Samples of 0.2 g tissue were placed into 1.5 mL centrifuge tubes, and then 200 µL deionized water,
100 µL internal standard (IS), and 400 µL NaOH were added to the tubes. The tubes were vortexed and
placed in a 65°C water bath for 1 hour to incubate (75, 123). After incubation, the samples were
centrifuged for 5 minutes and transferred to a 12 mL polypropylene tubes, and 200 µL of HCl was added.
Another 2 mL of deionized water was added to the samples which were then vortexed, and this completed
the preparation of the sample for solid phase extraction. This hydrolysis pretreatment for SPE analysis
was adapted from Huang et al. to assist the release of basic drugs from the particulate cell material (75).
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To each Bond Elut Certify column, 1 mL of deionized water was added and eluted under positive
pressure. Then, 1 mL of methanol was added and eluted in the same manner in order to condition the
columns. For loading, all of the 3 mL sample was loaded into each of the columns, then eluted under
positive pressure.
To clean, 1 mL of deionized water was added and eluted, then 1 mL of 0.01M HCl was added and
eluted, and finally 2 mL of methanol was added and eluted, all in a similar manner.
For elution, 1 mL of MeOH/NH4OH (98:2) solution was eluted. The loading, wash, and elution procedure
was adapted from the publications of Jenkins et al. and Koesukwiwat et al. (76, 78). After the extraction,
the eluate was evaporated under a nitrogen stream, at 50°C, to dryness. This was then reconstituted with
100 µL of methanol, and the samples were transferred to a LC-MS/MS vial for analysis.
3.1.2.3.3. LLE
Samples of 0.2 g tissue were placed in a 15 mL conical centrifuge polypropylene tube, and then
200 µL deionized water, 100 µL IS, 50 µL NaOH, and 1.5 mL methyl tertbutyl ether (MTBE) were added to
the tubes. MTBE was chosen as the organic solvent based on the successful extraction of fentanyl from
blood and plasma in previous published LLE work (124, 125). The tubes were vortexed, and then
centrifuged for 5 minutes. After centrifugation, the supernatant was transferred to a 1.5 mL
microcentrifuge tube and the samples were evaporated under a nitrogen stream, at 50°C, to dryness. The
sample was reconstituted with 100 µL of methanol and transferred to a LC-MS/MS vial for analysis (Figure
3.4).

49

Figure 3.4: Workflows for the LLE, SPE, and QuEChERS extraction protocols.

3.1.2.4. Extraction Validation
3.1.2.4.1. Selectivity
The three analytes of interest and two deuterated internal standards were analyzed individually
at a concentration of 1 µg/mL using the MRM method to examine any interfering peaks. Aliquots of the
pooled beef liver specimens and 10 human liver specimens were extracted and analyzed to ensure no
interferences were present for the target analytes and internal standards. A negative control, blank matrix
with internal standard mix spike, was analyzed each run to determine any potential interferences.
Chromatographic analysis of these compounds was performed using Agilent MassHunter Qualitative
Analysis software version B.08.00.
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Potential for interference from other drug classes was evaluated by analysis of liver spiked with a
mix of 31 compounds incorporating other opioids, stimulants, depressants, synthetic cannabinoids,
synthetic cathinones, and supplements shown in Table 3.2.
Table 3.2: List of 31 compounds evaluated for potential interferences
Class

Compound

Class

Compound

Opioids

6-Acetylmorphine

Synthetic
Cannabinoids

JWH-018

Oxycodone

Opiates

Supplements

JWH-073

Hydrocodone

XLR-11

Buprenorphine

AB-FUBINACA

Norbuprenorphine

AB-PINACA

Ethylmorphine

MAM2201

Morphine

Stimulants

Amphetamine

Codeine

Methamphetamine

1S,2R (+)-Ephedrine

Cocaine

Methylphenidate

Synthetic Cathinones

Sibutramine

Caffeine

Cannabinoids

Synephrine
Octopamine

AlphaPyrrolidinopentiophenone
(A-PVP)
3,4-Methylenedioxy
Pyrovalerone
(MDPV)
Delta-9 THC (THC)
Cannabidiol (CBD)

Other Alkaloids

Mitragynine

Methylhexanamine
(DMAA)

3.1.2.4.2. Ionization Suppression/Enhancement
Ionization suppression or enhancement was evaluated at two concentrations, low and high, for
10 replicates at each concentration. Using a post-extraction addition approach, analyte peak areas of neat
standards (Set 1) are compared to matrix samples fortified with neat standards after extraction (Set 2).
Set 1 consisted of neat standards prepared at 1 (low) and 10 (high) µg/kg and injected 6 times to establish
a mean peak area for each concentration. Set 2 consisted of ten 0.2 g aliquots of beef liver, for each low
and high concentration, extracted and spiked with the low and high concentration respectively. The
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average area of each set (𝑋̅) was used to calculate the suppression or enhancement effect at each
concentration for each analyte is as follows:

𝐼𝑜𝑛𝑖𝑧𝑎𝑡𝑖𝑜𝑛 𝑠𝑢𝑝𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 𝑜𝑟 𝑒𝑛ℎ𝑎𝑛𝑐𝑒𝑚𝑒𝑛𝑡 (%) = (

𝑋̅ 𝐴𝑟𝑒𝑎 𝑜𝑓 𝑠𝑒𝑡 2
− 1) ∗ 100
𝑋̅ 𝐴𝑟𝑒𝑎 𝑜𝑓 𝑠𝑒𝑡 1

3.1.2.4.3. Bias and Precision
QC samples were analyzed at LOW, MED, and HIGH for fentanyl, norfentanyl, and 4-ANPP in
triplicate over five days. The source of liver in this parameter evaluation was pooled beef liver (n=6) which
is different from the standard 036. The ASB 036 encourages the use of matrix matched comparisons
however beef liver was used as the model for the bias and precision studies. To account for these
differences, further studies in the proof of applicability were performed to compare the impact of beef
liver to human liver. Bias was calculated as a percent deviation of the mean from the theoretical
concentration. Precision was evaluated by percent relative standard deviation (%CV) of the mean at each
concentration. The criteria for acceptable bias and precision (%CV) was set at ±20%.
3.1.2.4.4. Linearity of Calibration
Aliquots of 0.2 g of pooled beef liver were spiked with 5 µL of corresponding solutions to create
calibration samples at 0.5, 1, 2.5, 10, 50, and 100 µg/kg for fentanyl and norfentanyl with corresponding
concentrations of 0.4, 0.8, 2, 8, 40, and 80 µg/kg for 4-ANPP. Five replicates at each concentration were
analyzed and regression lines were generated using Agilent MassHunter software using a weight of (1/x).
3.1.2.4.5. Processed Sample Stability
To determine the stability of processed samples in the autosampler (4°C), aliquots of beef liver
were spiked at low (1 µg/kg) and high (10 µg/kg) concentrations followed by extraction. Triplicate analysis
at time frames: 0, 24, 48, and 72 hours were performed for each concentration. Average peak area was
calculated for each triplicate and compared to time zero. An acceptable bias threshold was set at ±20%.
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3.1.2.4.6. Limits
To evaluate the limit of detection (LOD) and lower limit of quantitation (LLOQ), aliquots of blank
liver were spike with decreasing concentrations of analytes. To determine LLOQ, triplicates at 0.4 µg/kg
4-ANPP and 0.5 µg/kg concentration for fentanyl and norfentanyl were analyzed over 3 days (n=9). Bias
and precision (%CV) for LLOQ was considered acceptable at ±20%. To determine LOD, triplicates at 0.08
µg/kg 4-ANPP and 0.1 µg/kg concentration for fentanyl and norfentanyl were analyzed over 2 days (n=6).
For LOD to be considered acceptable, signal to noise (s/n) ratios were to be above 3.3 and qualifier ratios
within ±20% to achieve chromatographic acceptance.
3.1.2.4.7. Proof of Applicability
Liver specimens from twelve authentic postmortem cases provided by the OCME
were submitted for analysis. Samples were analyzed using the QuEChERS extraction protocol presented
above. A comparison of spiked beef liver and spiked human liver at low, medium, and high concentrations
was also performed to display the methods ability to quantify the target analytes in human liver matrix.
3.1.2.4.8. Comparison of Extraction Techniques (Recovery, Matrix Effects, and Process Efficiency)
To calculate matrix effects (ME), recovery of the extraction (RE), and process efficiency (PE) three
formulas were utilized. Variables in the formulas represent the mean peak areas for the neat solution (A),
the mean peak areas for the standards spiked after extraction (B), and the mean peak areas for the
standards spiked before extraction (C)(39). Recovery, matrix effects, and process efficiency were used to
compare extraction methodologies for LLE, SPE, and the validated QuEChERS method. Low and high
concentrations were analyzed by all three techniques at five replicates (n=5).

𝑀𝐸(%) =

𝐵
∗ 100
𝐴

𝑅𝐸(%) =

𝐶
∗ 100
𝐵

𝑃𝐸(%) =

𝐶
∗ 100
𝐴
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3.1.3. Results and Discussion
3.1.3.1. Selectivity
With the MRM method, no interfering peaks were observed when the target analytes or internal
standards were analyzed individually. After analysis of the pooled liver specimens and 10 human liver
specimens, no interfering peaks were identified for the target analytes or internal standards. Figure 3.5
below shows a chromatogram for the three target analytes after extraction of the lowest calibrator (0.5
µg/kg) superimposed with the extraction of a blank matrix showing no interference peaks. Analysis of liver
spiked with a mix of 31 potential interfering drugs (Table 3.2) presented no evidence of interference.
Based on the full analysis of the single analysis, matrix extractions, and interference drug mix the MRM
method was deemed highly selective and no interference peaks were identified.
Fentanyl
Norfentanyl

4-ANPP

Figure 3.5: LC-MS/MS chromatogram for the MRM transitions of the three target analytes.

3.1.3.2. Ionization Suppression/Enhancement
Ionization suppression or enhancement was evaluated at two concentrations, low and high, for
10 replicates at each concentration following the ASB Standard 036 proposed requirements. The percent
ionization of suppression or enhancement for each target analyte as well as %CV are displayed in Table
3.3. Suppression or enhancement did not exceed ±10%, well within the ASB Standard 036 proposed
criteria of ±25% with %CV not exceeding ±20%. For interpretation of the ionization results, a negative
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percent ionization is indicative of suppression and a positive percent is indicative of enhancement. A value
of 0% is interpreted as no enhancement or suppression. Norfentanyl experienced enhancement at both
low and high concentrations while inversely 4-ANPP experienced suppression at low and high
concentrations. At low concentration, fentanyl experienced suppression and at the high a slight
enhancement. Based on the evaluation, the extraction method and subsequent LC-MS/MS analysis
experiences acceptable ionization suppression and enhancement.

Table 3.3: Ionization Suppression/Enhancement.

Compound
Fentanyl
4-ANPP
Norfentanyl

Ionization Suppression/Enhancement
Low 1 µg/kg
High 10 µg/kg
Mean %
%CV
Mean %
%CV
-10.0
-2.1
3.1

8.0
16.0
16.1

1.4
-0.3
2.8

17.5
11.6
9.5

3.1.3.3. Bias and Precision
QC samples were analyzed at LOW (1.0 µg/kg), MED (10 µg/kg), and HIGH (50 µg/kg) for fentanyl
and norfentanyl with corresponding concentrations of LOW (0.8 µg/kg), MED (8 µg/kg), and HIGH (40
µg/kg) for 4-ANPP in triplicate over five days (n=15). Table 3.4 displays the bias and precision results from
the analysis of these concentrations. The bias for all three target analytes at all three concentrations did
not exceed ±20%. Displayed below is repeatability (intra-day %CV), reproducibility (inter-day %CV), and
bias. The analyte with the least bias was norfentanyl at 1.5% and was the analyte with the least bias
(<±8.5%). Bias for 4-ANPP was between -19.9% and -14.7% which is within the acceptable ±20% however
much higher than the other analytes at all three concentrations. A possible reason for this is the lack of
use of a deuterated standard as the IS for 4-ANPP. Future work will include the use of D5-4-ANPP to
attempt to alleviate this issue.
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Table 3.4: Bias and Precision
Repeatability (%CV)

Reproducibility (%CV)

Bias (%)

Compound
LOW

MED

HIGH

LOW

MED

HIGH

LOW

MED

HIGH

Fentanyl

3.7

3.6

9.5

2.2

3.6

15.1

-15.8

-3.6

-2.5

4-ANPP

13.8

6.9

8.3

3.7

9.5

4.9

-19.9

-14.7

-16.1

Norfentanyl

3.7

4.6

9.9

12.2

6.6

11.9

-8.5

-5.3

1.5

3.1.3.4. Linearity of Calibration
For the calibration curves 6 levels were employed: 0.4, 0.8, 2, 8, 40, and 80 µg/kg for 4-ANPP and
0.5, 1, 2.5, 10, 50, and 100 µg/kg for fentanyl and norfentanyl. Five replicates at each concentration were
analyzed and regression lines were generated using Agilent MassHunter software using a weight of (1/x).
Table 3.5 below displays results for the five replicates. The R2 values for the calibration curve of the three
target analytes all exceeded 0.997 for the analytical measurable range (AMR) of 0.4-80 µg/kg for 4-ANPP
and 0.5-100 µg/kg for fentanyl and norfentanyl.
Table 3.5: Linearity of calibration.

y-intercept
(mean  SD, n = 5)

Slope
(mean SD, n = 5)

Fentanyl

0.0142  0.0026

0.0222  0.0007

4-ANPP

0.0102  0.0058

0.0199  0.0010

Norfentanyl

0.0125  0.0026

0.0205  0.0006

Compound

R2 range
(n = 5)
0.9974 –
0.9984
0.9973 –
0.9999
0.9978 –
0.9982

LOD
(ug/kg)

LLOQ
(ug/kg)

AMR
(ug/kg)

0.1

0.5

0.5-100

0.1

0.4

0.4-80

0.1

0.5

0.5-100

3.1.3.5. Processed Sample Stability
To determine the stability of processed samples, twelve 0.2 g aliquots of beef liver were spiked
at low (1 µg/kg) and high (10 µg/kg) concentrations followed by extraction. The twelve reconstituted
extracts for each concentration were combined and again aliquoted to LC-MS/MS vials for analysis. This
allowed for triplicate analysis at four-time frames: 0, 24, 48, and 72 hours for each concentration. Average
peak area was calculated for each triplicate and compared to time zero. The percent change from the
initial relative response to the time point analyzed for each target analyte is displayed in Table 3.6 below.
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The percent change threshold was established as the acceptable bias, therefore a ±20% change was
deemed acceptable for this method. A graph of the stability for the three target analytes is shown in Figure
3.6. For the time points analyzed, none exceeded the ±20% change criteria with the highest of 16.8% and
the lowest -1.6%. The three target analytes are stable in the autosampler (4°C) for up to 72 hours.
Table 3.6: Processed stability for samples stored in autosampler (4°C).
Low (%∆)a

Compound

High (%∆)a

48 hb

72 hb

24 hb

Fentanyl

1.5

1.8

4.3

4-ANPP

5.1

9.8

Norfentanyl

0.6

8.2

a

24 hb

b

48 hb

72 hb

1.9

-1.1

0.6

7.7

0.6

4.9

4.1

16.8

-1.6

-0.7

-1.6

Data expressed as percent change in relative response from initial to analyzed time point
Data in %

Figure 3.6: Graphical representation of the stability of the high concentration for processed samples stored in the autosampler
(4°C).

3.1.3.6. Limits
To determine LLOQ, triplicates at 0.4 µg/kg 4-ANPP and 0.5 µg/kg concentration for fentanyl and
norfentanyl were analyzed over 3 days (n=9). Bias for all three target compounds did not exceed the ±20%
acceptable criteria and the %CV was within the acceptable criteria. Bias for fentanyl, norfentanyl, and 4ANPP were -10.3, 1.3, and -14.5 respectively with %CV values of 4.9%, 5.8%, and 4.0% respectively. To

57

determine LOD, triplicates at 0.08 µg/kg 4-ANPP and 0.1 µg/kg concentration for fentanyl and norfentanyl
were analyzed over 2 days (n=6). The LOD calculated to be 0.1 µg/kg for all three analytes by achieving
the acceptable signal to noise (s/n) ratios above 3.3 and qualifier ratios within ±20% for chromatographic
acceptance.
3.1.3.7. Proof of Applicability
Of the liver specimens from the twelve authentic postmortem cases provided by the OCME, 10
were positive for fentanyl and norfentanyl while 7 were also positive for 4-ANPP. Figure 3.7 displays the
quantitation results for the OCME liver samples. The range of fentanyl concentrations were 56.6 to 462.3
µg/kg with a mean of 149.2 µg/kg (n=10). The range of norfentanyl concentrations were 1.9 to 50.0 µg/kg
with a mean of 14.1 µg/kg (n=10). The range of 4-ANPP concentrations were 3.2 to 23.7 µg/kg with a mean
of 7.5 µg/kg (n=7).
The concentrations reported in this study are in an agreement with the concentrations reported
by McIntyre, Luckenbill, and Palamalai (64, 65, 115). A review by McIntyre found that the postmortem
central blood concentrations of fentanyl detected in 179 cases had a range of 1.8-176 ng/mL with an
average of 20.61 ng/mL (115). In the same review, 87 liver fentanyl concentrations from cases in Los
Angeles had a range of 6.9-689 µg/kg with a mean of 93.3 µg/kg while 16 liver fentanyl concentrations
from cases in San Diego had a range of 3.8-270 µg/kg with an average of 74.1 µg/kg (115). A similar study
by Luckenbill found fentanyl concentrations in 9 liver tissue samples in a range from 37-179 µg/kg with a
mean of 83.1 µg/kg and in 3 heart tissue samples ranging from 52.8-179 µg/kg with a mean of 124 µg/kg
(65). Palamalai presented a review of cases that fentanyl was detected at postmortem investigations that
deaths were deemed non-drug related, mix drug related or fentanyl caused deaths. Those findings
consisted of liver fentanyl concentrations in five non-drug related deaths with a range of 11-104 µg/kg
and a mean of 38 µg/kg; liver fentanyl concentrations in 26 mix drug related deaths ranging from 6-235
µg/kg and a mean of 80 µg/kg; and liver fentanyl concentrations in 33 fentanyl related deaths ranging
from 18-365 µg/kg and a mean of 104 µg/kg (64). The values for the studies are displayed in Table 3.7.
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The method presented by the authors covers an analytical range fit for the purpose of analysis of fentanyl
and the two major metabolites.
Table 3.7: Review of fentanyl liver concentrations (µg/kg).
Author

N

Low

High

Mean

Luckenbill-2008

9

37

179

124

McIntyre-2012
(Los Angeles)

87

6.9

689

93.3

McIntyre-2012
(San Diego)

16

3.8

270

74.1

Palamalai-2013
(Non-drug related)

5

11

104

38

Palamalai-2013
(Mix drug related)

26

6

235

80

Palamalai-2013
(Fentanyl COD1)

33

18

365

104

This Study

10

56.6

462

149

1

Cause of death

For the comparison of beef liver and human liver as a matrix, the bias for both matrices at all three
concentrations (LOW, MED, and HIGH) was below ±13% with a %CV below 13.8% (n=5). Table 3.8 displays
the results for the bias, precision, and statistical test to compare the bias for the beef and human liver
extractions. A paired T-test (at a 95% confidence interval) was performed to compare the bias for the beef
and human liver extractions with all p-values generated above 0.05 indicating no significant differences
between the two groups. Based on this data the is not a significant difference between the beef liver and
human liver extractions allowing for application to human liver extractions.
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Figure 3.7: Box plot of quantitative results for the OCME case samples.
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Table 3.8: Comparison of beef and human liver extractions at low, med, and high concentrations (n=5).
T-testa

Bias and Precision
Compound

Low
Biasb

Med
CVb

Biasb

High

Low

Med

High

CVb

Biasb

CVb

P-valuec

P-valuec

P-valuec

Beef Liver
Fentanyl

-9.1

11.4

12.3

11.6

5.5

7.2

0.27

0.37

0.09

4-ANPP

-4.4

13.8

13.0

10.6

2.8

5.3

0.34

0.51

0.90

Norfentanyl

-7.5

11.3

11.7

11.6

0.1

7.0

0.15

0.12

0.56

Human Liver
Fentanyl

3.2

5.2

11.4

4.3

2.9

1.7

4-ANPP

5.2

10.1

8.5

6.0

-2.4

0.9

Norfentanyl

0.2

7.1

6.3

6.7

-5.2

1.7

a
b
c

T-test for the comparison of the beef and human tissue (n=5)
Data in %
A p-value of >0.05 indicates no significant difference in the means for bias

3.1.3.8. Comparison of Extraction Techniques
Recovery, matrix effects, and process efficiency were used to compare extraction methodologies
for LLE, SPE, and the validated QuEChERS method. Low and high concentrations were analyzed by all three
techniques at five replicates (n=5) and the results are displayed in Table 3.9. The lowest recovery for 4ANPP using the QuEChERS, LLE, and SPE techniques were 90.2%, 66.3%, and 46.4% respectively. Overall,
the QuEChERS technique met all the acceptable criteria set by Matuszewski et al. with recoveries higher
than 90.2%, matrix effects greater than 80.4%, and process efficiencies greater than 76.7% with %CV
values below 12.8% for all target analytes (107). The LLE and SPE techniques failed to meet acceptable
criteria for recoveries (±20%) and matrix effects (±25%) at multiple concentrations for multiple analytes.
The mean recovery for the QuEChERS extraction was 94.5% with a range of 90.2% to 97.2%; the mean
recovery for the LLE method was 88.2% with a range of 78.2% to 99.8%, and the mean recovery for the
SPE method was 86.3% with a range of 57.9% to 112.5%. The QuEChERS technique generated the highest
mean recovery with the smallest range of recoveries compared to the LLE and SPE techniques presented
in this study. The process efficiency for the QuEChERS extraction was above 76% for all three analytes
compared to the LLE and SPE methods that only produced a process efficiency above 76% for norfentanyl.
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Process efficiency compares the spiked pre-extract specimen with the neat specimen, incorporating the
entire extraction process including both recovery and matrix effect
into the percent. A desired PE is ±25% and the QuEChERS extraction is the only method of the three
presented in this study that achieved it for all three analytes.
Table 3.9: Matrix effects, recovery, and process efficiency for the 3 extraction techniques (n=5).
Matrix Effectsa
Compound

Low
Mean

Recoverya
High

CV

Mean

Low
CV

Mean

Process Efficiencya
High

CV

Low

High

Mean

CV

Mean

CV

Mean

CV

QuEChERS
Fentanyl

80.4

2.9

89.3

1.8

97.2

12.4

95.1

7.3

78.1

12.1

98.7

7.2

4-ANPP

85.0

5.2

95.2

2.4

90.2

9.0

95.1

12.8

76.7

8.7

95.2

2.4

Norfentanyl

87.0

1.9

111.0

3.6

96.0

5.9

117.0

6.2

83.5

5.9

117.0

6.3

LLE
Fentanyl

65.3

17.3

72.0

8.8

78.2

10.8

75.9

8.8

51.1

19.1

73.4

8.3

4-ANPP

62.1

16.9

66.4

11.2

86.5

11.9

66.3

10.4

53.7

20.3

67.8

6.8

Norfentanyl

76.7

14.9

79.1

9.2

99.8

5.9

82.6

7.8

76.5

14.5

79.8

7.3

SPE
Fentanyl

69.7

5.0

64.1

5.5

88.6

8.0

62.4

8.4

61.7

8.4

63.7

8.5

4-ANPP

52.3

9.9

54.8

23.7

57.9

12.0

46.4

23.3

30.3

15.5

52.9

13.4

Norfentanyl

100.8

5.3

126.2

5.1

112.5

5.9

106.7

2.4

113.5

7.7

134.6

5.7

a

Data in %

For postmortem analysis fentanyl is the primary target analyte and the QuEChERS extraction
outperformed the LLE and SPE techniques for fentanyl with ME (80.4%), RE (97.2%), and PE (78.1%). The
RE of fentanyl using the QuEChERS extraction was 97.2% compared to the LLE and SPE methods with RE
of 78.2% and 88.6% respectively. The QuEChERS extraction outperformed the LLE and SPE methods in
repeatability with %CV values of less than 15% for all ME, RE, and PE parameters whereas, LLE and SPE
produced multiple above 15% and at least one above 20% which is above the threshold of acceptance. In
comparison of the LLE and SPE techniques presented here, the SPE method produced better ME, RE, and
PE results for fentanyl and norfentanyl than the LLE method. However, the LLE method generated better
ME, RE, and PE for the analysis of 4-ANPP. Between the LLE and SPE techniques presented in this study
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there was not a clearly superior method. However, the QuEChERS technique performance was superior
to both the LLE and SPE techniques presented in this study.
3.1.3.9. Conclusions
The QuEChERS extraction and subsequent LC-MS/MS method was fully validated for fentanyl,
norfentanyl, and 4-ANPP in liver tissue. The bias for all three target analytes at all three concentrations
did not exceed ±20% with repeatability and reproducibility within the ±20% threshold. The R2 values for
the calibration curve of the three target analytes all exceeded 0.997 for the analytical measurable range
(AMR) of 0.4-80 µg/kg for 4-ANPP and 0.5-100 µg/kg for fentanyl and norfentanyl. The QuEChERS
technique had recoveries higher than 90.2%, matrix effects greater than 80.4%, and process efficiencies
greater than 76.7% with %CV values below 12.8% for all target analytes. The concentrations reported in
this study, 56.6 to 462.3 µg/kg with a mean of 149.2 µg/kg (n=10), are in an agreement with the
concentrations reported by McIntyre, Luckenbill, and Palamalai.
Overall, the QuEChERS technique met all the acceptable criteria and was shown to be effective at
extracting and quantitating fentanyl, norfentanyl, and 4-ANPP. The presented QuEChERS extraction
outperformed the presented LLE and SPE techniques while reducing the amount of QuEChERS materials
required for the extraction and the pretreatment process. Drug extraction from tissue requires a method
that is sensitive, reduces the matrix effects, and allows for direct extraction from the tissue. The presented
modified QuEChERS protocol meets all the requirements for liver extraction and reduces the risk of cross
contamination in the homogenization process.
The above QuEChERS extraction was selected for expansion to include other fentanyl analogs and
to validate for extraction of fentanyl and metabolites from insect tissues (larvae, pupae, empty puparium,
and adult flies) presented in the next chapters.
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3.2. Section 2: Expansion of Method to 34 Fentanyl Analogs
3.2.1. Overview
Opioid addiction is a severe national crisis that affects public health, social and economic welfare.
With the number of fentanyl overdose-related deaths rising at alarming rates, the interpretation of
toxicological findings in these cases is a crucial component in medicolegal investigations. However, the
vast number of emerging analogs combined with the potency of these drugs create several analytical
challenges. It is necessary to develop a comprehensive strategy to facilitate the extraction of novel
synthetic opioids (NSO) including fentanyl and its major metabolites from complex biological specimens
such as liver tissue.
Objectives for this study include an expansion of a quick, easy, cheap, effective, rugged, and safe
(QuEChERS) extraction and subsequent LC-MS/MS analysis, validation of the method following the
American Academy of Forensic Sciences Standards Board (ASB) standard 036 requirements, and
application to authentic liver specimens for 34 analytes including fentanyl, metabolites, and fentanyl
analogs. With the emergence of NSO’s, it is important for laboratories to have sensitive and effective
extraction strategies for complex biological samples, a wide range of analytes to encompass potential
emerging NSO’s, and surveys of which specific NSO’s are prevalent in the drug overdose community. This
chapter presents an advancement in the combat of opioid epidemic by offering a fully validated protocol
that complement the analytical toolkit in forensic toxicology laboratories and medical examiners offices.
This section is reproduced in part with permission from Cox, J., Mathison, K., Ott, C., DelTondo, J., Kraner,
J.C., DeCaprio, A.P., et al., Journal of Analytical Toxicology, 2021: 10.1093/jat/bkab009.
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3.2.2. Introduction
Fentanyl is a highly effective µ-opioid agonist with a potency of 50-100 times that of morphine
that is used clinically as a schedule II drug and, like other opioids, has considerable addictive potential (91,
92). Illicitly manufactured fentanyl (IMF) and analogs have been abused individually and combined with
other drugs like heroin often in counterfeit pill formulations (96–99). The structural scaffold of fentanyl
can be modified in numerous ways to generate various versions of novel fentanyl analogs and this is
exploited to produce IMF and analogs (91, 92, 98). A deadly combination of intentional and unintentional
misuse of fentanyl analogs and the high potency of the drug class has led to an increase in overdose deaths
(96, 98, 126). Novel synthetic opioids (NSOs) consist of different classes incorporating fentanyl analogs (4anilinopiperidine class), U-47700 type drugs (benzamide class), and MT-45 type drugs (piperazine
derivatives) that all target the µ-opioid receptors (77, 92, 127). NSOs have a wide range of potencies with
carfentanil as the most potent at up to 100 times more potent than fentanyl (91). Due to its potency,
carfentanil has been involved in a multitude of overdose cases around the world in the past decade (110,
128–132).
Postmortem toxicological analysis in fentanyl related overdose is complicated by high potency of
the drug, often resulting in low analyte concentrations and associations with toxicity, multi-drug use,
novelty of emerging fentanyl analogs, and postmortem redistribution (63, 98, 133, 134). To overcome this
adversity, toxicologists often examine multiple specimen matrices from different sources, including blood
(femoral or heart), urine, vitreous fluid, liver tissue or other tissues (63, 134). For analysis of drugs that
are susceptible to postmortem redistribution (PMR), liver tissue analysis is used to complement heart and
femoral blood concentrations (64). As decomposition and the postmortem interval (PMI) progress, it has
been proposed that tissues such as liver provide a more useful indication of antemortem drug
concentrations compared to blood concentrations . As PMR occurs, the blood concentrations in the
central cavities for drugs with a high volume of distribution (Vd) often increases compared to those from
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peripheral areas, a phenomenon contributed to by passive diffusion of drugs from the surrounding organs
(117, 118). Fentanyl is considered to have a high Vd and fentanyl analogs that are structurally related are
likely to exhibit similar characteristics and susceptibility to PMR (135).
Extraction of drugs from liver tissue is complex due to the high lipid and salt content naturally
occurring in the matrix that can be further complicated as decomposition introduces byproducts from the
putrefaction process as the PMI progresses (136–138). In 2003, a quick, easy, cheap, effective, rugged,
and safe (QuEChERS) extraction method was established to detect pesticides in complex produce samples
(79). To mediate the complications encountered with a postmortem tissue such as liver, a modified
QuEChERS extraction can be used (1, 80, 83). The two-part process of QuEChERS makes it an ideal
procedure for tissue analysis due to a direct organic solvent extraction step followed by a dispersive solid
phase extraction (d-SPE) step (4). This allows for direct solvent extraction from the tissue combined with
the reduction of matrix effects, lipids, and other unwanted compounds via d-SPE (1, 4, 80, 83). QuEChERS
extractions have been applied to drugs from liver tissue for benzodiazepines by Usui et al. and for fentanyl
by this research group (1, 4). Application of QuEChERS to fentanyl analogs has been limited to acetyl
fentanyl from urine in a fatal poisoning and to the knowledge of the authors there has not been an
application of a QuEChERS extraction for fentanyl analogs from liver tissue (82).
Presented in this study is a development of a QuEChERS extraction and subsequent LC-MS/MS
analysis, a validation of the method following the ASB standard 036 requirements, and application to 22
authentic liver specimens for 34 analytes including fentanyl, metabolites, and fentanyl analogs.
3.2.3. Methods
3.2.3.1. Chemicals and Materials
Drug standards: 2'-fluoro ortho-fluorofentanyl, (±)-cis-3-methyl butyryl fentanyl (HCl),
(±)-trans-3-methyl fentanyl (HCl), acetyl fentanyl, acryl fentanyl, acryl fentanyl-D5, benzodioxole fentanyl,
benzyl fentanyl (HCl), butyryl fentanyl (HCl), butyryl norfentanyl (HCl), cyclopentyl fentanyl (HCl),
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despropionyl

ortho-fluorofentanyl,

furanyl

fentanyl

3-furancarboxamide

isomer

(HCl),

meta-fluorofentanyl (HCl), methoxyacetyl fentanyl, para-chlorofentanyl (HCl), para-chloroisobutyryl
fentanyl (HCl), para-fluoro acrylfentanyl, para-fluoroisobutyryl fentanyl (FIBF), para-methoxyfentanyl
(HCl), tetrahydrofuran fentanyl (HCl), thienyl fentanyl (HCl), thiofentanyl (HCl), U-47700, U-47700-D6,
valeryl fentanyl, valeryl fentanyl-D5, αmethyl acetyl fentanyl (HCl), αmethyl butyryl fentanyl (HCl),
αmethyl thiofentanyl (HCl) and β-hydroxythiofentanyl (HCl) were obtained from Cayman Chemical (Ann
Arbor, MI) and were reconstituted or diluted to concentrations of 10 μg/mL or 100 μg/mL in methanol.
Drug standards: 4-ANPP, carfentanil oxalate, fentanyl, furanyl fentanyl (HCl), norfentanyl oxalate,
cyclopropyl fentanyl, carfentanil-D5, fentanyl-D5, norfentanyl-D5, 4-ANPP-D5 and acetyl fentanyl-D5
were obtained from Cerilliant (Round Rock, TX) at concentrations of 1 mg/mL or 100 μg/mL in methanol.
Optima® liquid chromatography-mass spectrometry (LC-MS) grade methanol, acetonitrile, formic acid and
ammonium formate were purchased from Thermo Fisher Scientific (Fair Lawn, NJ). All water was purified
using a Direct-Q® 3 UV Water Purification System (Darmstadt, Germany). The QuEChERS original
extraction salt packets (containing 6 g magnesium sulfate and 1.5 g sodium chloride) and 2 mL dispersiveSPE tubes (containing 25 mg of primary secondary amine (PSA), 25 mg end-capped octadecylsilane
(C18EC) and 150 mg magnesium sulfate) were purchased from Agilent Technologies. A Mixer Mill MM 200
was utilized for homogenization was obtained from Retsch® (Haan, Germany). Steel zinc plated BB balls
(0.177 cal, 4.5 mm) were obtained from Daisy (Rogers, AR).
Human liver specimens used in method development and validation were received from West
Virginia University (WVU) Human Gift Registry (n=5) from specimens received May 2019 to July 2019 and
the Office of the Chief Medical Examiner Office (OCME) in Charleston, West Virginia (n=17) from cases
throughout 2019. Quantitative analysis was performed on authentic human liver specimens provided
from both the suspected fentanyl-related deaths investigated by the Office of the Chief Medical Examiner
Office (OCME) in Charleston, West Virginia and the West Virginia Human Gift Registry. The specimens
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from the West Virginia Human Gift Registry were not suspected of fentanyl related overdose deaths. Blank
human liver specimens (n=10) were also received from the West Virginia Human Gift Registry and were
tested for the presence of fentanyl analogs before use. These liver specimens were used for the validation
of the method as individual samples and equal portions were homogenized with a blender for the pooled
specimens (n=10). All samples were stored at -20°C prior to analysis for approximately 4 to 10 months. All
specimens were de-identified from personal identifying information and this study was determined to be
exempt from Institutional Review Board (IRB) review due to postmortem specimen use and lack of human
subject involvement.
3.2.3.2. LC-MS/MS
The quantification method was performed on an Agilent 6470 Triple Quad LC-MS/MS system
coupled with an Agilent 1290 Infinity II LC system. Chromatographic separation was achieved on a Zorbax
Eclipse Plus C18 RRHD 3.0x100 mm, 1.8 μm column with 0.1% formic acid and 5 mM ammonium formate
in water (mobile phase A) and 0.1% formic acid in methanol (mobile phase B). Data acquisition was
performed in dynamic multiple reaction monitoring (dMRM) mode with positive ESI with a principal
dMRM transition for quantitation and a qualifier dMRM transition for each analyte. A gradient elution at
a flow rate of 0.3 mL/min was run as follows: initial hold for 1 min at 5% mobile phase B with a ramp to
60% mobile phase B for 1 min, followed by a ramp to 70% B in 4 mins, followed by a ramp to 80% for 1
min, followed by a ramp to 95% for 30 s with a hold of 30 s, and finally a 2.5 min post run for re-equilibrium
at 5% B.
The MS source parameters were performed as follows: gas temperature 325°C; gas flow 9 L/min;
nebulizer 45 psi; sheath gas flow 9 L/min; capillary voltage 3500 V; and charging voltage 500 V.
Optimization of the data acquisition parameters was performed utilizing Agilent MassHunter Optimization
software version B.08.02 in MRM mode to select the optimal precursor ions with corresponding
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fragmentor voltage and selection of product ions with associated collision energies for each transition.
The optimized parameters are listed in Table 3.10.
The quantitation of analytes was performed using Agilent MassHunter Quantitative software
version B.08.00. Relative responses were calculated using the absolute response of the drug in relation to
response of the internal standard and plotted against drug concentrations.
The LC-MS/MS analysis was validated following the American Academy of Forensic Sciences
Standards Board (ASB) standard 036 requirements (104). Evaluated parameters include interference
studies, ionization suppression/enhancement, dilution integrity, limits of quantitation, linearity,
processed sample stability, bias, and precision.
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Table 3.10: MS parameters for the 6470 Agilent system.
Compound
2’-fluoro ortho-Fluorofentanyl
4-ANPP
α-Methyl Acetyl Fentanyl (3)
α-Methyl Butyryl Fentanyl (11)
α-Methyl Thiofentanyl
β-Hydroxythiofentanyl
Acetyl Fentanyl (2)
Acryl Fentanyl
Benzodioxole Fentanyl
Benzyl Fentanyl (5)
Butyryl Fentanyl (10)
Butyryl Norfentanyl
Carfentanil (7)
Cis-3-Methyl Butyryl Fentanyl (12)
Cyclopentyl Fentanyl
Cyclopropyl Fentanyl
Despropionyl ortho-Fluorofentanyl
Fentanyl (6)
FIBF
Furanyl Fentanyl
Furanyl Fentanyl 3furancarboxamide isomer
Meta-Fluorofentanyl
Methoxy Acetyl Fentanyl
Norfentanyl (1)
Para-Chlorofentanyl
Para-Chloroisobutyryl Fentanyl
Para-Fluoro Acryl Fentanyl
Para-Methoxyfentanyl
Tetrahydrofuran Fentanyl
Thienyl Fentanyl (4)
Thiofentanyl
Trans-3-methyl Fentanyl (8)
U-47700 (9)
Valeryl Fentanyl (13)
a Bold

Transitiona
373.2
373.2
281.2
281.2
337.2
337.2
365.3
365.3
357.2
357.2
359.2
359.2
323.2
323.2
335.2
335.2
429.2
429.2
323.2
323.2
351.2
351.2
247.2
247.2
395.2
395.2
365.3
365.3
377.3
377.3
349.2
349.2
299.2
299.2
337.2
337.2
369.2
369.2
375.2
375.2
375.2
375.2
355.2
355.2
353.2
353.2
233.2
233.2
371.2
371.2
385.2
385.2
353.2
353.2
367.2
367.2
379.2
379.2
329.2
329.2
343.2
343.2
351.2
351.2
329.1
329.1
365.3
365.3

→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→

206
123
188
105
91
119
202.1
91
97
125
111
97
188
105
105
188
149
105
91
174.1
105
188.1
84.1
55.1
335.1
113
105
202.1
188.1
105
105
77
105
77
105
188
188
105
188
105
188.1
105
188.1
105
188
105
84
55.1
188.1
105
188.1
105
188.1
105
188.1
105
188.1
105
97
53.1
194.1
111
202.1
105
173
145
105
188

Fragmentor Energy
(V)

Collision
Energy (V)

106
106
122
122
144
144
122
122
124
124
124
124
98
98
94
94
144
144
124
124
144
144
100
100
136
136
142
142
144
144
124
124
104
104
146
146
92
92
146
146
124
124
144
144
92
92
107
107
124
124
144
144
124
124
124
124
124
124
124
124
124
124
144
144
86
86
100
100

28
48
16
36
56
28
24
60
60
32
44
52
24
44
44
24
36
56
48
20
44
28
20
48
16
36
48
24
28
48
52
104
36
84
48
24
28
48
24
48
28
48
28
44
24
44
20
44
28
48
28
48
24
48
28
48
24
48
36
92
24
44
24
44
36
64
48
28

Internal Standard
D5-Acryl Fentanyl
D5-4-ANPP
D5-Acetyl Fentanyl
D5-Fentanyl
D5-Valeryl Fentanyl
D5-Fentanyl
D5-Acetyl Fentanyl
D5-Acryl Fentanyl
D5-Acetyl Fentanyl
D5-4-ANPP
D5-Valeryl Fentanyl
D5-Norfentanyl
D5-Carfentanil
D5-4-ANPP
D5-Valeryl Fentanyl
D5-Fentanyl
D5-Acryl Fentanyl
D5-Fentanyl
D5-Acryl Fentanyl
D5-4-ANPP
D5-4-ANPP
D5-Acryl Fentanyl
D5-4-ANPP
D5-Norfentanyl
D5-Acryl Fentanyl
D5-4-ANPP
D5-Acryl Fentanyl
D5-Fentanyl
D5-Fentanyl
D5-Carfentanil
D5-4-ANPP
D5-Fentanyl
D6-U-47700
D5-Valeryl Fentanyl

transition indicates quantifier transition; Numbers next to compounds relate to Figure 1
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3.2.3.3. Sample Preparation
The amount of sample required for the QuEChERS extraction was reduced to 0.1 g while limiting
the risk of cross contamination by homogenizing the sample in a single reaction tube (4). The apparatus
utilized steel beads and a bead beater type homogenizer allowing for homogenization of tissue while
avoiding cross contamination risks associated with bladed devices (1). Liver tissue is often fatty in nature
with many lipids and a modified QuEChERS protocol was selected to reduce the impact of the fatty nature
of liver tissue (137, 138).
The QuEChERS extraction presented below is an adaptation from previous work from Cox et al.
with expanded application to the 34 fentanyl analogs in this panel (4). Tissue samples weighing 0.1 g were
placed in a 1.5 mL centrifuge tube, followed by 400 µL deionized water, 100 µL internal standard mix (IS),
and 700 µL acetonitrile, along with 3 steel beads. The tubes were vortexed, and 0.2 g QuEChERS original
extraction salt was added to the tubes. The samples were then vortexed, mixed with a mixer mill for 3
min, centrifuged for 5 min, and the supernatant was transferred to a QuEChERS dispersive tube. The tubes
were vortexed and centrifuged again for 5 min. The supernatant was transferred to a new 1.5 mL
centrifuge tube for dry down under a nitrogen stream at 50°C to dryness. The samples were reconstituted
with 100 µL of methanol and transferred to LC-MS/MS vials for analysis (4). The internal standard mix (IS)
consisted of eight deuterated compounds: acryl fentanyl-D5, carfentanil-D5, fentanyl-D5, norfentanyl-D5,
U-47700-D6, valeryl fentanyl-D5, 4-ANPP-D5 and acetyl fentanyl-D5 at a concentration of 25 ng/mL.
3.2.3.4. Validation
3.2.3.4.1. Calibration model
Aliquots of 0.1 g of pooled human liver were spiked with 10 µL of corresponding solutions to
create calibration samples. Group A calibration solutions were created at 0.5, 1, 5, 10, 50, and 100 µg/kg
for 2-fluoro ortho-fluorofentanyl, acryl fentanyl, fentanyl, FIBF, furanyl fentanyl, norfentanyl, U-47700 and
valeryl fentanyl. Group B calibration solutions were created at 0.1, 0.5, 1, 5, 10, 50 and 100 µg/kg for
acetyl fentanyl, carfentanil and methoxy acetyl fentanyl. Group C calibration solutions were created at
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0.25, 0.5, 2.5, 5, 25, and 50 µg/kg for β-hydroxythiofentanyl, cis-3-methyl butyryl fentanyl, cyclopentyl
fentanyl, cyclopropyl fentanyl and despropionyl ortho-fluorofentanyl. Group D calibration solutions were
created at 0.1, 0.2, 1, 2, 10 and 20 µg/kg for α-methyl acetyl fentanyl, α-methyl butyryl fentanyl, α-methyl
thiofentanyl,

benzodioxole

fentanyl,

meta-fluorofentanyl,

para-fluoro

acryl

fentanyl,

para-

methoxyfentanyl, tetrahydrofuran fentanyl, thiofentanyl and trans-3-methyl fentanyl. Group E calibration
solutions were created at 0.05, 0.1, 0.5, 1, 5 and 10 µg/kg for 4-ANPP, benzyl fentanyl, butyryl fentanyl,
butyryl norfentanyl, furanyl fentanyl 3-furancarboxamide isomer, para-chlorofentanyl, parachloroisobutyryl fentanyl and thienyl fentanyl. Five replicates at each concentration were analyzed and
regression lines were generated using Agilent MassHunter software using a weight of (1/x). A stock
solution containing a mix of 2-fluoro ortho-fluorofentanyl (1 ng/µL), 4-ANPP (0.1 ng/µL), acetyl Fentanyl
(1 ng/µL), acryl Fentanyl (1 ng/µL), α-methyl acetyl fentanyl (0.2 ng/µL), α-methyl butyryl fentanyl (0.2
ng/µL), α-methyl thiofentanyl (0.2 ng/µL), benzodioxole fentanyl (0.2 ng/µL), benzyl fentanyl (0.1 ng/µL),
β -hydroxythiofentanyl (0.5 ng/µL), butyryl fentanyl (0.1 ng/µL), butyryl norfentanyl (0.1 ng/µL),
carfentanil (1 ng/µL), cis-3-methyl butyryl fentanyl (0.5 ng/µL), cyclopentyl fentanyl (0.5 ng/µL),
cyclopropyl fentanyl (0.5 ng/µL), despropionyl ortho-fluorofentanyl (0.5 ng/µL), fentanyl (1 ng/µL), FIBF
(1 ng/µL), furanyl fentanyl (1 ng/µL), furanyl fentanyl 3-furancarboxamide isomer (0.1 ng/µL), metafluorofentanyl (0.2 ng/µL), methoxy acetyl fentanyl (1 ng/µL), norfentanyl (1 ng/µL), para-chlorofentanyl
(0.1 ng/µL), para-chloroisobutyryl fentanyl (0.1 ng/µL), para-fluoro acryl fentanyl (0.2 ng/µL), paramethoxyfentanyl (0.2 ng/µL), tetrahydrofuran fentanyl (0.2 ng/µL), thienyl fentanyl (0.1 ng/µL),
thiofentanyl (0.2 ng/µL), trans-3-methyl fentanyl (0.2 ng/µL), U-47700 (1 ng/µL), and valeryl fentanyl (1
ng/µL) was used as the highest calibrator and serial diluted for the remaining calibrators in the calibration
curve.
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3.2.3.4.2. Interference studies
Potential interferences were evaluated using three separate approaches: evaluating blank matrix
effects, interferences from stable-isotope internal standards, and potential interferences from commonly
encountered analytes. Blank matrix samples from 10 individual sources of human liver were extracted
without the addition of internal standard to demonstrate any matrix interferences. To evaluate any
interferences from internal standards or interferences from standards to internal standards; blank matrix
was spiked with internal standard only and an additional blank matrix replicate was spiked with at the
highest calibration concentration with no internal standard added. The evaluation of potential
interferences from other drug classes was performed by the analysis of blank liver spiked with a mix of 31
compounds incorporating other opioids, stimulants, depressants, synthetic cannabinoids, synthetic
cathinones, and supplements shown in Table 3.11. Chromatographic analysis of these compounds was
performed using Agilent MassHunter Qualitative Analysis software version B.08.00.
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Table 3. 11: List of 31 compounds evaluated for potential interferences.
Class

Compound

Class

Compound

Opioids

6-Acetylmorphine

Synthetic Cannabinoids

JWH-018

Opiates

Supplements

Oxycodone

JWH-073

Hydrocodone

XLR-11

Buprenorphine

AB-FUBINACA

Norbuprenorphine

AB-PINACA

Ethylmorphine

MAM2201

Morphine

Stimulants

Amphetamine

Codeine

Methamphetamine

1S,2R (+)-Ephedrine

Cocaine

Methylphenidate

Synthetic Cathinones

Sibutramine

AlphaPyrrolidinopentiophenone (α PVP)
3,4-Methylenedioxy
Pyrovalerone
(MDPV)

Caffeine

Cannabinoids

Synephrine
Octopamine

Delta-9 THC (THC)
Cannabidiol (CBD)

Other Alkaloids

Mitragynine

Methylhexanamine
(DMAA)

3.2.3.4.3. Ionization suppression/enhancement
Ionization suppression or enhancement was evaluated at two concentrations, low and high, for
10 replicates at each concentration following the ASB Standard 036 requirements (104). A desired percent
ionization suppression or enhancement is ±25% with a percent relative standard deviation (%CV) not
exceeding 20%. Using a post-extraction addition approach, analyte peak areas of neat standards (Set 1)
are compared to matrix samples fortified with neat standards after extraction (Set 2). Set 1 consisted of
neat standards prepared at 1 (low) and 10 (high) µg/kg and injected 6 times to establish a mean peak area
for each concentration. Set 2 consisted of ten 0.1 g aliquots of individual human livers in duplicate, for a
low (n=10) and high (n=10) concentration, extracted and spiked with the low and high concentration

74

respectively. The average area of each set (▁X) was used to calculate the suppression or enhancement
effect at each concentration for each analyte is as follows:

𝐼𝑜𝑛𝑖𝑧𝑎𝑡𝑖𝑜𝑛 𝑠𝑢𝑝𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 𝑜𝑟 𝑒𝑛ℎ𝑎𝑛𝑐𝑒𝑚𝑒𝑛𝑡 (%) = (

𝑋 𝐴𝑟𝑒𝑎 𝑜𝑓 𝑠𝑒𝑡 2
− 1) ∗ 100
𝑋 𝐴𝑟𝑒𝑎 𝑜𝑓 𝑠𝑒𝑡 1

3.2.3.4.4. Bias and precision
For bias and precision calculations, a blank pooled matrix of human liver (n=10) was spiked and
analyzed at low, med, and high concentrations for the 34 target analytes in triplicate over five days (n=15).
Bias was calculated as a percent deviation of the mean from the theoretical concentration. Precision was
evaluated by percent relative standard deviation (%CV) of the mean at each concentration. The criteria
for acceptable bias and precision (%CV) was set at ±20%.
3.2.3.4.5. Calibration model
Aliquots of 0.1 g of pooled human liver were spiked with 10 µL of corresponding solutions to
create calibration samples. Group A calibration solutions were created at 0.5, 1, 5, 10, 50, and 100 µg/kg
for 2-fluoro ortho-fluorofentanyl, acryl fentanyl, fentanyl, FIBF, furanyl fentanyl, norfentanyl, U-47700 and
valeryl fentanyl. Group B calibration solutions were created at 0.1, 0.5, 1, 5, 10, 50 and 100 µg/kg for
acetyl fentanyl, carfentanil and methoxy acetyl fentanyl. Group C calibration solutions were created at
0.25, 0.5, 2.5, 5, 25, and 50 µg/kg for β-hydroxythiofentanyl, cis-3-methyl butyryl fentanyl, cyclopentyl
fentanyl, cyclopropyl fentanyl and despropionyl ortho-fluorofentanyl. Group D calibration solutions were
created at 0.1, 0.2, 1, 2, 10 and 20 µg/kg for α-methyl acetyl fentanyl, α-methyl butyryl fentanyl, α-methyl
thiofentanyl,

benzodioxole

fentanyl,

meta-fluorofentanyl,

para-fluoro

acryl

fentanyl,

para-

methoxyfentanyl, tetrahydrofuran fentanyl, thiofentanyl and trans-3-methyl fentanyl. Group E calibration
solutions were created at 0.05, 0.1, 0.5, 1, 5 and 10 µg/kg for 4-ANPP, benzyl fentanyl, butyryl fentanyl,
butyryl norfentanyl, furanyl fentanyl 3-furancarboxamide isomer, para-chlorofentanyl, parachloroisobutyryl fentanyl and thienyl fentanyl. Five replicates at each concentration were analyzed and
regression lines were generated using Agilent MassHunter software using a weight of (1/x). The highest
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calibrator concentration contained a mix of 2-fluoro ortho-fluorofentanyl (1 ng/µL), 4-ANPP (0.1 ng/µL),
acetyl Fentanyl (1 ng/µL), acryl Fentanyl (1 ng/µL), α-methyl acetyl fentanyl (0.2 ng/µL), α-methyl butyryl
fentanyl (0.2 ng/µL), α-methyl thiofentanyl (0.2 ng/µL), benzodioxole fentanyl (0.2 ng/µL), benzyl fentanyl
(0.1 ng/µL), β -hydroxythiofentanyl (0.5 ng/µL), butyryl fentanyl (0.1 ng/µL), butyryl norfentanyl (0.1
ng/µL), carfentanil (1 ng/µL), cis-3-methyl butyryl fentanyl (0.5 ng/µL), cyclopentyl fentanyl (0.5 ng/µL),
cyclopropyl fentanyl (0.5 ng/µL), despropionyl ortho-fluorofentanyl (0.5 ng/µL), fentanyl (1 ng/µL), FIBF
(1 ng/µL), furanyl fentanyl (1 ng/µL), furanyl fentanyl 3-furancarboxamide isomer (0.1 ng/µL), metafluorofentanyl (0.2 ng/µL), methoxy acetyl fentanyl (1 ng/µL), norfentanyl (1 ng/µL), para-chlorofentanyl
(0.1 ng/µL), para-chloroisobutyryl fentanyl (0.1 ng/µL), para-fluoro acryl fentanyl (0.2 ng/µL), paramethoxyfentanyl (0.2 ng/µL), tetrahydrofuran fentanyl (0.2 ng/µL), thienyl fentanyl (0.1 ng/µL),
thiofentanyl (0.2 ng/µL), trans-3-methyl fentanyl (0.2 ng/µL), U-47700 (1 ng/µL), and valeryl fentanyl (1
ng/µL).
3.2.3.4.6. Limits
To evaluate the limit of detection (LOD) and lower limit of quantitation (LLOQ), aliquots of blank
liver were spiked with concentrations at the lowest non-zero calibrator. Triplicates of unique blank matrix
sources spiked at the lowest non-zero calibrator were analyzed over 3 days (n=9). Bias and precision (%CV)
for LLOQ was considered acceptable at ±20%. For LOD to be considered acceptable, signal to noise (s/n)
ratios were to be above 3.3 and qualifier ratios within ±20% to achieve chromatographic acceptance.
3.2.3.4.7. Carryover and dilution integrity
To evaluate carryover, blank matrix samples were injected directly after injections of samples 3
times greater than the highest calibrator using a triplicate analysis. Carryover is considered not significant
if present below 10% of the lowest calibrator (LLOQ). To evaluate dilution integrity, a human liver sample
in triplicate was spiked to 3 times the highest calibrator and the extract was diluted 1:5 with an extract of

76

blank matrix with internal standard (106). The process was repeated over a period of 5 runs (n=15) and
the criteria for acceptable bias and precision (%CV) was set at ±20%.
3.2.3.4.8. Processed sample stability
To determine the stability of processed samples in the autosampler (25°C), aliquots of human liver
were spiked at low (5 µg/kg) and high (50 µg/kg) concentrations followed by extraction. Triplicate analysis
at time frames: 0, 24, 48, and 72 hours were performed for each concentration. Average peak area was
calculated for each triplicate and compared to time zero. An acceptable bias threshold was set at ±20%.
3.2.3.4.9. Recovery, matrix effects and process efficiency
To calculate matrix effects (ME), recovery of the extraction (RE), and process efficiency (PE) three
formulas were utilized. Variables in the formulas represent the mean peak areas for the neat solution (A),
the mean peak areas for the standards spiked after extraction (B), and the mean peak areas for the
standards spiked before extraction (C)(107). Recovery, matrix effects, and process efficiency were
evaluated using pooled human liver tissue (n=10). Low and high concentrations were analyzed at ten
replicates (n=10). A desired matrix effect is between 75% and 125% and the desired recovery is between
80% and 120% with a percent relative standard deviation (%CV) not exceeding 20%.

𝑀𝐸(%) =

𝐵
∗ 100
𝐴

𝑅𝐸(%) =

𝐶
∗ 100
𝐵

𝑃𝐸(%) =

𝐶
∗ 100
𝐴
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3.2.3.4.10. Proof of applicability
Liver specimens from 22 authentic postmortem cases provided by the OCME were submitted for
analysis. Samples were analyzed using the QuEChERS extraction protocol presented above to display the
methods ability to quantify the target analytes from the human liver matrix.
3.2.4. Results and Discussion
3.2.4.1. Calibration model
Five replicates at six different concentrations were analyzed and linear regression lines were
generated using Agilent MassHunter software using a weight of (1/x). The analytical measurement range
(AMR) is listed in Table 5 for each analyte. The R2 values for all the calibration curves exceeded 0.99 and
the residuals for each set of 5 replicates were plotted and no discernable pattern was identified indicating
a random dispersion. This allows for linear analysis of the 34 analytes utilizing a weight of (1/x).
3.2.4.2. Interference studies
Blank matrix samples from 10 individual sources of human liver were extracted without the
addition of internal standard to determine potential matrix interferences. Chromatographic analysis of
these compounds was performed using Agilent MassHunter Qualitative Analysis software version B.08.00.
No interferences from the blank matrices were observed.
No interfering peaks from the high standards were observed for the internal standards and no
interfering peaks were observed from the internal standards for the target analytes. The evaluation of
commonly encountered interferences from other drug classes was performed by the analysis of blank
liver spiked with a mix of 31 compounds incorporating other opioids, stimulants, depressants, synthetic
cannabinoids, synthetic cathinones, and supplements shown in Table 2. No interferences from the 31
compounds were observed.
Isobaric compounds were identified, and individual standards were injected to ensure that
chromatographic separation occurred. Figure 3.8 displays the chromatogram of 11 isobaric compounds in
the method. The numbers in figure 3.8 correspond to the numbers in table 3.10 for the dMRM transitions
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monitored. The analytes themselves did not cause interferences with each other. The concentration of
each inject standard was 500 ng/mL.

Figure 3.8: Chromatogram of the 11 isobaric fentanyl analogs with norfentanyl and carfentanil for reference. Numbers 1-13 in
the figure correspond to Table 1.

3.2.4.3. Ionization suppression/enhancement
Ionization suppression or enhancement was evaluated at a low and high concentration for 10
replicates at each concentration following the ASB Standard 036 requirements. The percent ionization
suppression or enhancement and %CV for each target compound is presented in Table 3.12. The criteria
for acceptance is ±25% ionization suppression or enhancement with a %CV not exceeding 20%. All 34
analytes were within the criteria with the low concentration ranging from -10.2% to 23.7% ionization
suppression or enhancement and the high concentration ranging from -7.1% to 11.0% ionization
suppression or enhancement. The only compound to exceed ±15% for suppression or enhancement was
butyryl norfentanyl at the low concentration at 23.7% enhancement. This was within the acceptable range
but noted as being considerably higher than any other analyte. A reason for this could be attributed to
the compound being a metabolite and therefore did not have a deuterated internal standard that was
similar enough in structure.
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3.2.4.4. Bias and precision
For bias and precision calculations, a blank pooled matrix of human liver (n=10) was spiked and
analyzed at low, medium, and high concentrations for the 34 target analytes in triplicate over five days
(n=15) and the results are displayed in Table 3.13. The bias for all 34 fentanyl analogs were within ±20%
and the %CV did not exceed 20%. None of the 34 fentanyl analogs had a bias that exceeded ±10% for any
of the low, medium, or high concentrations. The bias for the low ranged between -9.2% and 4.7%. The
bias for the medium ranged between 0.5% and 6.9% and the high ranged between -6.9% and 1.9%. Benzyl
fentanyl had a higher bias for low and medium concentrations however it did not exceed ±10%. The
addition of a deuterated internal standard for this compound could help reduce the bias for this fentanyl
analog. The between run and within run precision for all 34 fentanyl analogs were within the acceptable
criteria. Benzodioxole fentanyl had the highest within run %CV at the low concentration and had the
highest %CV for any analyte at any concentration but was still within the acceptable limit.
3.2.4.5. Limits
Triplicates of unique blank matrix sources spiked at the lowest non-zero calibrator were analyzed
over 3 days (n=9). Bias and precision (%CV) for LLOQ was considered acceptable at ±20% and are displayed
in Table 3.14. The bias for the LLOQs ranged from -7.8% to 12.0% and within the acceptable criteria. For
LOD to be considered acceptable, signal to noise (s/n) ratios were to be above 3.3 and qualifier ratios
within ±20% to achieve chromatographic acceptance. LOD values for each of the 34 fentanyl analogs are
listed in Table 3.14 below.
3.2.4.6. Carryover and dilution integrity
To evaluate carryover, blank matrix samples were injected directly after injections of samples with
concentrations three times greater than the highest calibrator using a triplicate analysis. No significant
carryover of analytes was detected in the blank matrix following the injection of samples with
concentrations three times greater than the highest calibrator. Table 3.15 displays the values of bias and
precision calculated for each analyte analyzed for dilution integrity. For the 34 analytes, the bias for the
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dilution integrity samples did not exceed ±10.1% or a precision greater than 12.5 %CV. Overall, the bias
for all analytes were negative indicating a lower than anticipated value. Even though the bias is deemed
acceptable this should be monitored in the future. The least dilution integrity bias was calculated for 4ANPP (-2.6 %) and the highest was para-fluoro acryl fentanyl (-10.1%).
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Table 3.12: Ionization suppression/enhancement.
Ionization Suppression/Enhancement
Compound

Low

High

Mean %

%CV

Mean %

%CV

2’-fluoro ortho-Fluorofentanyla

7.5

9.8

2.9

5.3

4-ANPPd

10.7

11.2

2.9

4.7

α-Methyl Acetyl

2.2

10.3

6.8

8.5

α-Methyl Butyryl Fentanylc

6.1

10.4

8.3

8.7

α-Methyl Thiofentanylc

-3.5

10.9

5.0

6.5

β-Hydroxythiofentanylb

-10.2

13.5

-0.3

6.6

Fentanyla

Acetyl

Fentanylc

7.3

10.3

9.3

7.5

Acryl Fentanyla

0.5

6.1

3.9

5.7

Benzodioxole Fentanylc

14.5

10.8

7.6

8.7

Benzyl

Fentanyld

-0.4

13.3

6.5

9.1

Butyryl

Fentanyld

Butyryl Norfentanyld
Carfentanila
Cis-3-Methyl Butyryl

8.7

4.3

7.5

17.4

10.9

13.2

5.8

7.0

-0.1

3.8

2.7

12.2

0.4

5.3

Fentanylb

1.7

7.6

3.7

4.8

Cyclopropyl Fentanylb
Despropionyl orthoFluorofentanylb
Fentanyla

5.3

9.5

5.0

4.9

0.5

14.5

2.3

8.0

3.4

7.5

0.1

4.8

FIBFa

8.8

14.0

11.0

17.6

Cyclopentyl

Fentanylb

9.0
23.7

Fentanyla

Furanyl
Furanyl Fentanyl 3furancarboxamide isomerd
Meta-Fluorofentanylc

7.9

8.0

3.4

6.5

11.2

10.5

4.3

9.2

2.3

16.2

2.3

4.7

Methoxy Acetyl Fentanyla

-4.4

15.8

-7.1

15.9

Norfentanyla

11.9

11.1

4.2

5.6

Para-Chlorofentanyld

8.9

10.8

6.0

11.2

14.5

16.3

10.2

19.2

Para-Chloroisobutyryl
Fentanyld
Para-Fluoro Acryl Fentanylc

7.9

10.9

3.3

6.0

Para-Methoxyfentanylc

3.6

9.6

5.5

6.5

Tetrahydrofuran Fentanylc

5.1

8.8

2.4

7.4

Fentanyld

Thienyl

-0.6

9.4

4.1

12.4

Thiofentanylc

-8.5

16.6

0.2

5.5

Trans-3-methyl Fentanylc

1.5

6.1

4.5

7.7

U-47700a

6.9

4.3

3.5

2.5

4.0

8.3

Fentanyla

Valeryl
3.5
6.8
Low concentration at 1 µg/kg, and high concentration at 50 µg/kg
b Low concentration at 0.5 µg/kg, and high concentration at 25 µg/kg
c Low concentration at 0.2 µg/kg, and high concentration at 10 µg/kg
d Low concentration at 0.1 µg/kg, and high concentration at 5 µg/kg
a
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Table 3.13:: Bias and precision data for the 34 fentanyl analogs.
Compound
2’-fluoro orthoFluorofentanyla
4-ANPPd

Bias (%)
LOW

MED

-3.2

Between Run (%CV)
HIGH

LOW

MED

HIGH

4.7

-0.2

6.1

5.4

-1.2

3.2

-2.9

11.0

Within Run (%CV)
LOW

MED

HIGH

6.9

5.5

4.8

9.2

9.6

9.1

9.6

9.6

11.0

α-Methyl Acetyl Fentanylc
α-Methyl Butyryl
Fentanylc
α-Methyl Thiofentanylc

2.3

1.6

0.3

16.8

7.4

7.6

12.5

9.6

13.2

-0.9

0.5

-6.9

5.5

5.6

16.5

6.4

5.8

12.2

4.6

4.3

0.8

13.9

4.3

5.5

11.5

4.8

5.7

β-Hydroxythiofentanylb

-3.0

5.1

-0.3

17.5

7.2

7.8

16.9

10.5

8.1

Acetyl Fentanyla

-7.8

5.3

0.3

8.3

6.8

8.8

10.4

10.3

14.4

Acryl Fentanyla

-0.1

6.0

-0.6

5.5

6.8

7.1

7.3

5.8

9.1

Benzodioxole

-3.2

4.6

0.8

13.5

6.7

6.5

19.3

9.2

8.9

Fentanyld

-9.2

6.5

0.3

13.1

7.9

7.7

15.2

11.9

8.9

Butyryl Fentanyld

-2.3

5.8

0.3

8.4

7.6

7.0

13.1

8.0

7.6

Butyryl Norfentanyld

-7.7

4.4

1.9

16.6

7.1

8.7

12.3

4.9

6.8

Carfentanila

-7.6

4.6

-0.1

8.6

7.2

6.9

9.9

7.7

9.6

-6.0

3.2

-2.0

7.8

4.6

7.0

9.1

5.7

10.1

Benzyl

Fentanylc

Cis-3-Methyl Butyryl
Fentanylb
Cyclopentyl Fentanylb

0.4

3.8

-1.6

6.3

5.4

7.2

5.4

6.4

7.4

Cyclopropyl Fentanylb
Despropionyl orthoFluorofentanylb
Fentanyla

-0.8

5.4

-1.0

6.4

6.2

6.2

10.1

6.0

7.0

-2.1

4.6

-1.2

8.4

6.2

6.8

9.2

6.7

8.9

-4.3

6.0

-0.8

7.1

7.5

7.4

10.6

6.3

7.8

FIBFa

-0.7

4.1

-0.8

5.6

5.3

6.6

5.2

4.0

9.2

Furanyl
Furanyl Fentanyl 3furancarboxamide isomerd
Meta-Fluorofentanylc

-2.9

4.0

1.4

7.4

5.1

6.4

9.1

7.4

10.2

-1.3

6.9

1.8

11.6

6.1

8.1

17.7

7.3

10.9

-0.7

3.5

-0.5

7.0

6.6

7.3

11.0

8.2

10.7

Methoxy Acetyl Fentanyla

-4.0

3.8

-1.6

9.6

7.5

7.9

8.2

9.3

11.0

Norfentanyla

-0.2

1.2

1.6

10.5

8.7

5.8

11.7

8.4

8.0

Para-Chlorofentanyld

-4.3

4.0

-0.1

11.5

7.4

8.2

8.4

9.9

8.9

-3.0

3.1

-3.3

11.3

7.0

8.4

15.4

10.1

11.1

4.2

4.1

-1.1

5.0

9.6

7.6

6.6

15.7

10.4

Fentanyla

Para-Chloroisobutyryl
Fentanyld
Para-Fluoro Acryl
Fentanylc
Para-Methoxyfentanylc

3.0

5.8

-1.1

9.3

6.1

7.5

16.7

7.0

9.4

Tetrahydrofuran Fentanylc

2.2

4.7

0.1

6.2

4.3

7.3

9.8

5.3

6.7

Thienyl Fentanyld

-3.1

5.4

-0.1

9.6

8.2

6.6

6.4

4.9

9.8

Thiofentanylc

1.5

3.4

-1.9

10.8

4.4

7.5

15.3

7.2

10.7

Trans-3-Methyl

Fentanylc

4.7

4.2

-1.5

5.1

6.1

8.0

7.9

5.7

9.1

U-47700a

3.2

6.1

0.3

7.4

6.6

7.8

9.0

6.5

8.7

Valeryl Fentanyla

-3.7

4.2

0.0

5.7

6.2

7.0

8.9

10.1

8.2

Low concentration at 0.5 µg/kg (with the exceptions of drugs acetyl fentanyl, carfentanil and methoxy acetyl fentanyl which are at 0.1 µg/kg),
medium concentration at 10 µg/kg, and high concentration at 80 µg/kg
b Low concentration at 0.25 µg/kg, medium concentration at 5 µg/kg, and high concentration at 40 µg/kg
c Low concentration at 0.1 µg/kg, medium concentration at 2 µg/kg, and high concentration at 16 µg/kg
d Low concentration at 0.05 µg/kg, medium concentration at 1 µg/kg, and high concentration at 8 µg/kg
a
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Table 3.14: LOD, LLOQ, and AMR.
LLOQb (n=9)

LODa
(µg/kg)

Bias

%CV

AMRc
(µg/kg)

2’-fluoro orthoFluorofentanyl

0.5

1.3

9.5

0.5-100

4-ANPP

0.05

4.2

12.1

0.05-10

α-Methyl Acetyl fentanyl

0.1

-5.6

12.8

0.1-20

α-Methyl Butyryl Fentanyl

0.1

14.1

15.6

0.1-20

α-Methyl Thiofentanyl

0.1

1.2

16.2

0.1-20

β-Hydroxythiofentanyl

0.25

-2.6

5.8

0.25-50

Acetyl Fentanyl

0.1

-7.0

9.3

0.1-100

Acryl Fentanyl

0.5

-0.4

10.3

0.5-100

Benzodioxole Fentanyl

0.1

3.8

16.4

0.1-20

Benzyl Fentanyl

0.05

3.5

12.2

0.05-10

Butyryl Fentanyl

0.05

-4.1

6.1

0.05-10

Butyryl Norfentanyl

0.05

-3.3

11.2

0.05-10

Carfentanil

0.1

-2.4

2.7

0.1-100

Cis-3-Methyl Butyryl
Fentanyl

0.25

-0.6

10.5

0.25-50

Cyclopentyl Fentanyl

0.25

-5.5

8.2

0.25-50

Cyclopropyl Fentanyl

0.25

1.5

8.8

0.25-50

Despropionyl orthoFluorofentanyl

0.25

-7.8

7.7

0.25-50

Fentanyl

0.5

-4.6

10.2

0.5-100

FIBF

0.5

-0.1

9.8

0.5-100

Furanyl Fentanyl

0.5

12.0

12.9

0.5-100

Furanyl Fentanyl 3furancarboxamide isomer

0.05

4.7

10.8

0.05-10

Meta-Fluorofentanyl

0.1

-5.5

16.4

0.1-20

Methoxy Acetyl Fentanyl

0.1

3.9

8.9

0.1-100

Norfentanyl

0.5

6.1

8.8

0.5-100

Para-Chlorofentanyl

0.05

-9.2

15.9

0.05-10

0.05

-3.8

14.5

0.05-10

0.1

7.3

9.8

0.1-20

0.1

-6.2

10.4

0.1-20

Compound

Para-Chloroisobutyryl
Fentanyl
Para-Fluoro Acryl
Fentanyl
Para-Methoxyfentanyl
Tetrahydrofuran Fentanyl

0.1

0.5

14.8

0.1-20

Thienyl Fentanyl

0.05

-6.4

15.8

0.05-10

Thiofentanyl

0.1

4.9

12.1

0.1-20

Trans-3-Methyl Fentanyl

0.1

3.0

10.0

0.1-20

U-47700

0.5

0.2

10.9

0.5-100

Valeryl Fentanyl

0.5

-12.7

7.3

0.5-100

LOD (Limit of detection)
b LLOQ (Lower limit of quantitation)
c AMR (Analytical measurement range)
a
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3.2.4.7. Processed sample stability
Processed sample stability in the autosampler was evaluated in triplicate at low and high
concentrations for four time intervals up to 72 hours. All 34 fentanyl analogs were stable beyond 48 hours
however valeryl fentanyl was exceeded 20% after 72 hours at the low and high concentrations (Table
3.16).
Table 3.15: Dilution integrity of post extraction dilution at a 1:5 dilution (n=15).
Compound
2’-fluoro ortho-Fluorofentanyla
4-ANPPd
α-Methyl Acetyl Fentanylc
α-Methyl Butyryl Fentanylc
α-Methyl Thiofentanylc
β-Hydroxythiofentanylb
Acetyl Fentanyla
Acryl Fentanyla
Benzodioxole Fentanylc
Benzyl Fentanyld
Butyryl Fentanyld
Butyryl Norfentanyld
Carfentanila
Cis-3-Methyl Butyryl Fentanylb
Cyclopentyl Fentanylb
Cyclopropyl Fentanylb
Despropionyl ortho-Fluorofentanylb
Fentanyla
FIBFa
Furanyl Fentanyla
Furanyl Fentanyl 3-furancarboxamide isomerd
Meta-Fluorofentanylc
Methoxy Acetyl Fentanyla
Norfentanyla
Para-Chlorofentanyld
Para-Chloroisobutyryl Fentanyld
Para-Fluoro Acryl Fentanylc
Para-Methoxyfentanylc
Tetrahydrofuran Fentanylc
Thienyl Fentanyld
Thiofentanylc
Trans-3-Methyl Fentanylc
U-47700a
Valeryl Fentanyla

Dilution Integrity (Bias %)

% CV

-6.3
-2.6
-5.6
-7.0
-6.0
-8.0
-6.6
-7.0
-6.1
-4.9
-7.3
-3.4
-4.6
-5.6
-5.5
-8.3
-7.1
-7.6
-5.7
-4.9
-6.6
-7.1
-4.3
-3.6
-6.5
-2.3
-10.1
-7.3
-7.9
-5.4
-6.1
-6.3
-7.4
-8.9

10.7
10.0
11.4
8.6
11.8
10.3
10.3
10.4
11.4
11.2
11.2
11.2
9.4
9.1
11.6
8.3
8.8
10.2
10.0
11.2
11.9
10.9
12.4
11.7
11.9
11.2
10.6
9.2
11.1
11.8
11.4
9.7
12.5
8.6

Concentration at 300 µg/kg
Concentration at 150 µg/kg
c Concentration at 60 µg/kg
d Concentration at 30 µg/kg
a

b

85

Table 3.16: Stability at a low and high concentration for the 34 analytes for processed samples stored in the autosampler (25 °C )
Low (% e)

Compound

High (% e)

24 h

48 h

72 h

24 h

48 h

72 h

2’-fluoro ortho-Fluorofentanyla

-0.3

2.7

7.1

-0.4

1.9

2.4

4-ANPPd

7.1

12.0

8.7

0.6

2.7

-0.5

α-Methyl Acetyl ]Fentanylc

0.7

5.0

-0.2

-2.5

4.6

-0.6

α-Methyl Butyryl Fentanylc

-0.3

4.6

4.6

-1.1

3.4

1.0

α-Methyl Thiofentanylc

1.2

2.1

-0.8

-0.4

0.4

-2.5

β-Hydroxythiofentanylb

1.3

13.9

10.7

-1.8

4.2

1.7

Acetyl Fentanyla

-1.2

4.6

2.8

-2.3

1.8

0.9

Acryl Fentanyla

-0.1

2.2

-0.1

-3.0

1.7

-2.2

Benzodioxole Fentanylc

-4.6

3.4

4.1

-1.5

3.9

0.9

Benzyl Fentanyld

1.6

8.1

2.0

0.2

0.7

-2.1

Butyryl Fentanyld

0.0

6.6

4.5

-1.9

2.7

-0.3

Butyryl Norfentanyld

3.0

5.4

-0.5

1.6

3.5

-0.6

Carfentanila

-1.6

3.0

3.6

-3.0

1.9

-0.4

Cis-3-Methyl Butyryl Fentanylb

4.0

7.5

3.4

1.4

2.8

2.2

Cyclopentyl Fentanylb

-5.5

2.1

9.1

-13.8

-0.3

4.6

Cyclopropyl Fentanylb

1.1

0.2

3.0

0.5

1.9

0.2

Despropionyl ortho-Fluorofentanylb

-6.7

2.6

2.0

-12.1

0.0

-1.0

Fentanyla

0.4

4.5

1.8

-1.7

3.3

0.9

FIBFa

2.2

5.4

6.6

0.1

4.83

2.2

Furanyl Fentanyla

0.3

2.8

0.2

-1.2

2.5

-0.2

Furanyl Fentanyl 3-furancarboxamide isomerd

-2.7

1.6

-1.0

-2.5

4.0

-2.9

Meta-Fluorofentanylc

2.2

4.6

2.7

-2.5

2.7

-1.0

Methoxy Acetyl Fentanyla

-0.8

3.0

-0.3

1.7

4.7

0.8

Norfentanyla

10.0

14.3

13.8

1.3

7.2

4.2

Para-Chlorofentanyld

-4.0

10.6

6.7

-8.9

3.6

-0.5

Para-Chloroisobutyryl Fentanyld

-3.6

13.5

5.6

-5.2

9.6

4.6

Para-Fluoro Acryl Fentanylc

-2.7

-3.8

4.0

-0.3

1.4

-2.2

Para-Methoxyfentanylc

-1.1

1.1

3.5

-1.3

-1.2

-1.6

Tetrahydrofuran Fentanylc

-4.1

6.4

-0.1

-1.8

1.1

0.1

Thienyl Fentanyld

-7.5

2.9

0.9

0.7

2.9

0.6
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Thiofentanylc

0.6

0.2

-2.0

0.1

0.7

-2.8

Trans-3-methyl Fentanylc

-4.9

3.2

1.7

-12.6

-1.4

-1.4

U-47700a

0.9

7.1

2.5

-1.6

2.6

-1.3

-12.2

-12.0

21.6

-4.7

5.1

31.2

Valeryl Fentanyla

Low concentration at 5 µg/kg, and high concentration at 50 µg/kg
Low concentration at 2.5 µg/kg, and high concentration at 25 µg/kg
c Low concentration at 1 µg/kg, and high concentration at 10 µg/kg
d Low concentration at 0.5 µg/kg, and high concentration at 5 µg/kg
e %  inidicates the percent change for the time interval response compared to time zero response
a

b

3.2.4.8. Recovery, matrix effects and process efficiency
The analysis of the recovery, matrix effects and process efficiency were calculated for each of the
34 fentanyl analogs at their respective concentrations listed in Table 3.17. The average matrix effects at
low and high concentrations for the 34 fentanyl analogs were 99.2% and 98.3% respectively. The average
recovery at low and high concentrations for the 34 fentanyl analogs were 101.1% and 104.4% respectively.
The average process efficiencies for all 34 fentanyl analogs were at 100.2% and 102.6% for the low and
high concentrations respectively.
3.2.4.9. Proof of applicability
Liver specimens from 22 authentic postmortem cases provided by the West Virginia OCME (n=17)
and WVU Human Gift Registry (n=5) were submitted for analysis. The human specimens submitted by the
OCME were from suspected drug related deaths, while the specimens from the WVU Human Gift Registry
were not suspected of drug related deaths. The northeastern U.S. is heavily impacted by drug overdose
deaths, containing the top six states with the highest age-adjusted mortality rates with West Virginia (51.5
per 100,000 standard population) having the highest rate (84).
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Table 3.17: Matrix effects, recovery, and process efficiency.
Compound
2’-fluoro orthoFluorofentanyl
4-ANPP
α-Methyl Acetyl
Fentanyl
α-Methyl Butyryl
Fentanyl
α-Methyl Thiofentanyl
β-Hydroxythiofentanyl
Acetyl Fentanyl
Acryl Fentanyl
Benzodioxole Fentanyl
Benzyl Fentanyl
Butyryl Fentanyl
Butyryl Norfentanyl
Carfentanil
Cis-3-Methyl Butyryl
Fentanyl
Cyclopentyl Fentanyl
Cyclopropyl Fentanyl
Despropionyl orthoFluorofentanyl
Fentanyl
FIBF
Furanyl Fentanyl
Furanyl Fentanyl 3furancarboxamide
isomer
Meta-Fluorofentanyl
Methoxy Acetyl
Fentanyl
Norfentanyl
Para-Chlorofentanyl
Para-Chloroisobutyryl
Fentanyl
Para-Fluoro Acryl
Fentanyl
Para-Methoxyfentanyl
Tetrahydrofuran
Fentanyl
Thienyl Fentanyl
Thiofentanyl
Trans-3-Methyl
Fentanyl
U-47700
Valeryl Fentanyl
a

Matrix Effects (%)
Low (1 µg/kg)
High (50 µg/kg)
Low (0.1 µg/kg)
High (5 µg/kg)
Low (0.1 µg/kg)
High (10 µg/kg)
Low (0.1 µg/kg)
High (10 µg/kg)
Low (0.1 µg/kg)
High (10 µg/kg)
Low (0.1 µg/kg)
High (25 µg/kg)
Low (1 µg/kg)
High (50 µg/kg)
Low (1 µg/kg)
High (50 µg/kg)
Low (0.1 µg/kg)
High (10 µg/kg)
Low (0.1 µg/kg)
High (5 µg/kg)
Low (0.5 µg/kg)
High (5 µg/kg)
Low (0.5 µg/kg)
High (5 µg/kg)
Low (1 µg/kg)
High (50 µg/kg)
Low (0.5 µg/kg)
High (25 µg/kg)
Low (0.5 µg/kg)
High (25 µg/kg)
Low (0.5 µg/kg)
High (25 µg/kg)
Low (0.5 µg/kg)
High (25 µg/kg)
Low (1 µg/kg)
High (50 µg/kg)
Low (1 µg/kg)
High (50 µg/kg)
Low (1 µg/kg)
High (50 µg/kg)
Low (0.1 µg/kg)

101.9
101.8
108.4
99
108.1
97.1
97.9
99.8
101.3
99.2
113.7
92.6
82.8
93.9
100.8
101.2
105
104
96.4
99.8
99.4
99
92.5
97.8
103
101.6
82.7
88.9
99.9
98.9
99.2
100
97.9
98.1
99.8
100.1
101.7
101.7
102.9
100.1
101.6

RSDa
(%)
11.6
5.3
13.5
8
13.2
8.3
12
8.1
14
8
24.1
8.5
11.1
8.2
9.7
5
11.6
6.6
11.6
6.8
9.5
5.5
9.3
3.8
9.7
6.6
11.5
9.3
10.1
7.5
10.8
7.4
10.2
6.3
9.1
5.1
10.4
6.1
9.4
5.3
9.4

Recovery (%)
97.6
109.3
97.5
105.6
114.5
102.5
95.2
95.7
96.5
97.3
95.6
96.8
114.4
124.5
97.9
116.2
111.7
97.7
107.3
98.9
99.4
110.5
95.5
104.4
97.8
102.8
102.7
100
95.5
97.4
99.5
95.6
99.5
101.4
97.5
112.6
95.9
99.6
101.8
130.3
103.6

RSDa
(%)
8.2
7.5
8.7
9.5
21.6
10.2
10
9.3
14.2
8.7
23.3
9.4
10.2
10.5
6.2
7
14.1
7.7
16
8
6.2
7.4
7.4
7.5
7.4
8.2
11.5
11.2
7.3
8.6
8.3
7.9
8.7
7.4
7
6.7
6.2
7.6
6.2
7.9
5.3

Process Efficiency (%)
99.4
111.3
105.7
104.6
123.8
99.5
93.2
95.5
97.8
96.5
108.7
89.7
94.7
117
98.6
117.6
117.3
101.6
103.4
98.7
98.8
109.3
88.3
102.1
100.7
104.5
85.0
89.0
95.5
96.4
98.8
95.7
97.4
99.5
97.4
112.6
97.5
101.3
104.8
130.4
105.3

RSDa
(%)
12.1
6.5
13.4
7.6
22.7
8.6
13.2
7.5
15.8
6.7
25.4
7
12.5
7.6
9.9
6
16.5
5.6
18.4
6.5
10.1
6.2
9.1
6.9
10.3
7.4
10.9
8.9
11.2
6.7
12.5
6.1
11.6
5.7
10
5.8
10.6
6.4
9.6
7.4
8.4

High (5 µg/kg)

99.9

5.7

127

8.3

126.8

7.6

Low (0.1 µg/kg)
High (10 µg/kg)
Low (1 µg/kg)
High (50 µg/kg)
Low (1 µg/kg)
High (50 µg/kg)
Low (0.1 µg/kg)
High (5 µg/kg)
Low (0.1 µg/kg)
High (5 µg/kg)
Low (0.1 µg/kg)
High (10 µg/kg)
Low (0.1 µg/kg)
High (10 µg/kg)
Low (0.1 µg/kg)
High (10 µg/kg)
Low (0.1 µg/kg)
High (5 µg/kg)
Low (0.1 µg/kg)
High (10 µg/kg)
Low (0.1 µg/kg)
High (10 µg/kg)
Low (1 µg/kg)
High (50 µg/kg)
Low (1 µg/kg)
High (50 µg/kg)

102.1
98.4
76.8
86.4
110.4
94.3
100
99.3
102.1
100.5
94.4
101.9
95.7
99.4
97.6
96.3
101
99.8
97
95.7
96.7
98
101.8
99
100.1
99.6

12.8
7.5
11.4
7
13.5
4.4
11.1
7.3
11.2
6.8
21.2
10
14.2
7.5
12.4
7.2
12.3
7.8
25.2
7.3
13.4
6.5
9.2
7.1
9.4
5.4

98.5
95.6
106.1
118
97.8
116.3
99.6
96.2
105.7
105.8
104.3
96.7
102.3
93.9
93.9
95.6
98.7
100.3
121.5
97.4
93.3
95.8
98.2
98.2
100.5
114.1

12.4
9.1
9.4
10.5
14
9.1
10.1
8.4
8
9.6
18
10.7
14
8.4
10.1
7.8
10.1
8.2
20.6
8.2
12.7
7.7
7.5
8
6.2
7.2

100.6
94.1
81.5
102
108
109.7
99.6
95.5
108
106.4
98.4
98.6
97.9
93.4
91.7
92.1
99.7
100.1
117.9
93.2
90.2
93.9
100
97.2
100.6
113.7

15.9
7.3
11
9.2
11.4
9.1
12.1
6.7
11.8
8.7
19.5
8.4
14.6
6.9
11.5
6.1
13.6
6.9
22.2
6.2
15.3
6.5
9.8
6.4
9.9
6

RSD (relative standard deviation)
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Of the 22 specimens, 17 contained fentanyl and metabolites plus at least one fentanyl analog.
Three specimens were positive for only fentanyl and metabolites. Two specimens were only positive for
FIBF as the only analyte present. The highest concentration for any fentanyl analog was 541 µg/kg for
FIBF, which was the only target analyte detected in that sample. Nine of the 22 samples contained at least
two fentanyl analogs in addition to fentanyl and metabolites. Three of the 22 samples contained three
fentanyl analogs along with fentanyl and metabolites. The concentrations for fentanyl (n=20) ranged
between 3.6 µg/kg to 165 µg/kg with a mean of 54.7 µg/kg. The fentanyl analog that was most
encountered was methoxyacetyl fentanyl (n=11) with a minimum concentration of 0.2 µg/kg, a maximum
of 4.6 µg/kg, and a mean of 1.3 µg/kg. Acetyl fentanyl was detected in six specimens with a mean
concentration of 23.3 µg/kg and carfentanil was found in five specimens with a mean concentration of 8.4
µg/kg. Methoxyacetyl fentanyl and acetyl fentanyl have a potency of approximately 0.3 times that of
fentanyl however carfentanil has a potency of 30 to 100 times that of fentanyl (91). Of the 22 specimens,
three contained only fentanyl with metabolites and two contained only a fentanyl analog. This indicates
that fentanyl was detected in combination with at least one fentanyl analog in a majority of the liver
specimens. Due to the potency of fentanyl analogs and the various degrees of tolerance for different
users, a wide range of concentrations encountered in case samples is not uncommon and have been
reported in recent publications (130, 139).
All of the specimens from the WVU Human Gift Registry were positive for norfentanyl and fentanyl, with
mean concentrations of 6.4 µg/kg (range 1.0 to 14.1 µg/kg) and 30.5 µg/kg (range 3.9 to 117) respectively.
All samples were positive for at minimum one target analyte from the 34 compounds and the results are
shown in Table 3.18. For the 17 OCME samples, norfentanyl was detected in 11 and fentanyl in 15, with
mean concentrations of 10 µg/kg (range 0.5 to 45 µg/kg) and 62.8 µg/kg (range 3.6 to 165 µg/kg)
respectively. The concentrations of norfentanyl and fentanyl were substantially higher in the OCME liver
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specimens compared to those from the WVU Human Gift Registry, which is to be expected as the OCME
specimens were from drug related overdose deaths while the others involved therapeutic use.
Table 3. 18: Authentic postmortem liver results.
# positive
samples

Mean
(µg/kg)

Standard
Deviation

Median
(µg/kg)

Min
(µg/kg)

Max
(µg/kg)

Fentanyl

20

54.7

48.8

51.2

3.6

164.9

Norfentanyl

16

8.9

11.6

5.9

0.5

45

4-ANPP
Methoxy Acetyl
Fentanyl
Acetyl Fentanyl

15

8.9

8.9

6.9

0.9

33.6

11

1.3

1.4

0.9

0.2

4.6

6

7.2

9.7

2.0

0.3

23.3

Carfentanil

5

2.0

3.6

0.3

0.2

8.4

FIBF
α-Methyl Acetyl
Fentanyl
Trans-3-methyl
Fentanyl
Valeryl Fentanyl

4

138.8

268.5

6.6

0.6

541.4

2

1.0

–

1.0

1.0

1.1

1

32.4

1

1.1

–
–

–
–

–
–

–
–

Compound

Various NSOs have been studied in multiple matrices including blood, urine, hair, oral fluid, and
other tissues however, the matrices most studied are blood or urine (77, 126, 127, 140–142). Recent
publications on extractions from postmortem blood and tissue report percent ionization suppression for
fentanyl analogs greater than -20% while using traditional solid phase extraction (SPE) techniques that
utilize organic solvents in mL volumes per sample (133, 142). The method developed in this study
presented percent ionization suppression/enhancement numbers below 15% for most analytes while
using amount of organic solvent in µL volumes per sample. Extraction techniques that are used to
overcome these challenges are often expensive and time consuming however, this study presents a costeffective method for direct organic solvent to tissue extraction in combination with a d-SPE clean up that
does not require large volumes of solvent compared to conventional SPE techniques.
The presented work is an expansion of a previously liver extraction focused on only fentanyl while
this study expanded the panel to more fentanyl analogs. Overall, the method was validated following the
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criteria of the ASB 036 but has its limitations. The dilution integrity having a negative bias for all 34
analytes could be a weakness that can be improved even though it passed validation. A limitation of the
study is not having paired matrix evaluation. Future work would be to test paired matrix samples (blood,
liver, brain, etc) to draw conclusions and expand the value of the analysis to postmortem toxicology
interpretations.
3.2.5. Conclusions
The QuEChERS extraction and subsequent LC–MS/MS method was fully validated using the ASB
Standard 036 requirements for fentanyl, metabolites, and fentanyl analogs in liver tissue. The bias for all
34 target analytes at low, medium, and high concentrations did not exceed ±20% with repeatability and
reproducibility within the 20% threshold. The QuEChERS technique had recoveries > 93.3%, MEs > 76.8%
and process efficiencies > 81.5% for all 34 target analytes. For storage in the autosampler, the samples
are stable for 48 hours for all 34 fentanyl analogs and all but valeryl fentanyl were stable for 72 hours. Of
the 22 authentic postmortem samples, 17 were multidrug positive with at least one fentanyl analog and
fentanyl present indicating a prevalence of multiple fentanyl types in use. Nine of the 22 samples
contained at least two fentanyl analogs plus fentanyl and metabolites. Three of the 22 samples contained
three fentanyl analogs plus fentanyl and metabolites.
Overall, the QuEChERS extraction met all the acceptable criteria set by the ASB Standard 036
requirements and was shown to be effective at extracting and quantitating fentanyl and fentanyl analogs.
The presented QuEChERS protocol meets all the requirements for liver extraction and proved to be
effective at analyzing authentic liver specimens.
With the number of fentanyl overdose-related deaths continuing to increase, the interpretation
of toxicological findings in these cases is crucial. The presented work consists of a comprehensive strategy
to facilitate the extraction of novel synthetic opioids (NSO) including fentanyl and its major metabolites
from a complex biological specimen, liver tissue. This chapter presented a sensitive and effective

91

extraction strategy for liver tissue, an analytical method for 34 analytes to encompass potential emerging
NSO’s, and a survey of which specific NSO’s are prevalent in the drug overdose community. This chapter
provides an advancement in the combat of opioid epidemic by offering a fully validated protocol that
complement the analytical toolkit in forensic toxicology laboratories and medical examiners offices.
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Chapter 4: Evaluation of the Effects of Fentanyl on Blowfly Larva and Application of
QuEChERS Extraction Method for the Quantitation of Fentanyl and Metabolites from
Larva and Pupa (Lucilia sericata)
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4.1. Chapter Overview
In this chapter, section 1 presents the validation of the extraction method for the analysis of fentanyl
and metabolites from larva and pupa tissue for part of task 1.b. Also presented is the preliminary study
for the purpose of validating the extraction method with extraction from authentic insect samples.
Section 2 of this chapter presents the morphometric comparisons for the larva and pupa reared in
task 2.a. For all the insect stages, physical characteristics were recorded to evaluate the effects each
treatment had on growth (task 2.b). To determine the effects of fentanyl on the growth and development
of the blow flies, the mass, and percent stage (first instar, second instar, third instar, or pupa) of the insect
were statistically compared using nested ANOVA (task 2.c). Tukey-HSD test will be applied to determine
which treatments are significantly different within each replicate. These statistical tests will determine if
the drug treatments have any significant effects on the insect’s development. Age estimation using the
mean length will be presented as well as the maximum length collected at each day.
Section 3 of this chapter presents the toxicological findings for the larva and pupa for task 1.e. The
presented modified QuEChERS extraction was used for extraction of the feeding media liver and the insect
tissue. The survey of fentanyl and metabolites detected in the larva and pupa is presented in this section.
For task 3.a, a regression plot was created for a comparison of the fentanyl concentrations detected in
the insect tissue to the liver fentanyl concentrations to establish any correlation of the concentrations.

4.2. Section 1: Validation of QuEChERS Extraction for Larva and Pupa
4.2.1. Introduction
Entomological techniques are utilized in forensic investigations to estimate the minimum time since
death—this approach, consisting of using the growth and development of insects. Maggots follow a
predictable life cycle that xenobiotics can influence. Even though entomology can be used to estimate the
minPMI

due to the predictable nature of insect growth, the base assumption of predictable growth in a

given environment is violated when insects are affected by xenobiotic influences if drugs or poisons
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present in the cadaver they have colonized (43–45). Forensic entomotoxicology, an area of growing
interest , is concerned with the detection of drugs or toxins in insects, and exploring the implications such
materials may pose on insect development (42, 50). For instance, recent reports including
methamphetamine, cocaine, ketamine, morphine, and tramadol have shown contrasting effects on insect
development (45–49). Stimulant drugs such as methamphetamine and cocaine, appeared to have an
increasing effect on the physical development rate and body size of the blow flies (46, 48). It was found
that the overall developmental time was shorter in the presence of cocaine, and the general insect growth
being larger for both cocaine (Chrysomya albiceps (Wiedemann) and Chrysomya putoria (Wiedmann)
(Diptera: Calliphoridae)) and methamphetamine laced diets (Calliphora stygia (Fabricius) (Diptera:
Calliphoridae)) (46, 48). Among depressant-type drugs, morphine was shown to have no significant effect
on size or development rates of C. stygia (47); however, ketamine and tramadol appeared to increase
body size for the larvae of Lucilia sericata (Meigen) (Diptera: Calliphoridae) (45, 49). Changes in physical
characters or developmental rates of insects due to the presence of xenobiotics can significantly impact
minPMI

estimations, leading to either under- or overestimation of time since death (46). Understanding

the effects that drugs can have on insect growth and development is important in terms of estimating
minPMI

in cases that involve toxins or overdose deaths (50). Bioaccumulation of drugs and toxins in insect

life stages has been documented and used to corroborate cause of death as well (39, 50, 58, 59, 110). In
instances with advanced decomposition, exsanguination, and even burn victims, traditional biological
matrices of fluid or tissue may not be available or additional matrices of analysis for corroboration may
be needed (39, 50, 59).
In 2019, there were 49,860 reported deaths in the United States, due to overdose of opioids such
as heroin and oxycodone and 36,359 deaths related to synthetic opioids including fentanyl (85). Fentanyl
is of particular concern as it is a highly effective µ-opioid agonist up to 50-100 times as potent as morphine
(91). Mixed-drug preparations of heroin with fentanyl and/or other synthetic opioids also associated with
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a large number of deaths (113, 143). In response to epidemic, our research group is currently focused on
the design and development of novel extraction approaches that facilitates the isolation, purification,
enrichment of fentanyl and other novel psychoactive substances in different biological matrices, including
indirect sources such as necrophilous insects.
An effective extraction of fentanyl from the insect matrix is a critical step to provide an accurate
interpretation on drug presence and overall developmental outcomes. Heroin, methadone, morphine,
and tramadol are exemplars that have been tested over insect matrices and subjected to extraction
mechanisms with varying performance rates (43–45, 47, 144). Previous studies have shown limitations to
extract methamphetamine from larval stages but better success rates at detecting the drug in later stages
of pupae, empty puparia, and adults (46). The inability to extract this stimulant drug from the larval stages
was attributed to the limitations of the methanolic extraction used in combination with the lipid content
of larval tissue (46, 145). Therefore, releasing the drug from the matrix plays a significant role in gaining
insight on drug content. To this end, emerging techniques such as QuEChERS are necessary when dealing
with tissue specimens. QuEChERS stands for quick, easy, cheap, effective, rugged, and safe and it has been
reported as a versatile extraction technique to process human liver tissue, blood, and hair (4, 79, 146–
148). This research work will expand the scope of application towards the extraction of larva and pupa
tissue following specific validation guidelines from the Academy Standard Board 036. A quantitative
method using tandem mass spectrometry for the quantitation of fentanyl and metabolites using tandem
mass spectrometry is also reported.
While several drugs have been explored in entomotoxicological studies, little is known about the
direct effects that fentanyl may pose on the growth and development of blow fly larvae. Therefore, it is
crucial to understand the role of this drug in the development of Lucilia sericata blow flies. The
overarching goals of this study are to evaluate the developmental effects of fentanyl on immature stages
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of the blow fly Lucilia sericata (Meigen)) and to monitor the prevalence of fentanyl and metabolites from
larval and pupal tissue after feeding on liver tissue with the presence of fentanyl.
4.2.2. Methods
4.2.2.1. Adult Colony
Adult colonies of L. sericata were established in May 2018 from field collected specimens from
Morgantown, West Virginia, USA. The collected insects were allowed to grow to adulthood and adults
were identified as L. sericata by physical morphological characters (62). The colony was housed in
BugDorm1 (MegaView Co., Ltd., Taiwan) screen cages (30 cm x 30 cm x 30 cm) stored in a Percival
I36LLVLC8 incubator (Percival Scientific, Inc., Perry, Iowa, USA) at 25 °C (± 0.5 °C) at 65% relative humidity
(± 10%) with a 12:12 (L:D) photoperiod. Adults were given honey and water ad libitum and raw beef liver
was provided for oviposition. New generations were separated from adults after oviposition to signal the
beginning of the next generation and were moved to a new screen cage during emergence.
4.2.2.2. Experimental Design
In order to truly test the ability of the QuEChERS extraction to extract fentanyl and metabolites
from larva and pupa tissue, authentic insects that feed on tissue fortified with fentanyl were required. To
create authentic insects as toxicology specimens, fentanyl was spiked into 20 g aliquots of human liver
homogenate to evaluate four concentrations: control (0 µg/kg), low (10 µg/kg), medium (100 µg/kg), and
high (350 µg/kg) concentrations. To each aliquot of liver, approximately 50-60 eggs (by mass) were placed
and allowed to feed undisturbed until time of collection. Egg mass estimates were generated by weighing
16 egg masses (average n = 26) and by calculating the mass of one egg. The average weight of one egg
was used to divide the mass of the eggs placed on the livers to estimate the number of eggs placed. For
the larval treatment, third instar larvae at day 4 post transfer. For the pupal treatment, pupae were
collected at day 12 after transfer. Larvae were collected and heat killed with boiling water for 90 s and
rinsed with methanol before stored at -20 °C with no liquid preservatives added (7, 40, 46). Collected
pupae were rinsed with deionized water and then methanol before being stored at -20 °C with no addition
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of any liquid preservative. No preservative was chosen due to the larval cuticle acting as a semipermeable
membrane which can allow water or ethanol to diffuse into the body cavity and potential to leech out the
target analytes into the preservative solution (149). To evaluate developmental effects, the mass (mg),
length (mm), and width (mm) of the collected insects were documented (Figure 4.1). Metrics also
evaluated were survivor rates, percent stage, and percent pupated. Statistical analysis was not performed
as there was only one replicate for each collection day, the measurement of physical characters was purely
exploratory. Insects from each treatment level and day of collection were randomly selected (n=5) and
extracted using the validated QuEChERS extraction. Larval specimens were also randomly selected into
pools of four for triplicate analysis of pooled samples (n=3).

(a)

(b)

Figure 4.1: Larvae (day 4) and pupae (day 12) measurements of length and width (mm).
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4.2.2.3. Chemicals and Materials
Drug standards: fentanyl, norfentanyl, 4-ANPP, fentanyl-D5, 4-ANPP-D5, and norfenanyl-D5 were
obtained from Cerilliant (Round Rock, Tx) at concentrations of 1 mg/mL or 100 μg/mL in methanol. βhydroxy fentanyl (hydrochloride) was purchased from Cayman Chemical (Ann Arbor, MI) and was
reconstituted to a concentration of 100 μg/mL in methanol. Optima® liquid chromatography-mass
spectrometry (LC-MS) grade methanol, acetonitrile, formic acid, and ammonium formate were purchased
from Thermo Fisher Scientific (Fair Lawn, NJ). Water was purified using a Direct-Q 3 UV Water Purification
System (Darmstadt, Germany). The QuEChERS original extraction salt packets (containing 6 g magnesium
sulfate and 1.5 g sodium chloride) and 2 mL dispersive-SPE tubes (containing 25 mg of primary secondary
amine, 25 mg end-capped octadecylsilane (C18EC) and 150 mg magnesium sulfate) were purchased from
Agilent Technologies. A Mixer Mill MM 200 was utilized for homogenization and was obtained from Retsch
(Haan, Germany). Steel zinc plated BB balls (0.177 cal, 4.5 mm) were obtained from Daisy (Rogers, AR)
and were cleaned with hexane before use.
4.2.2.4. LC-MS/MS
Quantitation of fentanyl and metabolites was performed using an Agilent 6470 Triple Quadrupole
system coupled with an Agilent 1290 Infinity II LC system. A Zorbax Eclipse Plus C 18 RRHD 3.0 x 100 mm,
1.8 μm column was used for chromatographic separation using mobiles phases of 0.1% formic acid and 5
mM ammonium formate in water (mobile phase A) and 0.1% formic acid in methanol (mobile phase B).
Data acquisition was performed in dynamic multiple reaction monitoring (dMRM) mode with positive ESI
with a principal dMRM transition for quantitation and one qualifier dMRM transition for each analyte. For
chromatographic separation a gradient elution at a flow rate of 0.3 mL/min was run as follows: initial hold
for 0.5 min at 60% mobile phase B with a ramp to 65% for 3 min, followed by a ramp to 95% for 0.5 min
with a hold for 1 min and a 3 min post run for re-equilibrium at 60% B. Chromatographic separation is
shown in Figure 4.2.
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Figure 4.2: Chromatographic separation of norfentanyl, β-hydroxy fentanyl, 4-ANPP, and fentanyl at the LLOQ.

Quantifier transitions are displayed above.

Agilent MassHunter Optimization software version B.08.02 was used to optimize the dMRM
transitions for the optimal precursor ions with corresponding fragmentor voltage and selection of product
ions with associated collision energies (CE). The selected parameters are listed in Table 4.1. MS source
parameters: gas temperature 325 °C; gas flow 9 L/min; nebulizer 30 psi; sheath gas flow 10 L/min; capillary
voltage 3500 V and charging voltage 500 V. Quantitation was performed using Agilent MassHunter
Quantitative software version B.08.00. Relative responses were calculated using the absolute response of
each drug in relation to the response of the corresponding deuterated internal standard and plotted
against expected drug concentrations for the calibrators.
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Table 4.1: MRM MS method parameters.
Compound

Transitiona

Fragmentor
(V)

CE (V)

337.2→188.0
Fentanyl

β-Hydroxyfentanyl

233.2→150.0

20
117

342.3→105.0

238.2→55.1

D5-Fentanyl

4

-

4

-

4

-

24
141
48
20
107
48
20
114

286.2→105.0
a

4
40

286.2→188.1
D5-4-ANPP

D5-Norfentanyl

56
144

238.2→84.0
D5-Norfentanyl

4
20

342.3→188.0
D5-Fentanyl

D5-4-ANPP
4

36

353.2→91.0
353.2→132.1

D5-Fentanyl

16
122

233.2→84.0
Norfentanyl

4
48

281.2→188.0
281.2→105.0

Internal Standard

24
146

337.2→105.0
4-ANPP

Cell Acc (V)

40

Precursor ion followed by product ion, quantifier transition is bold

4.2.2.5. Sample preparation
The QuEChERS extraction was validated using a target sample aliquot of 0.2 g of insect tissue larval
or pupal as appropriate. To verify spiking concentration, liver specimens were extracted at 0.2 g aliquots
and were quantified using a previously validated protocol (4). Larva specimens were weighed for
extraction as single samples and pools of four insects for triplicate analysis (n=3) with the results
presented as μg/kg. Pupa specimens were analyzed only as individual samples due to low survival rates
and low number of insects collected. Insect specimens were placed into a 1.5 mL centrifuge tube, followed
by 400 μL deionized water, 100 μL internal standard mix (IS), and 700 μL acetonitrile combined with three
steel beads. Afterwards, 0.2 g of QuEChERS original extraction salt was added to the tubes, vortexed,
mixed on a mixer mill for 3 min, centrifuged for 5 min, and the resulting supernatant was transferred to a
QuEChERS dispersive-SPE tube. Tubes were vortexed then centrifuged for 5 min before the supernatant
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was transferred to a new 1.5 mL microcentrifuge tube for dry down under a nitrogen stream at 50 °C to
dryness. Samples were reconstituted with 100 μL methanol and transferred to vials for LC-MS/MS
analysis. This extraction protocol was adapted and validated for larva and pupa tissue from work published
by Cox et al. for the extraction of liver tissue (4). The IS was comprised of three deuterated compounds:
fentanyl-D5, norfentanyl-D5, and 4-ANPP-D5 at a concentration of 1 ng/mL.
4.2.2.6. Validation parameters
The QuEChERS extraction and LC-MS/MS analysis was validated following the American Standards
Board (ASB) 036 requirements (104). Evaluated parameters included calibration model, interference
studies, ionization suppression/enhancement, dilution integrity, limits of quantitation, processed sample
stability, bias, and precision.
4.2.2.6.1. Calibration model
A calibration stock mix of fentanyl (2 ng/μL), 4-ANPP (2 ng/μL), norfentanyl (10 ng/μL), and βhydroxy fentanyl (8 ng/μL) was created for spiking tissues in the calibration curve and represents the
highest calibrator. Using this solution, a serial dilution was performed to create stock solutions at
concentrations of 0.004, 0.008, 0.04, 0.2, 1, and 2 ng/μL (ppm) for fentanyl and 4-ANPP with
concentrations of 0.02, 0.04, 0.2, 1, 5, and 10 ng/μL (ppm) for norfentanyl and 0.012, 0.032, 0.16, 0.8, 4,
and 8 ng/μL (ppm) for β-hydroxy fentanyl. To each 0.2 g insect calibrator sample, 5 μL of each stock
solution was added to create the calibration curve.
4.2.2.6.2. Interference studies
To evaluate interferences a high concentration (highest calibrator) of the target analytes was
injected with no IS to show any interference of the drug standards to the IS. Conversely, an aliquot of IS
with no target analytes was injected to observe any interference caused by the IS. Matrix interferences
were evaluated by extracting blank matrix sources (n=10) for both larva and pupa with no IS added. To
evaluate potential interferences from commonly encountered compounds, a mix of common drugs
encountered in toxicology (n=31) was injected (Table 4.2).
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Table 4.2: List of 31 compounds evaluated for potential interferences.
Class

Compound

Class

Compound

Opioids

6-Acetylmorphine

Synthetic Cannabinoids

JWH-018

Opiates

Supplements

Oxycodone

JWH-073

Hydrocodone

XLR-11

Buprenorphine

AB-FUBINACA

Norbuprenorphine

AB-PINACA

Ethylmorphine

MAM2201

Morphine

Stimulants

Amphetamine

Codeine

Methamphetamine

1S,2R (+)-Ephedrine

Cocaine

Methylphenidate

Synthetic Cathinones

AlphaPyrrolidinopentiophenone (α
-PVP)
3,4-Methylenedioxy
Pyrovalerone

Sibutramine

(MDPV)
Caffeine

Cannabinoids

Synephrine
Octopamine

Delta-9 THC (THC)
Cannabidiol (CBD)

Other Alkaloids

Mitragynine

Methylhexanamine
(DMAA)

4.2.2.6.3. Ionization suppression/enhancement
Ionization suppression or enhancement was evaluated at two concentrations, low and high, for
ten replicates at both concentrations following the ASB Standard 036 requirements. To be deemed
acceptable, the percent ionization suppression or enhancement shall not exceed ±25% with a percent
relative standard deviation (%CV) not exceeding 20% (104). A post-extraction addition approach was
utilized by comparing neat standards (Set 1) to blank matrix samples fortified with neat standard after
extraction (Set 2). Set 1 consisted of neat standards prepared at low (2 times the LLOQ) and high (50% of
the highest calibrator) and were injected ten times to establish the mean peak area for each target
analyte. Set 2 consisted of ten individual blank matrix sources (larva and pupa) in duplicate, for low (n=10)
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and high (n=10) concentration, extracted and spiked with the low and high concentration, respectively,
after extraction. The average area of each set (𝑋) was used to calculate the suppression or enhancement
effects at each concentration for each analyte is as follows:

𝐼𝑜𝑛𝑖𝑧𝑎𝑡𝑖𝑜𝑛 𝑠𝑢𝑝𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 𝑜𝑟 𝑒𝑛ℎ𝑎𝑛𝑐𝑒𝑚𝑒𝑛𝑡 (%) = (

𝑋 𝐴𝑟𝑒𝑎 𝑜𝑓 𝑠𝑒𝑡 2
𝑋 𝐴𝑟𝑒𝑎 𝑜𝑓 𝑠𝑒𝑡 1

− 1) ∗ 100

4.3.3.6.4. Bias and Precision
For bias and precision calculations, blank larval and pupal tissue samples were spiked and
analyzed at low, medium, and high concentrations for fentanyl and metabolites in triplicate over five days
(n=15). Bias was calculated as a percent deviation of the extracted mean concentration from the
theoretical concentration with an acceptable bias not exceeding ±20%. Precision was evaluated by
percent standard deviation (%CV) of the mean at each concentration with the criteria of not exceeding
20%.
4.2.2.6.5. Limits
For the evaluation of the limit of detection (LOD) and the lower limit of quantitation (LLOQ), blank
matrix sources for larval and pupal tissue were spiked with concentrations at the lowest non-zero
calibrator. Triplicates of each blank matrix sources were spiked at the lowest non-zero calibrator and
analyzed over three days (n=9). The acceptable parameters were bias (±20%) and precision (%CV ≤ 20%).
For LOD, chromatographic acceptance was evaluated and deemed acceptable when signal to noise (s/n)
ratios were above 3.3 and qualifier ratios did not exceed ±20%.
4.2.2.6.6. Carryover and Dilution Integrity
Blank matrix samples were injected directly after injections of samples three times greater than
the highest calibrator in triplicate analysis to evaluate carryover. Carryover was not considered significant
if present below 10% of the lowest calibrator (LLOQ). For dilution integrity, blank matrix samples from
both sources were spiked at concentrations three times the highest calibrator in triplicate and extracted
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simultaneously with blank matrix only spiked with internal standard in triplicate. The resulting extract was
diluted 1:5 (S:T) with the extracted blank matrix with internal standard (5, 106). The process was repeated
over a period of five runs (n=15) and the dilution integrity was deemed acceptable if bias did not exceed
±20% and the precision (%CV) did not exceed 20%.
4.2.2.6.7. Processed Sample Stability
To determine the stability of processed samples for both larval and pupal tissue in the
autosampler (25 °C), blank larva and pupa samples were spiked at low and high concentrations and
extracted. Post extraction reconstituted samples, for low and high respectively, were pooled and
aliquoted to LC-MS/MS vials. Triplicate analysis at time frames: 0, 12, 24, 36, 48, 60, and 72 hr were
performed for each concentration. Average peak area was calculated for each triplicate and compared to
time zero. An acceptable bias threshold was set at ±20%.
4.2.2.6.8. Recovery and Process Efficiency
To calculate recovery of the extraction (RE) and process efficiency (PE) two formulas were utilized.
Variables in the formulas represent the mean peak areas for the neat solution (A), the mean peak areas
for the standards spiked after extraction (B), and the mean peak areas for the standards spiked before
extraction (C) (107). Recovery and process efficiency were at low and high concentrations for ten
replicates (n=10) for each matrix type. Ideally, a perfect recovery or process efficiency would be 100% and
±20% of this value is desired while not exceeding a %CV of 20%. The ASB Standard 036 does not have a
requirement for recovery or process efficiency and the ±20% while not exceeding a %CV of 20% is a selfimposed guideline.
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𝑅𝐸(%) =

𝐶
∗ 100
𝐵

𝑃𝐸(%) =

𝐶
∗ 100
𝐴

4.2.3. Results
4.2.3.1. Validation
Six different concentrations for five runs (n=15) were analyzed for both larva and pupa tissue by
linear regression lines generated using Agilent MassHunter software with a weight of (1/x). The linear
range or analytical measurement range (AMR) is displayed in Table 4.3 for each analyte in both matrices.
As part of the evaluation of the calibration model, the R2 values for the calibration curves exceeded 0.99
and the residuals for each set of five replicates were plotted with no discernable pattern being identified
indicating a random dispersion. This allows for linear analysis of the analytes presented using a weight of
(1/x).
Table 4.3: LOD, LLOQ, and AMR for larvae and pupae extractions.
Larvae
LLOQ (n=9)

LOD/LLOQ
(µg/kg)

Bias

%CV

AMR
(µg/kg)

4-ANPP

0.1

-3.4

12.1

0.1-50

β-Hydroxyfentanyl

0.4

1.7

9.0

0.4-200

Fentanyl

0.1

-1.5

14.6

0.1-50

Norfentanyl

0.5

4.6

12.1

0.5-250

LLOQ (n=9)

Compound

Pupae
LOD/LLOQ
(µg/kg)

Bias

%CV

AMR
(µg/kg)

4-ANPP

0.1

-6.0

13.2

0.1-50

β-Hydroxyfentanyl

0.4

-4.6

12.7

0.4-200

Fentanyl

0.1

-11.1

10.5

0.1-50

Norfentanyl

0.5

3.9

16.8

0.5-250

Compound
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Blank matrix samples from 10 individual insect sources for both larval and pupal tissue were
extracted without addition of standards or internal standards to determine any matrix interferences.
Chromatographic analysis of these injections was performed using Agilent MassHunter Qualitative
Analysis software version B.08.00 and no interference peaks from the blank matrices were observed.
No interfering peaks were observed from the high standards to the internal standards or from the
internal standards to the target analytes. A neat mix of 31 commonly encountered analytes, encompassing
other opioids, stimulants, depressants, synthetic cannabinoids, synthetic cathinones, and dietary
supplements, was injected and no interferences were observed.
4.2.3.2. Ionization suppression/enhancement
Ionization suppression or enhancement was evaluated at low and high concentrations (n=10) for
both larval and pupal tissue following the ASB Standard 036 requirements. The percent ionization
suppression or enhancement and %CV for all four target analytes are presented in Table 4.4. The criteria
for acceptance was ±25% ionization suppression or enhancement with a percent relative standard
deviation (%CV) not exceeding 20%. The four target analytes were within the criteria for acceptance at
both high and low concentrations for both insect tissue types. For the larval tissue, the percent ionization
suppression or enhancement for the four analytes ranged from -10.9% to 17.9% for the low and ranged
from 2.8% to 8.2 % for the high while not exceeding a %CV of 14.2%. For the pupal tissue, the percent
ionization suppression or enhancement ranged from -5.5% to 1.1% at the low concentration and ranged
from 3.0% to 8.8% for the high while not exceeding a %CV of 16.6%.
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Table 4.4: Ionization suppression/enhancement, recovery, and process efficiency for the larval and pupal tissue (n=10).
Ionization
Suppression/Enhancementa
Compound

Low
Mean

High
CV

Mean

Recoverya
Low

CV

Mean

Process Efficiencya
High

CV

Low

High

Mean

CV

Mean

CV

Mean

CV

Larvae
4-ANPP

-3.5

4.8

6.6

8.7

96.3

13.8

83.7

11.4

92.9

13.2

89.2

13.0

βHydroxyfentanyl

10.2

7.2

4.7

8.2

103.5

10.4

98.2

12.7

114.1

8.9

102.8

12.5

Fentanyl

-10.9

14.2

2.8

8.5

111.8

11.3

96.4

12.2

99.6

15.3

99.1

11.3

Norfentanyl

17.9

6.9

8.2

9.2

97.4

12.0

101.0

12.7

114.9

10.8

109.2

11.9

Pupae
4-ANPP

-5.5

9.3

3.0

5.4

103.9

6.2

104.3

12.3

98.2

8.5

107.4

12.1

βHydroxyfentanyl

-4.9

16.6

8.8

5.1

107.9

15.8

98.9

6.5

102.6

8.1

107.6

4.7

Fentanyl

-5.1

9.8

7.1

5.0

102.1

7.6

102.4

8.9

96.9

9.9

109.6

7.8

Norfentanyl

1.1

12.0

6.4

7.3

94.5

7.1

104.3

9.0

95.6

12.6

111.1

6.5

a

Data in %

4.2.3.3. Bias and precision
For the bias and precision calculations, blank insect matrix was spiked and extracted at low,
medium, and high concentrations in triplicate over five runs (n=15) for both larva and pupa tissue (Table
4.5). The bias for all four analytes in both insect matrices were within ±20% and the %CV did not exceed
20%, meeting the ASB Standard 036 requirements. For the larval tissue, the bias for the low ranged from
-4.6% to 10.1%, the medium ranged from -3.5% to 5.0%, and the high ranged from -4.9% to -2.0%. For the
pupal tissue, the bias for the low ranged from -1.5% to 11.3%, for the medium ranged from -4.8% to 0.7%, and for the high ranged from -4.8% to -0.4%. Of the four analytes and two matrices, only β-hydroxy
fentanyl experienced a bias greater than ±10% at 10.1% bias for the low larva matrix and 11.3% bias for
the low pupa matrix. These elevated percent bias values could be due to not having a deuterated internal
standard for this analyte; however, the values are still well within the criteria for acceptance.
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Table 4.5: The bias and precision validation data for larvae and pupae extractions (n=15).
Larvae
Compound

Bias (%)

Between Run (%CV)

Within Run (%CV)

LOW

MED

HIGH

LOW

MED

HIGH

LOW

MED

HIGH

4-ANPPa

-4.6

-3.5

-3.8

10.6

8.5

8.7

10.8

6.8

7.0

β-Hydroxyfentanylb

10.1

5.0

-2.0

9.5

7.5

5.4

9.5

5.3

3.7

Fentanyla

-2.9

-1.4

-2.4

8.5

7.9

5.7

8.1

4.3

3.6

Norfentanylc

0.1

1.5

-4.9

12.2

7.2

7.0

7.0

3.8

4.1

Pupae
Compound

Bias (%)

Between Run (%CV)

Within Run (%CV)

LOW

MED

HIGH

LOW

MED

HIGH

LOW

MED

HIGH

4-ANPPa

0.1

-3.8

-4.8

8.9

4.7

7.0

8.8

3.7

8.4

β-Hydroxyfentanylb

11.3

-0.7

-0.4

8.4

5.1

6.8

6.7

4.4

6.2

Fentanyla

-1.5

-1.3

-2.2

12.1

8.0

5.1

6.8

5.5

5.9

2.9

8.3

Norfentanylc

7.1
-4.8
-1.8
5.9
3.2
7.2
4.3
Low concentration at 0.2 µg/kg, medium concentration at 5 µg/kg, and high concentration at 40 µg/kg
b Low concentration at 0.8 µg/kg, medium concentration at 20 µg/kg, and high concentration at 160 µg/kg
c Low concentration at 1.0 µg/kg, medium concentration at 25 µg/kg, and high concentration at 200 µg/kg
a

4.2.3.4. Limits
Triplicates of individual larva and pupa matrix sources were spiked at the lowest non-zero
calibrator and analyzed over three runs (n=9) to satisfy the requirements for the limit of detection and
lower limit of quantitation (104). Bias and precision for the LLOQ (Table 4.3) were considered acceptable
within ±20% for bias and the %CV not exceeding 20%. The bias for the LLOQ for the larval tissue ranged
from -3.4% to 4.6% and for the pupal tissue ranged from -11.1% to 3.9%. The requirements for the LOD
and LLOQ by the ASB Standard 036 were met for both matrices.
4.2.3.5. Carryover and dilution integrity
To determine any carryover, extracted blank matrix samples were injected directly after injections
of samples with concentrations three times greater than the highest calibrator in triplicate analysis. This
was performed for both the larval and pupal matrices. No significant carryover of the target analytes was
detected in the blank matrix injections for either matrix.
For the dilution integrity evaluation, bias and precision was calculated for each analyte and is
shown in Table 4.6. For the four target analytes in the larval tissue the dilution integrity did not exceed
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±12.7% for bias and did not exceed 14.1% for %CV. For the pupal tissue the dilution integrity did not
exceed ±9.7% for bias and did not exceed 11.2% for %CV. For the larva extractions, the bias of the dilution
integrity ranged from -12.7% to -5.9% indicating a tendency for the dilution to have a lower than
anticipated value. In contrast, the dilution integrity bias for the pupa extracts ranged from 1.3% to 9.7%
indicating a slightly inflated value than expected. This could be attributed to matrix effect at the high
concentration for the pupa extraction as the pupa extractions at the high-end experience slight ionization
enhancement.
Table 4.6: Dilution integrity for the larvae and pupae extractions at a 1:5 dilution.
Larvae
Compound

Target Concentration (µg/kg)

Dilution Integrity (% Bias)

% CV

4-ANPP
β-Hydroxyfentanyl
Fentanyl
Norfentanyl

150
600
150
750

-12.7
-5.9
-10.3
-11.3

14.1
10.7
13.5
12.9

Pupae
Compound

Target Concentration (µg/kg)

Dilution Integrity (% Bias)

% CV

4-ANPP
β-Hydroxyfentanyl
Fentanyl
Norfentanyl

150
600
150
750

1.3
9.7
7.8
7.4

9.9
11.2
10.1
8.7

4.2.3.6. Processed sample stability
Processed sample stability in the autosampler was evaluated for both insect matrices in triplicate
at low and high concentrations over time intervals up to 72 hours (Table 4.7). For the larva extractions, all
four analytes were stable up to 72 hr at both the low and high concentrations. Norfentanyl changed the
most in response with the low concentration increasing to 15.8% of the time zero response. For the pupa
extractions, all the analytes were stable up to 72 hr for both the low and high concentrations. The analyte
with the most instability, 4-ANPP decreased in regard to the time zero response at both the low and high
concentrations at 72 h with -15.4% and -14.3% respectively.

110

4.2.3.7. Recovery and process efficiency
Recovery and process efficiency was evaluated simultaneously with ionization suppression or
enhancement and the results are displayed in Table 4.4. The recoveries and process efficiencies for both
matrices at the low and high concentrations were deemed acceptable within ±20% of the target recoveries
and the %CV not exceeding 20%. Overall, 4-ANPP and fentanyl recovered more efficiently in the pupa
extractions compared to the larva extraction at both concentrations. Conversely, β-hydroxy fentanyl and
norfentanyl had slightly better recoveries for the larva extractions compared to the pupa extractions. The
precision for the recovery and process efficiency did not exceed 15.8% with the majority being below 13%.
Table 4.7: Stability at a low and high concentration for the larvae and pupae extractions for processed samples stored in the
autosampler (25 °C).
Larvae
Low (% d)

High (% d)

Compound
12 h

24 h

36 h

48 h

60 h

72 h

12 h

24 h

36 h

48 h

60 h

72 h

4-ANPPa

3.8

0.7

1.5

1.5

1.8

-4.8

-1.8

-3.2

-3.4

-1.0

-2.8

-12.7

β-Hydroxyfentanylb

2.9

0.1

-3.1

5.8

7.1

2.9

-0.1

1.4

0.0

4.9

4.6

-3.1

Fentanyla

3.4

4.5

-4.4

3.2

7.5

0.0

-0.9

1.3

-0.5

1.8

1.2

-6.6

Norfentanylc

9.8

9.3

9.2

13.6

14.3

15.8

-0.4

-1.9

-1.9

2.4

1.0

-7.7

Pupae
Low (% d)

Compound

High (% d)

12 h

24 h

36 h

48 h

60 h

72 h

12 h

24 h

36 h

48 h

60 h

72 h

4-ANPPa

-2.6

-10.8

1.1

-5.7

-7.5

-15.4

-6.2

-11.0

-1.1

-8.8

-6.8

-14.3

β-Hydroxyfentanylb

2.8

-3.7

3.0

-1.9

0.2

2.2

-4.6

-6.9

2.7

-2.2

0.7

-4.2

Fentanyla

-3.4

-5.0

2.9

-4.4

-2.9

-1.6

-4.6

-6.6

1.0

-4.7

-2.3

-7.6

Norfentanylc

3.9

-3.1

6.2

9.2

14.0

5.1

-3.6

-9.2

-2.2

-2.9

-0.7

-8.9

Low concentration at 0.2 µg/kg, and high concentration at 25 µg/kg
Low concentration at 0.8 µg/kg, and high concentration at 100 µg/kg
c Low concentration at 1 µg/kg, and high concentration at 125 µg/kg
d %  indicates the percent change for the time interval response compared to time zero response
a

b
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4.2.3.8. Entomotoxicology Results
After spiking liver tissue with varying fentanyl concentrations (0, 10, 100, and 350 ug/kg), we
anticipate observing fentanyl and metabolites in the larva and pupal stages of the insects feeding on the
spiked tissues. The presence of these drugs and metabolites is expected to create a difference in physical
development (mass, length, and width) of the insects in comparison to the control groups. Insects were
collected from the treatment groups after four and twelve days of allowing the insects to feed on the
spiked human liver tissue. Five larvae and five pupae were randomly selected from each collection day for
QuEChERS extraction of fentanyl and metabolites (Table 4.8). Larva samples were also analyzed in pools
of four larva for triplicate analysis (Table 8). Individual larva and pooled larva were analyzed to determine
the best course for sampling of insects for toxicology analysis. From the larvae collected on day four,
fentanyl was detected in all the treatments except for the control liver tissue spike. The average
concentrations (n=5) for the single larvae collected at day four were: low treatment 1.3 ± 0.4 µg/kg,
medium treatment 11.6 ± 5.0 µg/kg, and high treatment 26.9 ± 12.8 µg/kg. Fentanyl and norfentanyl were
detected in the pooled larva samples (n=4) with average concentrations (n=3) for the low treatment at
1.6 ± 0.3 µg/kg, medium treatment at 18.4 ± 2.2 µg/kg, and high treatment at 31.5 ± 2.4 µg/kg for fentanyl.
Norfentanyl was detected in the medium and high treatments at 0.7 ± 0.1 µg/kg and 1.4 ± 0.2 µg/kg,
respectively. From the pupae collected on day twelve, fentanyl was only detected in the medium and high
treatment groups. Average fentanyl concentrations for the pupae from the medium treatment were 0.14
± 0.04 ug/kg and from the high treatment group 0.32 ± 0.12 µg/kg. Liver to larvae ratios were calculated
for the day four larvae for low 7.5 ± 2.2 µg/kg, medium at 8.1 ± 3.9 µg/kg, and high at 9.1 ± 3.8 µg/kg. The
average liver to larvae ratio between the three groups was 8.2 ± 3.2 ug/kg. A correlation plot for the liver
to larvae concentration was generated for the day four data set. The correlation determined an R 2= 0.753
for the liver to larvae concentration as a proof of concept.
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Table 4.8: Larvae and pupae fentanyl concentrations from day four and day twelve collections.
Insect Concentrations
Larvaea (µg/kg)

Pupaeb (µg/kg)

Compound
Controlc

Lowc

Mediumc

Highc

Controld

Lowd

Mediumd

Highd

4-ANPP

ND

ND

ND

ND

ND

ND

ND

ND

β-Hydroxyfentanyl

ND

ND

ND

ND

ND

ND

ND

ND

Fentanyl

ND

1.3 ± 0.4

11.6 ± 5.0

26.9 ± 12.8

ND

ND

0.14 ± 0.04

0.32 ± 0.12

Norfentanyl

ND

ND

ND

<LLOQ

ND

ND

ND

ND

Pooled Larvae (µg/kg)
Compound
Controlc

Lowc

Mediumc

Highc

4-ANPP

ND

ND

ND

ND

β-Hydroxyfentanyl

ND

ND

ND

ND

Fentanyl

ND

1.6 ± 0.3

18.4 ± 2.2

31.5 ± 2.4

Norfentanyl

ND

<LLOQ

0.7 ± 0.1

1.4 ± 0.2

Liver to Larvae Ratios
Compound

Fentanyl

Controlc

Lowc

Mediumc

Highc

ND

7.5 ± 2.2

8.1 ± 3.9

9.1 ± 3.8

a

Larvae (n=5) collected from day four for each treatment group
Pupae (n=5) collected from day twelve for each treatment group
c
Treatments: Control (0 µg/kg), Low (9.0 µg/kg), Medium (79 µg/kg), and High (207 µg/kg) quantitated from liver tissue collected at time of egg
placement
d
Treatments: Control (0 µg/kg), Low (10 µg/kg), Medium (61 µg/kg), and High (436 µg/kg) quantitated from liver tissue collected at time of egg
placement
e
Pooled Larva (n=4) collected from day four for each treatment group and analyzed in triplicate (n=3)
b

4.2.3.9. Insect measurements
Entire cohorts of each treatment were collected, and all insects were measured. Insect
measurements from the two collection days and each of the four treatment groups were compiled and
images were taken but due to single replication, no statistical significance could be drawn and the act was
a function of practice for section 2 of this chapter.
Survivorship rates based on calculated eggs placed and insects collected on the two collection
days were generated (Table 4.9). The high treatment group experienced the highest mortality at 71.8%
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mortality for day four collection and an 88% mortality rate for day twelve with only six total insects
collected from the high treatment. The control group experienced a mortality rate of 21.7% and 25.6% for
the day four and day twelve collections. The percentage of insects from egg placement to pupation ranged
from 12% to 45% for the day twelve collection. The high treatment had the lowest percent pupated (12%)
of any of the treatment and control groups.
Table 4.9: Survivor rates for the day four and day twelve insect collections.
Day 4
Larvae
Treatmentb
Eggs Placed

Collected

Mortality (%)a

Control

65

51

21.7

Low

67

54

19.4

Medium

51

48

5.8

High

66

19

71.8
Day 12

Total Insects Collected

Pupae

Treatmentc
Eggs Placed

Collected

Mortality (%)a

Pupae

Larvae

%Pupateda

Control

54

40

25.6

19

21

35.3

Low

52

33

36.4

13

20

25.1

Medium

66

63

4.6

30

33

45.4

High

50

6

88.0

6

0

12.0

Displayed in %
Treatments: Control (0 µg/kg), Low (9.0 µg/kg), Medium (79 µg/kg), and High (207 µg/kg) quantitated from liver tissue collected at
time of egg placement
c Treatments: Control (0 µg/kg), Low (10 µg/kg), Medium (61 µg/kg), and High (436 µg/kg) quantitated from liver tissue collected at
time of egg placement
a

b

4.2.4. Discussion
4.2.4.1. Validation
Following the ASB Standard 036 requirements, a full validation was performed for both insect
matrices. Both matrices were evaluated over six calibrators and linear regression analysis with a weight
of (1/x) was deemed appropriate by evaluation of bias, precision, R2 values, and residual plots over five
runs. No interferences from blank matrix, target analytes themselves, or from commonly encountered
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analytes were identified. Ionization suppression or enhancement was within acceptable criteria for all
analytes in both matrices at both concentrations evaluated. Overall, the pupa matrix appeared to be less
impacted by ionization suppression or enhancement with percent ionizations under ± 9% for all analytes
in both concentrations. The larvae extractions experienced more ionization effects at the low end
compared to the high and to the pupa matrix. Norfentanyl for the larvae extractions experienced the most
ionization enhancement (17.9%) at the low concentration compared to all the other analytes in any
concentration or matrix. Conversely, fentanyl experienced the most ionization suppression (-10.9%) at the
low concentration for the larva matrix. In comparison of the two insect matrices, pupae experienced less
ionization suppression or enhancement, obtained greater recoveries, and maintained overall better
process efficiencies (Table 4). The differences could be due to the developmental progress of the insect.
It has been shown that necrophagous fly larvae have increased lipid development between day three and
six of development with a decrease after day seven (46, 145). The increased lipid content combined with
the metamorphosis occurring in the pupae could be contributing factors to the matrix effects and
recoveries calculated. The bias and precision for both matrices were well within the required criteria with
β-hydroxy fentanyl at the low concentration having the highest bias of 11.3% and all other analytes at the
three concentrations were below ± 10.1%. For autosampler stability, the larval and pupal extractions were
stable for up to 72 hr with no analyte exceeding ± 15.8% response change from time zero. Fentanyl and
4-ANPP experienced a decrease in response for both low and high concentrations over time and
norfentanyl experienced an increase over time at low concentrations but a decrease at the high
concentration. β-Hydroxyfentanyl experience a mixed result for stability with increases and decreases in
concentration over time for both concentrations.
4.2.4.2. Entomotoxicology
From all three treatments, among the spike compounds, only fentanyl was detected in either the
single-specimen larvae or pupae extractions. With the presence of metabolites not detected in the single

115

insect extractions, the single insects most likely contained metabolites below our limit of detection.
Although the quantifying transition for norfentanyl was observed in the high-concentration treatment, it
did not meet the full criteria for acceptability. As expected, the percentage of larvae from each treatment
with detectable fentanyl increased as the treatment concentration increased and the detection of
norfentanyl in the pooled larva specimens. The treatment concentrations low (10 μg/kg), medium (100
μg/kg), and high (350 ug/kg) were based on the findings from Palamalai et al who presented findings of
liver fentanyl concentrations in five non-drug related deaths ranging from 11–104 μg/kg with a mean of
38 μg/kg; liver fentanyl concentrations in 26 mix drug related deaths ranging from 6–235 μg/kg with a
mean of 80 μg/kg; and liver fentanyl concentrations in 33 fentanyl-related deaths ranging from 18–365
μg/kg with a mean of 104 μg/kg (64). The low treatment corresponds to a low dose of fentanyl and not
necessarily related to cause of death, the medium is close to the mean of the mixed drug and fentanyl
related deaths and the high corresponds to the highest concentration reported by Palamai et al (64).
McIntyre et al presented data from 87 cases for liver fentanyl concentrations ranging from 6.9–689 μg/kg
with a mean of 93.3 μg/kg, indicative of the wide range of fentanyl concentrations detected in liver tissue
(115).
Detection of drugs in insects can be vital in corroborating traditional toxicology matrices or as the
only matrix available in cases with advanced decomposition, exsanguination, or burn victims (39, 58, 59).
Beyer et al. presented a case of suicide by overdose with phenobarbital where the body was badly
decomposed with no fluids or organs to test for drugs (58). The deceased had been last seen 14 days prior
to discovery and the remains were badly decomposed with the head, thorax, and abdomen completely
skeletonized (58). The decedent had a history of suicide attempts, a recent prescription for 100 tablets of
phenobarbital, and the bottle was found empty in her purse (58). Analysis and detection of phenobarbital
in the larva collected from the cadaver was the only toxicology results available for corroborating the
physical evidence found on the deceased (58). In a case presented by Bugelli et al., benzodiazepines and
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metabolites were detected in the burnt cadavers of a maternal filicide-suicide by fire (59). In this case, the
detection of drugs in the insects was used to corroborate the findings of drugs in the fluids and tissues
collected (59). When there is a death with a delayed recovery like suicide or drug overdose, advanced
decomposition of the body can occur to the point where insect tissue is the only matrix available or can
corroborate the findings of any more traditional matrix available (39).
The ratio of larvae concentration to liver concentration for each of the three treatments were
within a single standard deviation and the mean ratio between the groups 8.2 ± 3.2 μg/kg incorporated
all three mean ratios for the treatments. The simple linear regression of the liver to larva concentration
generated a R2 = 0.753 which indicates that 75.3% of the variation of the larva fentanyl concentration can
be predicted by the concentration of fentanyl in the liver. This limited correlation is similar to the findings
of El-Samad et al. that found correlation of larvae collected from rabbits dosed with tramadol (45). In a
dissertation, Peace et al. presented correlation R2 values ranging from 0.7727 to 0.9976 for barbital,
phenobarbital, pentobarbital, and thiopental for larvae concentrations to food source with the conclusion
of strong correlation (40). A moderate to strong correlation is needed to be able to draw quantitative
conclusions for interpreting human tissue concentration based on insect concentration. However, as both
current study and the El-Samad et al., have low number of replicates, stronger models may permit a
mathematical correlation between drug concentration within insect tissues and in the original human
tissue (45). Ideally, authentic tissue samples from authentic overdose casework with paired known blood
concentrations would be best for expansion for fentanyl relationship of insect to tissue concentrations as
well as expansion to at least three replications for statistical relevance and increased power of the test.
Of particular interest is recovery of fentanyl from pupae from the medium and high-concentration
treatment livers, which displays the persistence of this drug across the immature life stages of L. sericata.
It is consistent with successful extraction of methadone from puparia, the remnant casing in which the
pupa develops, derived from the larval integument (44). Nevertheless, the concentrations of fentanyl
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detected in the pupa tissue were much lower than the concentrations quantitated from the larvae (Table
8). The detection of fentanyl in lower concentrations in the pupae compared to the larvae indicates that
although the drug is persistent, the immature fly is able to eliminate fentanyl as it progresses through its
life stages. Metabolism of fentanyl is supported by the detection of norfentanyl in the pooled larval
samples. Norfentanyl was not part of the opioid spike mix, nor was it detected in the homogenized liver
samples taken at day 4 or day 12. Therefore, the only source of norfentanyl in the pooled samples must
have been the larvae themselves. Opioid metabolism has previously documented for heroin, methadone,
and codeine in various blow fly species (44, 103, 144). In the better-studied human system, fentanyl is
metabolized predominantly by cytochrome P450 isoforms (102). Cytochrome P450 monooxygenases have
been identified in Lucilia cuprina (Wiedemann) (Diptera: Calliphoridae) larva, where they are implicated
in organophosphate insecticide resistance in both L. cuprina and L. sericata (150–153). These
monooxygenases are likely to be the main path for metabolism in the insect and metabolic pathways for
the monooxygenases encourage biotransformation of drugs to less hydrophobic or more hydrophilic
compounds for excretion (44, 102). In blow fly larvae, water soluble or less hydrophobic molecules are
excreted out of the hemolymph via Malpighian tubules (44, 154). Given the observed reduction of fentanyl
concentration in the collected pupal samples and lack of detectable metabolites, it appears the insects
were able to eliminate the drug effectively, but incompletely, as fentanyl was still detected at the higher
treatments.
4.2.4.3. Insect development
The fentanyl produced observable development changes to the larval growth. The mass, length,
and width of the low and medium treatment groups were visibly larger than the control and high
treatment groups. These results are consistent with previous studies on blow fly larvae exposed to
ketamine, methamphetamine, and tramadol (45, 46, 49). Ordinarily, insects trade-off increased body size
with increased development time (155). However, in this experiment, 19 of 40 collected individuals (47%)
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in the control group had already pupated by day 12. In the low-concentration treatment, 13/33 (39%) had
pupated, and in the medium-concentration treatment, 30/63 (47%) had pupated (Table 4.9). These results
would seem to suggest the paradoxical response that for L. sericata, low concentrations of opioids may
actually increase the growth rate of the larval stage without a concurrent increase in its duration. Opioid
exposure does show a dose-response on development, as seen in the small number of survivors in the
high-concentration treatment. Although the surviving individuals reached the same body size as the
control group, only six of the original 50 eggs placed on the high treatment for day twelve survived to
collection. Among pupal treatments, the only significant difference in physical characteristics was a
slightly increased pupae length in the low concentration treatment compared to the medium and control
groups. Lower number of specimens combine with a high variance did not allow for a significant difference
in physical characteristics. The combined issues of high mortality and low number of pupated insects
creates the need for further work with more insects being placed and more replicates to fully evaluate
the later life stages. Estimation of minPMI can impact an investigation or cause of death and the impact of
drugs on the growth of insects is an important factor to consider when using an entomological based PMI
estimate.
4.2.5. Conclusion
Presented in this study is a full validation following the ASB Standard 036 requirements for a
QuEChERS extraction of fentanyl and metabolites from larval and pupal tissue. The method met all the
criteria mapped out by the ASB and was applied to authentic insect samples that were reared on human
tissue containing fentanyl. Fentanyl was detected in the larvae and pupae that were collected from the
human liver tissue. A moderate positive correlation for the liver to larvae concentrations was calculated
and provides hope that larvae can be used in the future to, at minimum, determine the presence of
fentanyl from feeding on human tissue and potentially estimate human tissue concentrations. The
fentanyl infused tissue had some effects on the development of the insects including an increase in larval
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mass, length, and width at low concentrations. At high concentrations the insects experienced a high
mortality rate alluding to low concentrations of fentanyl having a positive effect on the insect but a
negative effect at higher concentrations. Due to the high mortality rates at the high concentration, more
replicates are needed to fully evaluate the growth effects of fentanyl in the later life stages of the insects.
Overall, the QuEChERS extraction was successful at extracting fentanyl from larvae and pupae
collected from feeding on human liver tissue that contained fentanyl. This provides a method for detecting
and quantifying fentanyl in an alternate matrix, liver to larvae concentrations, and shows the persistence
of fentanyl through the insect life cycle to pupation.

4.3. Section 2: Physical Effects of Fentanyl on Larva and Pupa (Lucilia sericata)
4.3.1. Overview
This section presents the morphometric comparisons for the larva and pupa reared in task 2.a. To
determine the effects of fentanyl on the growth and development of the blow flies, the mass, and percent
stage (first instar, second instar, third instar, or pupa) of the insect were statistically compared using
nested ANOVA to determine if the control and treatment groups differ. Further Tukey-HSD test
determined which treatments are significantly different and due to sample size differences, restricted
maximum likelihood (REML) was applied. These statistical tests determined if the drug treatments have
any significant effects on the insect’s development. Age estimations were also performed using the mean
length for the larval stages on collection day. Maximum larval length for each treatment on days collected
were also presented.
Since entomological techniques utilize the growth and development of insects to estimate the
minimum time since death, it is crucial to understand the role of fentanyl in the development of Lucilia
sericata blow flies. Insects follow a predictable life cycle that xenobiotics can influence. While several
drugs have been explored in entomotoxicological studies, little is known about the direct effects that
fentanyl may pose on the growth and development of blow fly larvae.
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4.3.2. Morphometrics
For an entomologist to estimate the

minPMI,

the age of the oldest insects collected need to be

estimated (2, 17). This is typically accomplished in two ways: by identification of the insect life stage or by
estimation based on larval size which is usually length (17). The first age estimation method requires the
identification of the discrete and distinguishable stages of development that blow fly larva develop
through and the thermal history where the specimen developed (2, 17). This is often referred to as a
thermal summation model and uses linear regression to analyze the positive relationship of the insect’s
growth and temperature (2). An insect’s growth rate and development is driven by temperature and this
allows for a predictable growth rate (2, 17). Using this method, the development is measured as
physiological time in units of degree days or degree hours (2). The discrete life stages for the insect require
a certain amount of accumulated degree hours (ADH) to progress to the next stage of development and
by documenting the thermal summation of degree hours necessary for an insect to reach the stage at the
moment of collection a minPMI can be estimated (2).
The second method to estimate age is by measurement of larval size, most commonly larval
length (17, 33). This method relies on growth data from the species of the insect over different
temperatures (8, 17, 23, 37). Once a larva hatches from its egg, it will steadily and predictably grow until
it reaches pupation (17, 23). The larva continuingly grow in length as they feed and progress through their
larval stages of first, second, and third instar until they stop feeding at which they reach their peak length
(2, 37, 156). During the development time from third instar to pupa, the larva change in behavior by
stopping feeding and migrating or wandering from the feeding substrate (21, 33). This generates a nonlinear relationship for length to time for the larval stage as the growth rate while the larva are wandering
slows and the larva length decreases (37). Popular ways to calculate age based on length of larva include
growth curves, isomegalen, or isomorphen diagrams (2, 8, 17, 37, 156). For growth curves, the length of
the larval insect is the dependent variable plotted against time as the independent. With the literature
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curve data, the length of a collected larvae can be used to estimate an age of the insect if the temperature
is known (37, 156). For these curves, a polynomic equation can be generated to fit the curve and with the
length inputted, a time can be estimated (37). An isomegalen-diagram plots the time since hatching
against temperature with lines drawn for identical larval lengths (2, 156).
Drugs or toxins have been presented in literature to impact the growth of insects in terms of
temporal growth, life stage, and physical characteristics (39, 46, 157). Due to the desire for toxicological
analysis, the focus of this study is on the impacts of fentanyl on the life stage and morphometrics in terms
of how they would impact the estimation of minPMI rather than the raw temporal growth.
4.3.3. Methods
4.3.3.1. Design
Fentanyl was spiked into 200 g aliquots of human liver homogenate to evaluate four
concentrations: control (0 µg/kg), low (10 µg/kg), medium (100 µg/kg), and high (350 µg/kg)
concentrations. For replicate # 3, an authentic postmortem liver specimen with a fentanyl concentration
of 111 µg/kg, norfentanyl concentration of 8.1 µg/kg, and a 4-ANPP concentration of 5.8 µg/kg was
homogenized to be treated as a fifth treatment group. The 200 g treatment portions were aliquoted as
seven 25 g aliquots onto aluminum foil sheets inside 8 oz plastic containers (Figure 4.3) with sand as a
substrate for pupation. The center of the tops of the containers were cut out and a piece of cloth was
placed under the top, covering the container to allow airflow while preventing the escape of the insects.
To each aliquot of liver, approximately 70-90 eggs (by mass) were placed and allowed to feed undisturbed
until time of collection (Figure 4.5). The containers were housed in the Percival I36LLVLC8 incubator at 25
°C (± 0.5 °C) at 65% relative humidity (± 10%) with a 12:12 (L:D) photoperiod. Insects were collected at
seven sampling times: at 48 hours (day 2), 72 hours (day 3), 96 hours (day 4), 120 hours (day 5), 144 hours
(day 6), pupa (192 hours or day 10), and emergence (day 21) (Figure 4.4). Larvae were collected and heat
killed with boiling water for 90 s and rinsed with methanol before stored at -20 °C with no liquid
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preservatives added (7, 40, 46). Collected pupae were rinsed with deionized water and then methanol
before being stored at -20 °C with no addition of any liquid preservative. No preservative was chosen due
to the larval cuticle acting as a semipermeable membrane which can allow water or ethanol to diffuse
into the body cavity and potential to leech out the target analytes into the preservative solution (149).
Liver samples were collected at the time of egg placement (day 0) and at the day of collection to establish
the initial tissue concentrations and to evaluate any metabolism of the drugs by the feeding media. This
protocol was repeated for three replicates approximately 6-8 weeks apart. The colony was described in
section 1 of this chapter (4.1.3). For replicate #1, the colony was at generation 24, for replicate #2 the
generation was 26, and for replicate #3 the generation was 28.
To evaluate developmental effects, the mass (mg), length (mm), and width (mm) of the collected
insects were documented (Figure 4.4). Metrics also evaluated were survivor rates, percent stage, and
percent pupated. Statistical analysis for the physical characteristics including nested ANOVA and TukeyKramer HSD were performed using JMP Pro 15.1.0.

Figure 4.3: Fortified liver (25 g) aliquot (A) with 70-90 eggs placed (B).
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Figure 4.4: Schematic of the design workflow.

4.3.4. Results
Entire cohorts of each treatment were collected, and all insects were measured. For the statistical
analysis of the groups, mean was selected as the measure for length, width, and mass of the insects. In
the figures below, nested ANOVA (α = 0.05) followed by Tukey-HSD statistical tests were performed with
the letters A, B, and C representing significant difference. Treatments not connected by a letter are
considered significantly different from each other. By the nesting of the replicates and days, statistical
comparisons were performed for each treatment within replicate.
Table 4.10 shows the percent stage for the insects collected at each day by life stage. Small
differences can be observed but the percent stage for each treatment was not significantly different. The
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authentic or validation set is only a single replicate so no statistical comparisons can be made but the
percentages are displayed.
Table 4.10: Percent stage over time for each life stage (2nd instar larva, 3rd instar larva feeding, 3rd instar larva wandering, pupa,
and adult flies).

2nd Instar
Day Day
2
3

3rd Instar Feeding
Day
Day
Day
3
4
5

3rd Instar Wandering
Day Day Day Day Day
4
5
6
10
21

Pupa
Day
Day
10
21

Cntrla

100

0

100

28.1

0.0

71.9

100

100

19.4

7.8

80.6

19.3

73.0

Lowa

100

0

100

35.8

0.5

64.2

99.5

100

45.2

5.9

54.8

19.5

74.6

Meda

100

0

100

30.1

0.0

69.9

100

100

26.6

4.2

73.4

11.6

84.2

Higha

100

0

100

41.7

0.0

58.3

100

100

21.1

8.9

78.9

28.2

62.9

Authb

-

0

100

88.0

58.8

12.0

41.2

100

31.4

20.3

68.6

10.1

79.7

Adults
Day 21

a Total of all three replicates (n=3)
b The authentic or validation set represents only one replicate of data (n=1)

4.3.4.1 Mixed Effects Model
For the mixed effects model, the equation below was used.

1
̃=𝝁
𝒀
̃ + 𝛿𝑗 + 𝜏𝑖 + (𝛿𝜏)𝑗:𝑖 + (0
0
̃𝝆 + 𝚬
̃𝒖
+𝚬

𝛿𝑗:𝐿
𝜏𝑖:𝐿
0 0
1 0 0
1 0
𝜏
𝛿
1 0) ( 𝑖:𝑀 ) + (0 1 0) ( 𝑗:𝑀 ) + (0 1
0 1 𝜏𝑖:𝑊
0 0 1 𝛿𝑗:𝑊
0 0

(𝛿𝜏)𝑗:𝑖:𝐿
0
(𝛿𝜏)
0) (
𝑗:𝑖:𝑀 )
1 (𝛿𝜏)𝑗:𝑖:𝑊

In the equation, 𝑌𝐿 , 𝑌𝑀 , 𝑌𝑊 are the dependent variables measured on the larva. Collectively, they
𝑌𝐿
̃
𝑌
can be represented as 𝒀 = ( 𝑀 ). Let 𝜇𝐿 , 𝜇𝑀 , 𝜇𝑊 be the mean length, mass, and width of the population
𝑌𝑊
𝜇𝐿
of larva. Collectively, they can be represented as 𝝁
̃ = ( 𝜇𝑀 ). The Greek letters with 𝑖 𝑎𝑛𝑑 𝑗 subscripts are
𝜇𝑊
linear coefficients for categorical variables (i.e., factors) where the subscript represents the level of the
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̃𝝆 ~𝑀𝑁𝑉(0, Σρ ) represents the random effect
factor: 𝜏 (treatment), 𝛿 (day), and 𝜌 (replicate). Where 𝚬
̃𝒖 ~𝑀𝑁𝑉(0, Σu ) represents random errors.
due to replicates, and 𝚬
The mixed effects model using this equation, did not identify a trend or statistical difference in
the means for the treatment groups (α = 0.05). As shown in Figure 4.5, the replicates had variations too
great for the treatment groups to overcome. Potential reasons for this include the natural variation of the
insects, the variations in the liver tissues selected for the project, and the variation of the different
generations of the insects. However, within replicate differences were observed and discussed in later
sections. In Figure 4.5, the high treatment groups (purple) were higher than the control groups (orange)
within each replicate, however they did not exceed the predicted means for the treatments. This indicates
that the variations of the of the replicates was greater than the differences between the high treatment
and control group for the entire model.

Figure 4.5: Plot of predicted means via the mixed effects model.
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4.3.4.2. Mean Lengths Day 2
For day 2 replicate #1 and #2, there was no significant difference between the control and
treatment groups for length (Figure 4.6). For day 2 in replicate #3 (C), the low treatment group was
significantly longer than the other groups (t12.7, 48.3 = 1.93, p = 0.0281).

Figure 4.6: Comparison of mean lengths for insects collected on day 2 in replicates #1-3.

4.3.4.3. Mean Lengths Day 3
For the insects collected on day 3 in replicate #1 for the length (A), the low treatment was
significantly longer than the other three treatment groups (t 12.7, 51.6 = 2.62, p = 0.0116) (Figure 4.7). For
replicate #2 (B), the low treatment group was significantly longer than the other three groups (t12.7, 51.6 =
2.62, p = 0.0011). Also for replicate #2, the medium group was significantly shorter than the control group
(t12.7, 50.4 = -2.44, p = 0.0181). For replicate #3 for the insects collected on day 3 (C), the low and control
treatment groups were not significantly different. The medium and high treatment groups were
significantly longer than the low and control groups (t12.7, 50.7 = 3.18, p = 0.0025).
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Figure 4.7: Comparison of mean lengths for insects collected on day 3 for replicates #1-3.

4.3.4.4. Mean Lengths Day 4
For the larva collected on day 4 in replicate #1 (A), the mean lengths for the low and high
treatment groups were significantly lower than the control and medium groups (t 12.7, 50.3 = -2.14, p =
0.0376) (Figure 4.8). The medium treatment group had a mean length significantly longer than the other
groups (t12.7, 52.4 = 3.16, p = 0.0026). For the larva collected on day 4 in replicate #2 (B), the mean length of
the medium treatment group was significantly longer than the other three groups. For the insects
collected on day 4 in replicate #3 (C), the high and medium treatment lengths were significantly longer
than the control group (t12.7, 50.9 = 2.40, p = 0.0201).

Figure 4.8: Comparison of mean lengths for insects collected on day 4 for replicates #1-3.
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4.3.4.5. Mean Lengths Day 5
For mean length of the larva collected on day 5 in replicate #1 (A), the high treatment group was
significantly longer than the other three groups (t 12.7, 50.7 = 3.98, p = 0.0002) (Figure 4.9). For the larva
collected on day 5 in replicate #2 (B), the mean length of the high treatment was significantly higher than
the other three groups (t12.7, 52.4 = 3.62, p = 0.0007). For the insects collected on day 5 in replicate #3 (C),
the mean length for the low treatment group was significantly longer than the control group (t 12.7, 51.1 =
3.82, p = 0.0004) and the high treatment was significantly shorter than the control group (t12.7, 50.3 = -2.54,
p = 0.0144).

Figure 4.9: Comparison of mean lengths for insects collected on day 5 for replicates #1-3.

4.3.4.6. Mean Lengths Day 6
For length of the larva collected on day 6 in replicate #1 (A), there was no significance difference
observed between the four treatments for mean length (Figure 4.10). For the larva collected on day 6 in
replicate #2 (B), there was no significance difference observed between the four treatments for mean
length. For length of the larva collected on day 6 in replicate #3 (C), there was no significance difference
observed between the four treatments for mean length.
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Figure 4.10: Comparison of mean lengths for insects collected on day 6 for replicates #1-3.

4.3.4.7. Mean Lengths Day 10
For length of the pupa collected on day 10 in replicate #1 (A), no significant difference was
observed for the treatments compared to the control group (Figure 4.11). For the pupa collected on day
10 in replicate #2 (B), the mean length for the high treatment group was significantly shorter than the
other groups (t12.7, 51.6 = -2.30, p = 0.0249). For the pupa collected on day 10 in replicate #3 (C), no
significant difference was observed for the treatments compared to the control group.

Figure 4.11: Comparison of mean lengths for insects collected on day 10 for replicates #1-3.
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4.3.4.8. Growth Curves
The mean lengths for the control group for days 2 to 6 for each replicate (1-3) and the total
comparison were plotted and a polynomial regression was applied. The simulated equation and resulting
R2 value are presented in Table 4.11. Using the mean length for each treatment, the simulated equation
was used to calculate the estimation of the age of the larval cohort with time in days (Table 4.12). The
estimated age was compared to the day collected or ground truth for the age of the insect and is
presented in Table 4.12. A positive difference indicates an increase in estimated age compared to the
actual age and a negative number indicates a decrease in estimated age compared to the actual age. A
positive number also indicates a faster development rate and a negative number indicates a delay in
development. Polynomic equations for age estimation do have limitations, including lengths beyond the
asymptote of the equation and the late stage larva are much harder to predict with these models due to
the nature of the insect growth. The polynomic equation cannot estimate age based on a length beyond
its asymptote, therefore extraordinarily longer insects could produce inaccurate estimations and insects
that do not pupate for any reason could have a much more inaccurate age estimation.
4.3.4.8.1. Replicate #1

Figure 4.12: Growth curves for the four treatments for replicate #1.
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Plotted in Figure 4.12 is the mean larval length against time for the insects collected from the four
treatments in replicate #1. The control (blue) and medium (orange) treatments reached peak mean
lengths in the collection at day 4. The low (green) treatment reached the peak mean length on the day 3
collection and the high (red) treatment group reached the peak mean length on day 5. The largest
difference in calculated age to actual age was in the high treatment group at day 6 with a -1.4 day
difference. At and after the day 4 collection, the high treatment group had a -1.0 day difference or greater
indicating the estimated age of at least a day sooner than the actual age (Table 4.12). This is corroborated
by the peak length for the high treatment occurring a day later than the control group. The low treatment
age was artificially increased in the early collection days but decreased in the later collection days. This is
corroborated by the peak of the length for the low treatment group occurring a day before the control
group, an indication that the insects are progressing faster. The medium treatment group reached its peak
length on the same day as the control but the had a -0.9 day difference for the day 4 collection and a -1.0
day difference on collection day 6. For the medium and high treatment groups, the fentanyl
concentrations created an age estimation of 1.0 to 1.4 days shorter than the actual age in replicate #1.
4.3.4.8.2. Replicate #2

Figure 4.13: Growth curves for the four treatments for replicate #2.
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Plotted in Figure 4.13 is the mean larval length against time for the insects collected from the four
treatments in replicate #2. The control (blue) and low (green) treatments reached peak mean lengths in
the collection at day 3. The medium (orange) treatment group reached its length peak one day later on
collection day 4 and the high (red) treatment group reached its peak length two days later on collection
day 5. The mean lengths for the control group for days 2 to 6 were plotted and a polynomial regression
was applied (Figure 4.13). The largest difference in calculated age to actual age was in the high treatment
group at day 4 with a -1.2 day difference. This is corroborated by the peak length for the high treatment
occurring two days later than the control group. The low treatment age was artificially increased in the
early collection days (0.6 d) but decreased in the later collection days with a max of -1.0 day on collection
day 6. The low treatment peaked at on the same day as the control group but was significantly longer
than the control group (Figure 4.13). The medium had a -1.0 day difference for the day 4 collection and a
-0.9 day difference on collection day 6 (Table 4.12). This is corroborated by the peak length for the medium
treatment occurring one day later than the control group. For the medium and high treatment groups,
the fentanyl concentrations created an age estimation of 0.9 to 1.2 days shorter than the actual age in
replicate #2.
4.3.4.8.3. Replicate #3
Plotted in Figure 4.14 is the mean larval length against time for the insects collected from the five
treatments in replicate #3. The control (blue), medium (orange), and high (red) treatments reached peak
mean lengths in the collection at day 4. Both the medium and high treatment groups peaked at a
significantly longer length than the control group (Figure 4.14). The low (green) treatment group reached
its peak length on day 5.
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Figure 4.14: Growth curves for the five treatments for replicate #3.

The authentic (purple) group appeared to peak on day 6. The authentic set experienced the most
difference in estimated age to actual age on day 6 at -2.9 d. The authentic set had a difference of more
than -0.8 day for collection days 3 to 6. This difference in age is corroborated in the peak length for the
authentic set on day 6 or two days later than the control group. The low treatment experienced its
greatest difference in estimated age to actual age at the day 5 collection of -1.1 d. The length for the
medium and high treatment groups was elevated compared to control group with correlated to an
increase in estimated age. The high reached a peak difference in estimated age at 0.9 d for the insects
collected on day 3 and had a positive difference on days 4 and 5. The medium reached a peak difference
in estimated age at 0.6 d on collection day 3 but went down to an estimated -0.4 d on collection day 6
(Table 4.12). The high and medium treatments experienced an increase in estimated age in the earlier
collection days with a decrease as time continued to day 6. The low and authentic groups experience a
decrease in estimated age from the early collection days and persisted through the collection days.
4.3.4.8.4. Total
Plotted in Figure 4.15 is the mean larval length against time for the insects collected from the five
treatments in all three replicates combined. The control (blue) and medium (orange) treatments reached
peak mean lengths in the collection at day 4. The low (green) treatment reached the peak mean length
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on the day 3 collection and the high (red) treatment group reached the peak mean length between day 4
and day 5.

Figure 4.15: Growth curves for the five treatments for all three replicates combined.

The authentic (purple) group appeared to peak on day 6. For the combined means for the low,
medium, and high treatment groups, there was a slight increase in age estimation on collection days 3
and 4 but the age estimation decreased for collection days 5 and 6. There was a trend in all three replicates
of an increase or no change in age on collection day 3 followed by a steady decrease in the later collection
days. For the authentic set, the difference in the estimated age to actual at collection day 3 was -0.9 d and
steadily decreased down to -3.2 d by collection day 6. The estimated age for the treatments was lowest
on collection day 6 was the lowest in each treatment group ranging from -0.6 to -3.2 d.
The maximum lengths of the larva were also compared for each treatment and replicate (Figure
4.16). The control groups reach their maximum on collection day 4 for all the replicates but the treatment
groups lacked a true pattern. The authentic or validation set in replicate #3 only reached its maximum
length at day 6, assuming that it did not increase in length as day 6 was the last day collected as larva. The
low treatment group obtained the most variation with peak maximum lengths at collection day 3, day 4,
and day 5 for replicates #2, #1, and #3 respectively. The control group growth curves maintained a distinct
pattern, while the treatment groups did not maintain this pattern. The control length increased until the
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peak length, followed by a steady and steep decrease as the insects prepared for pupation. The high
treatment observed the most variation in this patter with typically slower time to reach a maximum length
and then a slower decrease in length.

Figure 4.16: The maximum length measured from the larva collected on each day.

Table 4.11: Equations for the growth curve of the control group for each replicate and as a total.

Control Growth Curve

Simulation equation

R2

Replicate #1

L = 0.561x3 - 7.7391x2 + 34.118x - 34.962

0.999

Replicate #2

L = 0.5976x3 - 8.3081x2 + 36.545x - 37.718

0.980

Replicate #3

L = 0.7863x3 - 10.672x2 + 45.976x - 49.729

0.995

Total

L = 0.4827x3 - 6.8853x2 + 31.276x - 32.496

0.999
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Table 4. 12: Age estimations generated using the equations from Table 4.11. Estimated ages were compared to the actual day
of collection to calculate a difference () age (d).
Replicate #1
 Age (d)

Estimated Age (d)
Treatment
Day 2

Day 3

Day 4

Day 5

Day 6

Day 2

Day 3

Day 4

Day 5

Day 6

Control

2.0

3.0

4.0

5.0

6.0

0.0

-0.0

-0.0

0.0

0.0

Low

2.0

3.3

4.5

4.9

5.5

0.0

0.3

0.5

-0.1

-0.5

Medium

2.0

2.8

3.1

5.4

5.0

0.0

-0.2

-0.9

0.4

-1.0

High

2.0

2.9

3.0

3.7

4.6

0.0

-0.1

-1.0

-1.3

-1.4

Replicate #2
 Age (d)

Estimated Age (d)
Treatment
Day 2

Day 3

Day 4

Day 5

Day 6

Day 2

Day 3

Day 4

Day 5

Day 6

Control

2.0

3.2

4.4

4.8

5.9

-0.0

0.2

0.4

-0.2

-0.1

Low

2.0

3.6

4.2

5.0

5.0

0.0

0.6

0.2

-0.0

-1.0

Medium

2.0

2.9

3.0

4.8

5.1

0.0

-0.1

-1.0

-0.2

-0.9

High

2.0

2.8

2.8

4.1

5.7

0.0

-0.2

-1.2

-0.9

-0.3

Replicate #3
 Age (d)

Estimated Age (d)
Treatment
Day 2

Day 3

Day 4

Day 5

Day 6

Day 2

Day 3

Day 4

Day 5

Day 6

Control

2.0

3.0

4.1

5.0

6.1

0.0

0.0

0.1

-0.0

0.1

Low

2.1

3.0

3.2

3.9

6.0

0.1

0.0

-0.8

-1.1

0.0

Medium

2.0

3.6

3.9

5.0

5.6

0.0

0.6

-0.1

0.0

-0.4

High

2.0

3.9

3.9

5.4

6.8

0.0

0.9

-0.1

0.4

0.8

Authentic

-

2.2

2.7

3.1

3.1

-

-0.8

-1.3

-1.9

-2.9

Total
 Age (d)

Estimated Age (d)
Treatment
Day 2

Day 3

Day 4

Day 5

Day 6

Day 2

Day 3

Day 4

Day 5

Day 6

Control

2.0

3.0

4.2

4.9

6.0

0.0

0.0

0.2

-0.1

-0.0

Low

2.1

3.2

4.5

4.6

5.4

0.1

0.2

0.5

-0.4

-0.6

Medium

2.0

3.1

4.1

5.1

5.3

0.0

0.1

0.1

0.1

-0.7

High

2.0

3.2

4.3

4.4

5.3

0.0

0.2

0.3

-0.6

-0.8

Authentic

-

2.1

2.5

2.8

2.8

-

-0.9

-1.5

-2.2

-3.2
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4.3.5. Discussion
This study presents morphometric measures of length, width, and mass for the insects collected;
however, larval length was the most significant physical character. In comparison of individual collection
days, at least one of the treatment groups (low, medium, or high) was significantly different from the
control group over all three replicates. In all three replicates, the maximum larval length reached was
higher in the high treatment group compared to the control group. In replicates #2 and #3, the low
treatment group reached a maximum length greater than that of the control group and in replicate #1 the
maximum lengths were not significantly different between the two groups. The medium treatment group
achieved a maximum length greater than the control group in replicate #3, a similar max length in replicate
#2, and a lower maximum length in replicate #1. Using a polynomial equation on the growth curve of the
control group, the estimation of age of the insects showed that there was often an increase in growth at
the early life stages, followed by a decrease in the later larval stages. The estimated age was compared to
the day collected for the age of the insect. A positive difference indicates an increase in estimated age
compared to the actual age and a negative number indicates a decrease in estimated age compared to
the actual age. A positive number also indicates a faster development rate, and a negative number
indicates a delay in development. In the low treatment group across all three replicates, the insects
collected on day 3 had a neutral or increase in age compared to the actual age and by day 5 or 6 had a
decrease in age estimation compared to the actual age. The largest discrepancy in actual age to estimated
age for the low treatment group was -1.1 in the insects collected on day 5 in replicate #3. For the medium
group, the age estimation starting at collection day 3 for replicates #1 and #2 was decreased compared to
the actual age and steadily decreased until collection day 6 with a final decrease of -1.0 d age in both
replicates. For replicate #3, the medium treatment group had an increase estimation of 0.6 d at collection
day 3 and then decreased to a final estimation of -0.4 d at collection day 6. For replicates #1 and #2, the
high treatment consistently had a decreased estimation of age compared to the actual age of the insect
beginning on collection day 3. For replicate #3, the high had an increased estimation for age for most of
138

the collection days compared to the actual age, this could be due to the extreme elevation of the length
of the high treatment group compared to the control. The high was significantly higher for the max length
on day 4 and obtained peak length at the same time as the control group which could have led to the
increased estimation. The authentic set was only applied to replicate #3 and the age estimation was
always decreased compared to the actual age beginning at collection day 3 and continuing through
collection day 6. The authentic set experienced the greatest discrepancy from estimated to actual age
ranging from -0.8 d at collection day 3 to -2.9 d on collection day 6. The peak maximum length for the
authentic set was finally reached at collection day 6, a full 2 days after the peak length was achieved for
the control group. A reason for the difference in the authentic set compared to the medium and high
treatments could be the presence of metabolites norfentanyl and 4-ANPP in the authentic liver specimen.
The treatment livers were not fortified with any metabolites and none were detected in the liver extracted
from collection days. The metabolite 4-ANPP is a known active metabolite in human metabolism
pathways, and it is unknown how this compound will impact the insects. For the combined replicates, the
average mean for the low, medium, and high treatment estimated ages were elevated compared to the
actual age at collection day 3 but decreased as time elapsed and ranged from -0.6 to -0.8 d by collection
day 6. For the authentic set, the difference in the estimated age at collection day 3 was -0.9 d and
decreased to -3.2 d by collection day 6. This was the largest discrepancy and an estimation of minPMI on
the larval length collected on day 6 would be underestimated by 3 days.
To estimate the

minPMI,

the age of the oldest insects collected need to be estimated by

identification of the insect life stage or by estimation based on larval length (2, 17). Drugs or toxins can
impact the growth and development of insects which in turn can impact the minPMI estimations (39, 50,
157). Even though there have not been publications for fentanyl effects on the growth of necrophagous
insects, other opioids have been investigated (39, 157). El-Samad et al. investigated the effects of
tramadol on L. sericata where they observed an increase in the time for the insects to progress from egg
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to adult eclosion (45). The control group in their study reached adulthood after 11.7 days but the three
treatment groups ranged from 13.9 to 15.1 days to reach eclosion (45). They also observed an increase in
larval length for the treatment groups with the maximum length achieved faster than the control group
indicative of an accelerated larval growth but the treatment groups still took longer to emerge in the later
stages (45). A similar trend was observed in the low treatment in this study and in the overall combination
of the replicates where the treatment groups grew longer than the control, reached the maximum length
faster but then still slowed as they approached the day 6 collection. Gosselin et al. explored the impact
that methadone has on L. sericata over five treatment groups (44). The study did not observe any
significant impact of the drug on the growth on the insect however, only empty puparium and adult
eclosion was measured for the impact of development (44). The effects of heroin on Boettcherisca
peregrina was investigated by Goff et al. by dosing live rabbits for four treatment concentrations plus a
control (158). They also observed a longer max length in the treatment groups and a faster maximum
length (158). The treatment groups also reached pupation before the control group but the control group
was the first to emerge with all four treatments taking longer to emerge as adults (158). This is also similar
to our study where we observed a longer maximum length and in the lower treatment reaching maximum
length faster than the control group but slowing down in development as development progressed. The
effect of morphine on various blow fly species has been evaluated (47, 159, 160). George et al.
investigated the effect of morphine on Calliphora stygia but they did not observe any significant effects
of the drug on the growth of the insect across four treatments that included a control (47). A potential
limitation of their study was only four time segments: day 4 (feeding), day 7 (wandering), pupation, and
adult eclosion were evaluated (47). Bourel et al. dosed rabbits with lethal concentrations of morphine to
evaluate the effects of the drug on L. sericata and discovered the insects developed at a slower rate (159).
They estimated the error estimation in

minPMI

to be as great as 24 h in the larval estimations and that

estimations based on puparia could be erroneous if the drugs is not taken into account (159). Rassi et al.

140

investigated the effect of morphine on Chrysomya albiceps and calculated an underestimation of the
minPMI

by 72 h for the larval development and 24 to 48 h based on the puparial development (160). Like

the study presented here, they found an increase in the maximum larval length in the higher treatment
groups compared to the control (160).
4.3.6. Conclusion
The low, medium, and high treatment groups reached a greater maximum length compared to
the control group in most of the replicates in terms of maximum mean length between collection days 3
and 6. The authentic set experienced the greatest decrease in estimated age (-2.9 d) compared to actual
age in replicate #3. This is an underestimation of 2.9 d for the age of the larva collected at day 6 in replicate
#3. The largest discrepancy in age estimation for the high treatment group was -1.4 d on collection day 6
in replicate #1, which is an underestimation of 1.4 d. The high treatment also had large underestimations
of -1.3 d, -1.2 d, and -1.0 d at collection day 5 replicate #1, collection day 4 replicate #2, and collection day
4 replicate #1, respectively. The low and medium treatment groups also had at least a -1.0 d
underestimation of age at two or more collection days. Every treatment group had an underestimation in
age of 1 d in at least one day of collection among the three replicates. With the impact of fentanyl on the
length of the larval length, it can be concluded that fentanyl can reduce the larval growth by at least 1 day
and up to 3 days. Even though a significant trend was not identified across the replicates for all treatments,
the impact on age estimation based on length and the variability of the length in the insects collected
from the treatment groups indicates that caution must be used when estimating minPMI when fentanyl is
present in the corpse.
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4.4. Section 3: Quantitation of Fentanyl and Metabolites from Larva and Pupa (Lucilia
sericata)
4.4.1. Overview
This section presents the toxicological findings for the larva and pupa for task 1.e. The validated
QuEChERS extraction presented in section 1 of this chapter was used for extraction of the feeding media
liver and the insect tissue. Presented is the survey of fentanyl and metabolites detected in the larva and
pupa. For task 3.a, a correlation plot was created for a comparison of the fentanyl concentrations detected
in the insect tissue to the liver fentanyl concentrations to establish any correlation of the concentrations.
The concentrations detected for the set of insects that fed on the authentic liver source were compared
to theoretical concentrations estimated from the correlation plots. The goal of this section is to evaluate
the toxicological value of the insect life stages, quantify any metabolites detected for evidence of
metabolism by the insect, and to draw any conclusions of the liver tissue concentration to insect tissue
concentrations.
4.4.2. Toxicology Matrix and Correlations
Detection of drugs in pupa and empty puparium has a benefit over larva because they persist on
the remains longer and are potentially available after other suitable toxicology specimens are unavailable
(111). Wood et al. detected nordiazepam and its metabolite oxazepam in larva and pupa that resulted
from rearing on beef heart tissue containing 1ug/g (1ppm) nordiazepam (161). Pien et al. performed a
similar study with nordiazepam, analyzing larva, pupa, and empty puparium for nordiazepam and
oxazepam in all three of the life stages of Calliphora vicina (162). When feeding on tissue with drugs
present, the drugs are deposited in fat bodies of larva and the chitinized exoskeleton of the pupa (154).
The function of the hardened, chitin cuticle of the pupa is to protect the insect from environment during
metamorphosis (44). The structure is resistant to chemical attack, microorganisms, and weathering (44).
Due to the structure of chitin, the drugs are often locked in and remain for an extended period of time
(34). When pupa emerge to adult flies, the empty puparia remains behind with the drugs trapped in the
chitin (44). Pupa and empty puparia, due to the strength of the chitin protected exoskeleton, can persist
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in the remains long after the soft tissue of the corpse have disappeared (34). This allows for toxicological
analysis to take place on the pupa and empty puparia even in advanced decomposition or skeletonized
remains when traditional toxicology specimens like blood, urine and organ tissue are not available for
testing. The use of empty puparium for toxicological analysis has utility due to their ability to exist for
extend periods on remains, even after skeletonization of the corpse (154). Miller et al. were able to isolate
amitriptyline and nortriptyline from empty fly puparia and beetle exuvia recovered from mummified
human remains in an indoor decomposition case (163). From stomach contents and analysis of the
desiccated brain, multiple drug intoxication, including amitriptyline, was identified as the cause of death
(163). The ability of empty puparia to remain in soil surrounding the remains for hundreds of years, makes
empty puparia a prime target specimen for toxicology analysis in cadavers discovered in the late stage of
decomposition (163).
Gosselin et al. identified strategies for standardizing entomotoxicological experimental designs
for research and interpretation of results with a key aim of extracting target compounds with a
straightforward methodology while maintaining sensitivity and minimizing matrix effects (111). Emphasis
is placed on the reduction of matrix effects like co-eluting compounds while maintaining acceptable
extraction recoveries (111). Da Silva et al. examined 55 entomotoxicology papers published between 1980
and 2016, finding 21% did not use any analytical methods to quantify the toxicant in the insects, 18% used
high performance liquid chromatography (HPLC) or GC/MS and 11% used radioimmunoassay (RIA) (61).
In the papers examined, 57% did not mention an extraction technique and the studies that did employed
a solid-phase extraction in 31% and a liquid-liquid extraction in 7% of the experiments (61). There is a
need to standardize an extraction and analysis technique in the field of entomotoxicology (61). This study
addressed that need by utilizing a QuEChERS extraction protocol combined with a LC-MS/MS analysis
method.
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Recent studies have demonstrated the possibility of correlating concentrations of drugs extracted
from insects compared to concentrations of the feeding substrate, however interpretation of results has
remained a controversial issue (39, 111). Estimation to the cause of death or relationships of blood or liver
tissue concentrations to drug concentrations recovered from insects feeding on a corpse remain
unachieved and are subject to debate (39, 111). Identifying this quantitative relationship is difficult due
to complicated influencing factors including: drug tropism in the body, postmortem redistribution, and
the extraction and detection efficiencies of the analytical techniques (39, 61, 111). Sallawad et al.
highlighted this need and lack of valuable research into the factors limiting the assessment of correlating
insect drug concentrations to tissue drug concentrations with the conclusion that further research into
entomotoxicology is necessary (42). The first step in achieving correlation between blood/tissue and
insect concentrations is to control or reduce the influencing factors by identifying correlations from insect
drug concentrations to single tissue type source drug concentrations. To address this critical need, liver
tissue fortified with fentanyl was the feeding media for the insects in this study. Concentrations were
compared to determine any correlation.
4.4.3. Methods
The samples from the design in methods 4.2.3 were used for the toxicology analysis of the
collected insects. Insects from collection days 3, 6, 10, and 21 were selected for toxicology analysis after
the imaging and morphometric characteristic measurements (Figure 4.5). The target groups were feeding
larva (day 3), wandering larva (day6), pupa (day 10), and empty puparium/adults (day21). Insects from
each treatment level and day of collection were randomly selected (n=5) and extracted using the validated
QuEChERS extraction. Larval specimens were also randomly selected into pools of four for analysis of
pooled samples (n=5). Insects were assigned numbers using the random number generator function in
excel (0 to 70) with the lowest numbers assigned to single replicates and the highest numbers selected
for the pooled samples. Liver samples were collected at the time of egg placement (day 0) and at the day
of collection to establish the initial tissue concentrations and to evaluate any metabolism of the drugs by
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the feeding media. A survey of the persistence and prevalence of fentanyl and metabolites was performed
followed by a correlation plot of liver concentration to insect concentration to evaluate any correlation.
4.4.4. Results
4.4.4.1. Survey of Drugs
The previously discussed validated QuEChERS extraction was applied to the larva and pupa
collected on days 3, 6, and 10 for all four treatments over three replicates with one additional treatment
set of an authentic postmortem liver specimen containing fentanyl. The insects were analyzed as single
samples and pooled together (n=4) for five replicates from each sample time.
For the single and pooled larva collected on day 3, fentanyl was detected and quantitated in all
treatments across all three replicates (Table 4.12). A trend emerged, as the concentration of the fortified
liver treatment increased, the concentration of fentanyl observed in the larval extractions also increased.
For the larva collected from the low treatment, the average concentration across the three replicates was
1.2 ± 0.5 µg/kg in the single specimens and 1.2 ± 0.5 µg/kg in the pooled larval samples. From the medium
treatment, the average concentration across the three replicates was 9.1 ± 4.1 µg/kg in the single
specimens and 8.5 ± 2.0 µg/kg in the pooled larval samples. From the high treatment, the average
concentration across the three replicates was 30.0 ± 10.5 µg/kg in the single specimens and 29.3 ± 9.3
µg/kg in the pooled larval samples. For all the fentanyl extractions, the pooled samples generated similar
concentrations to the single specimens but experienced reduced standard deviations. In the control insect
extractions, no fentanyl or metabolites were detected in any of the replicates. In extracts of the larva from
the low, medium, and high treatment groups, metabolites 4-ANPP and β-hydroxyfentanyl were not
detected in any of the replicates. The metabolite norfentanyl was quantitated in the single and pooled
larva collected from the high treatment livers in all three of the replicates. Norfentanyl concentrations for
the larval high treatment groups quantitated at 3.3 ± 1.5 µg/kg for the single larvae extraction and 2.1 ±
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1.2 µg/kg for the pulled larva extracts. Norfentanyl was detected in the pooled larva extractions from the
medium treatment group in all three replicates with an average of 0.8 ± 0.3 µg/kg.
For the single and pooled larva extracted from the authentic liver treatment, fentanyl, and
metabolites norfentanyl and 4-ANPP were quantitated. The authentic postmortem liver specimen was
quantitated with an average fentanyl concentration of 111 µg/kg, norfentanyl concentration of 8.1 µg/kg,
and a 4-ANPP concentration of 5.8 µg/kg at the time of egg placement. Since the metabolites were present
in the liver at the time of egg placement, the metabolites cannot be used as proof of metabolism by the
insects. For the single and pooled larva extractions for the authentic set, the fentanyl concentrations were
10.6 ± 4.1 µg/kg and 9.3 ± 1.2 µg/kg, respectively. The concentration for the authentic liver and the
fortified liver for the medium treatment were in similar concentration and the fentanyl concentrations
quantitated from the larva extractions were in similar concentration (Table 4.13). No metabolites were
detected in the fortified liver tissue on the day of collection.
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Table 4.13: Larval drug concentrations from day three collections for all three replicates.
Replicate #1
Single Larvaea (µg/kg)

Pooled Larvab (µg/kg)

Compound
Controlc

Lowc

Mediumc

Highc

Controlc

Lowc

Mediumc

Highc

4-ANPP

ND

ND

ND

ND

ND

ND

ND

ND

β-Hydroxyfentanyl

ND

ND

ND

ND

ND

ND

ND

ND

Fentanyl

ND

0.7 ± 0.05

7.0 ± 1.4

40.9 ± 9.9

ND

0.6 ± 0.03

6.5 ± 0.3

40.3 ± 3.1

Norfentanyl

ND

ND

2.1 ± 0.1

4.9 ± 0.4

ND

ND

1.0 ± 0.04

3.6 ± 0.1

Replicate #2
a

Pooled Larvab (µg/kg)

Single Larvae (µg/kg)
Compound
Controld

Lowd

Mediumd

Highd

Controld

Lowd

Mediumd

Highd

4-ANPP

ND

ND

ND

ND

ND

ND

ND

ND

β-Hydroxyfentanyl

ND

ND

ND

ND

ND

ND

ND

ND

Fentanyl

ND

1.8 ± 0.3

7.3 ± 1.5

21.4 ± 5.4

ND

1.8 ± 0.2

8.2 ± 1.1

19.1 ± 0.9

Norfentanyl

ND

ND

<LLOQ

3.5 ± 0.4

ND

ND

1.0 ± 0.1

1.9 ± 0.2

Replicate #3
Single Larvaea (µg/kg)

Pooled Larvab (µg/kg)

Compound
Controle

Lowe

Mediume

Highe

Controle

Lowe

Mediume

Highe

4-ANPP

ND

ND

ND

ND

ND

ND

ND

ND

β-Hydroxyfentanyl

ND

ND

ND

ND

ND

ND

ND

ND

Fentanyl

ND

1.2 ± 0.2

13.0 ± 5.1

27.7 ± 3.9

ND

1.2 ± 0.06

11.0 ± 1.0

28.5 ± 3.1

Norfentanyl

ND

ND

ND

1.4 ± 0.3

ND

ND

0.5 ± 0.05

2.8 ± 0.2

Authentic Set Larvae (µg/kg)
Compound
Medium

Single Authentic

Medium
Pooled

Pooled
Authentic

4-ANPP

ND

1.0 ± 0.3

ND

0.7 ± 0.1

β-Hydroxyfentanyl

ND

ND

ND

ND

Fentanyl

13.0 ± 5.1

10.6 ± 4.1

11.0 ± 1.0

9.3 ± 1.2

Norfentanyl

ND

7.6 ± 2.5

0.5 ± 0.05

2.8 ± 0.2

Total of 3 Replicates
Single Larvaea (µg/kg)

Pooled Larvab (µg/kg)

Compound
Control

Low

Medium

High

Control

Low

Medium

High

4-ANPP

ND

ND

ND

ND

ND

ND

ND

ND

β-Hydroxyfentanyl

ND

ND

ND

ND

ND

ND

ND

ND

Fentanyl

ND

1.2 ± 0.5

9.1 ± 4.1

30.0 ± 10.5

ND

1.2 ± 0.5

8.5 ± 2.0

29.3 ± 9.3

Norfentanyl

ND

ND

2.1 ± 0.1

3.3 ± 1.5

ND

ND

0.8 ± 0.3

2.1 ± 1.2

Larvae (n=5) Collected from day three for each treatment group
Pooled Larva (n=5) Pooled specimen of 4 larva collected from day three for each treatment group
Treatments: Control (0 µg/kg), Low (6.0 µg/kg), Medium (23.3 µg/kg), and High (239 µg/kg) quantitated from liver tissue collected at time of egg placement
d Treatments: Control (0 µg/kg), Low (12.6 µg/kg), Medium (53 µg/kg), and High (211 µg/kg) quantitated from liver tissue collected at time of egg placement
e Treatments: Control (0 µg/kg), Low (14.6 µg/kg), Medium (102 µg/kg), and High (209 µg/kg) quantitated from liver tissue collected at time of egg placement
a

b
c
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Figure 4.17: Box plot for the concentration of fentanyl quantitated for the single and pooled larva specimens collected from the
high treatment liver on day 3 for all three replicates (n=15).

Figure 4.18: Box plot for the concentration of fentanyl quantitated for the single and pooled larva specimens collected from the
medium treatment liver on day 3 for all three replicates (n=15).
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Figure 4.19: Box plot for the concentration of fentanyl quantitated for the single and pooled larva specimens collected from the
medium treatment liver on day 3 for all three replicates (n=15).

Figure 4.20: Box plot for the concentration of fentanyl quantitated for the single and pooled larva specimens collected from the
low treatment liver on day 3 for all three replicates (n=15).
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Figure 4.21: Box plot for the concentration of norfentanyl quantitated for the single and pooled larva specimens collected from
the high treatment liver on day 3 for all three replicates (n=15).

Figure 4.22: Box plot for the concentration of norfentanyl and 4-ANPP quantitated for the single and pooled larva specimens
collected from the authentic treatment liver on day 3 for all three replicates (n=5).

The box plot in figure 4.17 displays the concentration for fentanyl for the larva collected from the
high treatment liver specimens across the three replicates. The variation for the pooled larval samples
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were less compared to the single specimens while the single specimens had a higher maximum and lower
minimum than the pooled extractions. The box plot in figure 4.18 shows the concentration for fentanyl
for the larva collected from the medium treatment liver specimens across the three replicates. The single
extractions in replicate #3 observed the greatest variation. The box plot in figure 4.19 exhibits the
concentration for fentanyl for the larva collected from the low treatment liver specimens across the three
replicates. The similar trend of the pooled extractions having less of a spread is observed for the low
treatment groups as well. The box plot in figure 4.21 exhibits the concentration for norfentanyl for the
larva collected from the high treatment liver specimens across the three replicates. The box plot in figure
4.22 displays the concentration for norfentanyl and 4-ANPP for the larva collected from the authentic
postmortem liver specimen from replicate #3.
The fentanyl and metabolite concentrations detected from the larva collected on day 6 was
significantly lower than the concentrations detected on day 3 collections (Table 4.14). The highest mean
detected from the larva in day 3 was 40.9 µg/kg compared

to

the

highest

detected

fentanyl

concentration of 0.9 µg/kg for the high treatment on day 6. Fentanyl was quantitated in the high fortified
liver pooled larva samples for all three replicates and was the only group for fentanyl to be detected in all
three treatments. The metabolite 4-ANPP was not detected in any of the extractions, even in the authentic
specimen that had 4-ANPP present when the eggs were placed. Norfentanyl was present in some of the
extractions but the concentrations were reduced and was not detected as frequently. The metabolite βhydroxyfentanyl was detected in multiple groups after not being observed in the day 3 collected
specimens. β-hydroxyfentanyl was quantitated in the highest concentration at 0.9 ± 0.3 µg/kg in the
medium treatment pooled larval samples for replicate #3. β-hydroxyfentanyl was also quantified in the
pooled high treatment samples for replicates #2 and #3 while being detected below the LLOQ in single
larval extractions for the medium and high treatments in replicate #3.
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Table 4.14: Larval drug concentrations from day six collections for all three replicates.
Replicate #1
a

Pooled Larvab (µg/kg)

Single Larvae (µg/kg)
Compound
Controlc

Lowc

Mediumc

Highc

Controlc

Lowc

Mediumc

Highc

4-ANPP

ND

ND

ND

ND

ND

ND

ND

ND

β-Hydroxyfentanyl

ND

ND

ND

ND

ND

ND

ND

ND

Fentanyl

ND

ND

ND

0.9 ± 0.3

ND

ND

ND

0.9 ± 0.07

Norfentanyl

ND

ND

<LLOQ

1.7 ± 0.2

ND

ND

0.3 ± 0.06

0.6 ± 0.06

Replicate #2
Single Larvaea (µg/kg)

Pooled Larvab (µg/kg)

Compound
Controld

Lowd

Mediumd

Highd

Controld

Lowd

Mediumd

Highd

4-ANPP

ND

ND

ND

ND

ND

ND

ND

ND

β-Hydroxyfentanyl

ND

ND

ND

ND

ND

ND

ND

0.7 ± 0.2

Fentanyl

ND

ND

ND

ND

ND

ND

ND

0.05 ± 0.04

Norfentanyl

ND

ND

ND

ND

ND

ND

ND

ND

Replicate #3
a

Pooled Larvab (µg/kg)

Single Larvae (µg/kg)
Compound
Controle

Lowe

Mediume

Highe

Controle

Lowe

Mediume

Highe

4-ANPP

ND

ND

ND

ND

ND

ND

ND

ND

β-Hydroxyfentanyl

ND

ND

<LLOQ

<LLOQ

ND

ND

0.9 ± 0.5

0.4 ± 0.1

Fentanyl

ND

ND

ND

ND

ND

ND

0.2 ± 0.03

0.1 ± 0.03

Norfentanyl

ND

ND

ND

ND

ND

ND

<LLOQ

<LLOQ

Authentic Set Larvae (µg/kg)
Compound
Medium

Single Authentic

Medium
Pooled

Pooled
Authentic

4-ANPP

ND

ND

ND

ND

β-Hydroxyfentanyl

<LLOQ

ND

0.9 ± 0.5

ND

Fentanyl

ND

ND

0.2 ± 0.03

ND

Norfentanyl

ND

ND

<LLOQ

<LLOQ

Total of 3 Replicates
a

Pooled Larvab (µg/kg)

Single Larvae (µg/kg)
Compound
Control

Low

Medium
(n=5)

High (n=5)

Control

Low

Medium
(n=5)

High

4-ANPP

ND

ND

ND

ND

ND

ND

ND

ND

β-Hydroxyfentanyl

ND

ND

<LLOQ

<LLOQ

ND

ND

0.9 ± 0.5

0.5 ± 0.3

Fentanyl

ND

ND

ND

0.9 ± 0.3

ND

ND

0.2 ± 0.03

0.4 ± 0.4

Norfentanyl

ND

ND

<LLOQ

1.7 ± 0.2

ND

ND

0.3 ± 0.06

0.6 ± 0.06

Larvae (n=5) Collected from day six for each treatment group
Pooled Larva (n=5) Pooled specimen of 4 larva collected from day six for each treatment group
Treatments: Control (0 µg/kg), Low (6.0 µg/kg), Medium (23.3 µg/kg), and High (239 µg/kg) quantitated from liver tissue collected at time of egg placement
d Treatments: Control (0 µg/kg), Low (12.6 µg/kg), Medium (53 µg/kg), and High (211 µg/kg) quantitated from liver tissue collected at time of egg placement
e Treatments: Control (0 µg/kg), Low (14.6 µg/kg), Medium (102 µg/kg), and High (209 µg/kg) quantitated from liver tissue collected at time of egg placement
a

b
c
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The trend of decreased fentanyl concentrations continued to the pupal extractions (Table 4.15).
Fentanyl was only detected in the high treatment pupal specimens and was not detected in all extractions.
The single pupal extractions for all three replicates did not detect any fentanyl and fentanyl was only
quantitated in the high pooled sample for replicate #1 and below the LLOQ in replicates #2 and #3.
Detection and quantitation of the metabolites was also less frequent. Norfentanyl was quantitated in all
three treatments for both the single and the pooled pupa specimens in replicate #1 but was only detected
below the LLOQ for the single and pooled high specimens in replicate #2. Norfentanyl was quantitated in
the single and pooled pupal extractions for the high treatment group in replicate #3. For the pupa
collected from feeding on the authentic liver specimen, norfentanyl was quantitated in the single and
pooled specimens while fentanyl was only detected below the LLOQ in the single and pooled extractions
for fentanyl. β-hydroxyfentanyl was also detected in the pupal extractions indicating that this metabolite
can persist from the larval stage to the pupal life stage.
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Table 4.15: Pupal drug concentrations from day 10 collections for all three replicates.
Replicate #1
a

Pooled Pupab (µg/kg)

Single Pupae (µg/kg)
Compound
Controlc

Lowc

Mediumc

Highc

Controlc

Lowc

Mediumc

Highc

4-ANPP

ND

ND

ND

ND

ND

ND

ND

ND

β-Hydroxyfentanyl

ND

ND

ND

2.7 ± 1.8

ND

ND

1.1 ± 0.2

0.8 ± 0.5

Fentanyl

ND

ND

ND

ND

ND

ND

ND

0.08 ± 0.03

Norfentanyl

ND

2.0 ± 0.4

1.9 ± 0.1

1.8 ± 0.3

ND

0.5 ± 0.1

0.5 ± 0.1

0.5 ± 0.04

Replicate #2
Single Pupaea (µg/kg)

Pooled Pupab (µg/kg)

Compound
Controld

Lowd

Mediumd

Highd

Controld

Lowd

Mediumd

Highd

4-ANPP

ND

ND

ND

ND

ND

ND

ND

ND

β-Hydroxyfentanyl

ND

ND

ND

ND

ND

ND

ND

ND

Fentanyl

ND

ND

ND

ND

ND

ND

ND

<LLOQ

Norfentanyl

ND

ND

ND

<LLOQ

ND

ND

ND

<LLOQ

Replicate #3
a

Pooled Pupab (µg/kg)

Single Pupae (µg/kg)
Compound
Controle

Lowe

Mediume

Highe

Controle

Lowe

Mediume

Highe

4-ANPP

ND

ND

ND

ND

ND

ND

ND

ND

β-Hydroxyfentanyl

ND

ND

ND

ND

ND

ND

ND

ND

Fentanyl

ND

ND

ND

ND

ND

ND

ND

<LLOQ

Norfentanyl

ND

ND

ND

1.7 ± 0.1

ND

ND

ND

0.5 ± 0.03

Authentic Set Pupae (µg/kg)
Compound
Medium

Single Authentic

Medium
Pooled

Pooled
Authentic

4-ANPP

ND

ND

ND

ND

β-Hydroxyfentanyl

ND

ND

ND

ND

Fentanyl

ND

<LLOQ

ND

<LLOQ

Norfentanyl

ND

1.6 ± 0.1

ND

0.6 ± 0.3

Total of 3 Replicates
a

Pooled Pupab (µg/kg)

Single Pupae (µg/kg)
Compound
Control

Low (n=5)

Medium
(n=5)

High (n=5)*

Control

Low

Medium
(n=5)

High

4-ANPP

ND

ND

ND

ND

ND

ND

ND

ND

β-Hydroxyfentanyl

ND

ND

ND

2.7 ± 1.8

ND

ND

1.1 ± 0.2

0.8 ± 0.5

Fentanyl

ND

ND

ND

ND

ND

ND

ND

0.08 ± 0.03

Norfentanyl

ND

2.0 ± 0.4

1.9 ± 0.1

1.8 ± 0.2

ND

0.5 ± 0.1

0.5 ± 0.1

0.5 ± 0.03

Pupae (n=5) Collected from day 10 for each treatment group
Pooled Pupa (n=5) Pooled specimen of 4 pupa collected from day 10 for each treatment group
Treatments: Control (0 µg/kg), Low (6.0 µg/kg), Medium (23.3 µg/kg), and High (239 µg/kg) quantitated from liver tissue collected at time of egg placement
d Treatments: Control (0 µg/kg), Low (12.6 µg/kg), Medium (53 µg/kg), and High (211 µg/kg) quantitated from liver tissue collected at time of egg placement
e Treatments: Control (0 µg/kg), Low (14.6 µg/kg), Medium (102 µg/kg), and High (209 µg/kg) quantitated from liver tissue collected at time of egg placement
a

b
c
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4.4.4.2. Regression Plots
To evaluate the correlation of the insect tissue concentration to liver concentration, simple linear
regression plots were created to compare correlation. For best correlation, a minimum of three points are
necessary to create a linear regression. Therefore, correlation plots were only created for the feeding
larva extractions.

Figure 4.23: Regression plots for liver concentrations to larva concentrations for the single and pooled extractions collected on
day 3 in replicate #1.

The regression plots in figure 4.23 display the single and pooled larva concentrations to liver
concentrations. The R2 value for the single larva concentrations was 0.928 while the R2 value for the
pooled larva concentrations was higher at 0.988. An R 2 value of greater than 0.90 indicates a strong
correlation, showing that the larva concentrations from replicate #1 are strongly correlated to the liver
tissue that the insects fed on.

Figure 4.24: Regression plots for liver concentrations to larva concentrations for the single and pooled extractions collected on
day 3 in replicate #2.
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The regression plots in figure 4.24 display the single and pooled larva concentrations to liver
concentrations. The R2 value for the single larva concentrations was 0.908 while the R2 value for the
pooled larva concentrations was higher at 0.959. With R2 values greater than 0.90, the larva
concentrations from replicate #2 are strongly correlated to the liver tissue that the insects fed on.

Figure 4.25: Regression plots for liver concentrations to larva concentrations for the single and pooled extractions collected on
day 3 in replicate #3.

The regression plots in figure 4.25 display the single and pooled larva concentrations to liver
concentrations. The R2 value for the single larva concentrations was 0.937 while the R2 value for the
pooled larva concentrations was higher at 0.972. With R2 values greater than 0.90, the larva
concentrations from replicate #3 are strongly correlated to the liver tissue that the insects fed on. The
larva collected from the authentic liver specimen were not included in the correlation plots for replicate
#3. Instead, this data was used to test the correlation of the larva concentration to liver concentrations
for estimation of liver tissue concentration. The equation generated from the linear regression (Table
4.16) was used to estimate the liver concentration.
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Table 4.16: The linear regression equations for the regression plots with R 2 values.

Treatment

Equation

R2

Single Larva Replicate #1

y = 0.1683x + 0.8432

0.928

Pooled Larva Replicate #1

y = 0.1667x + 0.6823

0.988

Single Larva Replicate #2

y = 0.0989x + 0.8138

0.908

Pooled Larva Replicate #2

y = 0.0869x + 1.2233

0.959

Single Larva Replicate #3

y = 0.1342x - 0.428

0.937

Pooled Larva Replicate #3

y = 0.136x - 0.9299

0.972

Single Larva Total

y = 0.1444x - 0.0779

0.890

Pooled Larva Total

y = 0.141x - 0.1822

0.930

Using the equation generated from the linear regression of pooled larva concentration to liver
concentration for replicate #3 (Table 4.16), the quantitated larva concentration for the larva feeding on
the authentic liver sample was used to estimate the liver concentration. Table 4.17 displays the results for
that calculation. The average (n=4) concentration of the authentic liver was quantitated at 111.4 µg/kg.
The single larva estimated the liver concentration ranging from 43.1 to 113.9 µg/kg with an average of
87.7 µg/kg. The average bias (n=5) for the single larva estimates to the actual liver concentration was 21.7 µg/kg. One larva was quantitated as a low outlier and if removed the average bias (n=4) becomes 11.8 µg/kg. The pooled larva estimated the liver concentration ranging from 61.1 to 83.0 µg/kg with an
average of 75.7 µg/kg. The average bias (n=5) for the single larva estimates to the actual liver
concentration was -32.1 µg/kg. Both the single and the pooled liver concentrations using the linear
regression underestimated the actual liver concentration.
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Table 4.17: Liver concentration estimation using larval concentration by linear regression.

Sample

Larva Concentration Estimated Liver Concentration

Bias

Auth Single A

14.5

113.3

1.7

Auth Single B

14.6

113.9

2.2

Auth Single C

10.3

82.3

-26.1

Auth Single D

4.9

43.1

-61.3

Auth Single E

10.5

83.7

-24.9

Average

10.9

87.3

-21.7

Auth Pooled A

7.4

61.1

-45.1

Auth Pooled B

9.9

80.0

-28.2

Auth Pooled C

10.3

82.4

-26.0

Auth Pooled D

10.4

83.0

-25.5

Auth Pooled E

8.9

72.0

-35.3

Average

9.4

75.7

-32.1

Figure 4.26: Correlation plots for liver concentrations to larva concentrations for the single and pooled extractions collected on
day 3 for all three replicates.
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For an overall comparison, the entire set of replicate data of larva concentration to liver
concentrations were plotted. The outcome is shown in figure 4.26. The R2 value for the single larva
comparisons was the lowest of all the correlation plots at 0.890 and was the only one below 0.90. The R 2
value for the total pooled larva concentrations to liver concentrations was 0.930. Both plots indicate a
strong correlation for the larva concentration to the liver concentration of the treatment group. The R2
indicates that 93% of the variation in the larva fentanyl concentration can be explained by the liver
fentanyl concentration.
4.4.5. Discussion
Fentanyl was quantitated in all larva from collection day three for all three treatments of low,
medium, and high across the three replicates. These findings are similar to previous studies on opioids
where drugs are found in higher concentration while the insects are still feeding (45, 54, 103). By
quantitating fentanyl in all three treatments, a correlation plot and simple linear regression was
performed using the known concentrations of the fortified liver feeding substrate. Strong correlation of
larva concentration to liver tissue concentration was observed for all replicates in the single and pooled
larva specimens. The single larva to liver correlations observed an R2 value ranging from 0.908 to 0.937
and the pooled larva to liver correlations observed an R2 value ranging from 0.959 to 0.988. These strong
correlation values are similar to those reported by El-Samad et al., who reported strong correlation values
above 0.905 for tramadol dosed rabbit tissue fed on by L. sericata (45). To further investigate the utility
of the correlation, the larva collected from the authentic treatment group was used to test the ability of
the linear regression to estimate the liver fentanyl concentration using the larva fentanyl concentration.
After estimation, the single larva fentanyl extractions had an average bias (n=5) of -21.7 and the pooled
specimens had an average bias (n=5) of -32.1. After dropping an outlier, the average bias (n=4) for the
single larva was -11.8. It is not known what created the outlier, but this highlights why it is important to
analyze multiple replicates for insect toxicology analysis or to sample a pooled specimen. The pooled
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insect specimens had less variation or standard deviations among the replicates and the means of the
pooled specimens were not significantly different from the single samples for fentanyl. The fentanyl
concentrations quantitated from the insects increased in concentration as the liver concentration
increased producing a positive correlation however, there was little to no pattern for the metabolites
detected. This is most likely due to the individual insect’s ability to excrete the drug unmetabolized,
metabolize the drug, or eliminate the metabolites from their bodies (44, 103).
The presented QuEChERS extraction and LC-MS/MS analysis was successful in quantifying fentanyl
and metabolites from the insect tissue as well as the feeding media. Fentanyl and all three metabolites
were detected in at least one treatment group of insects across the three replicates. With the analysis of
the liver on the day of egg placement and collection of the insects not containing any of the three targeted
metabolites of fentanyl, it can be derived that the metabolism of the fentanyl occurred in the insect and
not in the feeding substrate. The extensive metabolism of fentanyl in humans has been well documented
with most elimination driven by first pass hepatic metabolism (102). Primary metabolites generated by
human metabolism of fentanyl are norfentanyl and despropionyl fentanyl (4-ANPP) with norfentanyl
being the most abundant (102). Cytochrome P450 is highlighted as the primary actor in the first pass
metabolism for fentanyl in human metabolic pathways (102).
Insects have an open circulatory system that means the blood of the insect is not contained by
blood vessels but are contained in a cavity called a hemocoel and their blood is called hemolymph due to
its mixing with other fluids (154). This allows for the potential broad recovery of drugs throughout the
insect as the xenobiotics will not be enclosed in blood vessels (154). The excretory system of an insect
consists of Malpighian tubules (MT) and the hindgut (28, 29). Each Malpighian tubule is a blind-ended
tube comprised of a single-layer of squamous epithelial cells (28, 29). The MT are responsible for the
transport of xenobiotics from within the insect’s coelom to the hindgut for excretion (29). There is
evidence of cytochrome P450 enzyme activity in the MT, resulting in metabolism of xenobiotics. The P450
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enzyme chemistry has been exploited to produce bioactivated insecticides where metabolism via the P450
enzyme creates a more toxic compound once metabolized in the insect (28, 29, 154). This enzyme activity
is potentially utilized when drugs are present in the insect as well, Maddrell and Gardiner reported
Calliphora erythrocephala and Musca domestica when bathed in nicotine, the fluid secreted by the insects
was a transformed compound other than nicotine (164). Thin layer chromatography (TLC) was used for
the analysis and the transformed compound was not identified (164).
Specific drug metabolism mechanisms for blow fly species have not been thoroughly investigated
and broad metabolic assumptions are difficult to ascertain. For Calliphora stygia, Parry et al. reported
when maintained on meat containing morphine, the insects only contained morphine with no substantial
metabolites detected (28). Excretion reported as clearance rate of morphine was reported indicating even
without significant metabolism for the drug in the insect, elimination of the drug was still possible (28). In
the pupal stage, morphine was reported as retained in the pupae when the Malpighian tubules are
degraded and reformed as part of metamorphosis (28). Directly before and during metamorphosis, the
morphine can be incorporated into the cuticle and excreted with the exuviae as the morphine in the empty
puparium was found in a higher concentration compared to the adult fly (28). Bourel et al. found morphine
excreted by epidermal cells by pore canals in the endocuticle and exocuticle (154). When the insect
transitions from the third instar larval stage to the pupa stage, the cuticle is sclerotized, trapping the drugs
in the puparium case in close proximity to the pore canals (154). This is evidence of deposition of drugs in
the cuticle as a storage mechanism and could be evidence of a mechanism for how incorporation of drugs
into the empty puparium occurs (154). Adult flies also excrete waste via meconium which is the first
excrement of the adult once it emerges as an adult fly. This meconium is used to facilitate waste that
accumulates during the pupa stage and if drugs are in this waste they can be excrete in this process that
could explain a decrease of drugs detected in the adults compared to the empty puparia.
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The extraction of drugs from insects after they accumulated and incorporated drugs from tissues
that they have fed on is not an undiscovered science (39, 50, 111). Even though multiple classes of drugs
have been investigated including opioids, very little if any information has been published on the
extraction of fentanyl and metabolites from insects and the persistence of the drug through insect life
stages (39, 54, 144). Fentanyl is a highly effective µ-opioid agonist with a potency of 50-100 times that of
morphine with considerable addictive potential but due to its potency is often detected in tissues at
relatively low concentrations (64, 91, 92). This is a challenge for toxicologists trying to use insects as a
proxy to determine qualitative or quantitative drug presence in the tissue the insects feed on as insects
often incorporate a smaller concentration of the drug compared to the feeding tissue (39, 45, 50, 103).
The QuEChERS extraction and LC-MS/MS analysis was able to extract and quantitate fentanyl and
metabolites from pupa, feeding, and wandering larva. Extraction from insect tissue can be difficult due to
their chitin exoskeleton, waxy cuticle, and fat bodies (46, 154, 163). It is not uncommon for
entomotoxicological studies to be unable to quantitate drugs or metabolites from low treatment
concentrations or from some mid-life stages followed by detection of drugs in later life stages (46, 103,
111). This study is not exempt from that either as the low treatment in the middle life stage insects
produced no drug quantitation results. However, in every replicate for each life stage, fentanyl or
metabolites were detected in either the single or pooled specimens highlighting the importance of using
a selective and sensitive instrument to analysis of insects as a toxicological matrix.
4.4.6. Conclusion
Using a method validated following the ASB Standard 036 requirements, a QuEChERS extraction
was used to quantitate fentanyl and metabolites from larval and pupal tissue. Fentanyl was detected in
the larvae and pupae that were collected from the human liver tissue. A strong positive correlation for
the liver to larvae concentrations was calculated and provides hope that larvae can be used in the future
to, at minimum, determine the presence of fentanyl from feeding on human tissue and potentially
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estimate human tissue concentrations. A correlation from a specific tissue is not the same as a full human
cadaver and metabolite and multidrug overdose deaths can be a complication for application to actual
casework. Fentanyl and all three metabolites were detected in at least one treatment group in all three
replicates. Metabolites of norfentanyl and β-hydroxyfentanyl were quantitated from the insect tissue
when the presence of those metabolites were not detected in the liver at the time of egg placement nor
at the time of collection. It can be derived that the most likely creation of these metabolites was
metabolism of fentanyl by the insect to these compounds. Also, the metabolite 4-ANPP was quantitated
from the feeding larva insects collected from the authentic liver specimen; however, this liver had a
quantified 4-ANPP prior to egg placement and with no other insect containing a quantifiable
concentration of 4-ANPP, no metabolism of fentanyl to 4-ANPP by the insects can be determined.
Overall, the QuEChERS extraction was successful at extracting fentanyl from larvae and pupae
collected from feeding on human liver tissue that contained fentanyl. This provides a method for detecting
and quantifying fentanyl and metabolites in an alternate matrix, liver to larvae concentrations, and shows
the persistence of fentanyl and metabolites through the insect life cycle to pupation.
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Chapter 5: Evaluation of the Effects of Fentanyl on Blowfly Adults and Application of
QuEChERS Extraction Method for the Quantitation of Fentanyl and Metabolites from
Empty Puparium and Adult Flies (Lucilia sericata)
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5.1. Chapter 5 Overview
In this chapter, section 1 presents the validation of the extraction method for the analysis of fentanyl
and metabolites from empty puparia and adult fly tissue for part of task 1.b. Also presented, is the
preliminary study for the purpose of evaluating extraction methods for empty puparia with the target of
choosing a method that efficiently recovers fentanyl and metabolites from the difficult matrix.
Section 2 of this chapter presents the morphometric comparisons for the adult flies collected in task
2.a. For all the insect stages, physical characteristics were recorded to evaluate the effects each treatment
had on growth (task 2.b). To determine the effects of fentanyl on the growth and development of the
blow flies, the mass, and percent stage of the insect were statistically compared using nested ANOVA (task
2.c). Tukey-HSD test will be applied to determine which treatments are significantly different within each
replicate. These statistical tests will determine if the drug treatments have any significant effects on the
insect’s development.
Section 3 of this chapter presents the toxicological findings for the empty puparia and adult fly tissue
for task 1.e. The presented modified QuEChERS extraction was used for extraction of the feeding media
liver and the insect tissue. The survey of fentanyl and metabolites detected in the empty puparia and adult
flies is presented in this section. For task 3.a, a correlation plot was created for a comparison of the
fentanyl concentrations detected in the insect tissue to the liver fentanyl concentrations to establish any
correlation of the concentrations.

5.2. Section 1: Validation of QuEChERS Extraction for Empty Puparia and Adult Flies
5.2.1. Late Insect Stage Overview
The previous chapter explored the utility of the larval and pupal stages in terms of toxicological
matrices and this section will explore the later life stages of L. sericata of empty puparia and adult flies.
Previous studies for the extraction of drugs and toxins from the later life stages of necrophagous flies
include methamphetamine, codeine, methadone, amitriptyline, cadmium, and thallium (44, 46, 103, 163,
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165). The value of insect specimens of puparia and empty puparia is rooted in the chitin exoskeleton that
is resistant to environmental factors and allows for the evidence to remain at the scene for months and
years after all other tissues used for toxicology analysis are no longer available (44, 163, 166). When drugs
or toxins are sequestered into the puparia cases that are left behind when an adult fly emerges, if a
toxicologist can extract those deposited drugs, a snapshot of drugs present in the body while the insect
was feeding after soft tissues and traditional biological fluids are not present (44, 163, 165).
In this section, the validation of the extraction method for the analysis of fentanyl and metabolites
empty puparia and adult fly tissue is presented. A preliminary study for the purpose of validating the
extraction method with extraction from authentic insect samples and to evaluate three extraction
techniques for the recovery of drug from authentic empty puparia specimens.
5.2.2. Introduction
After death, the natural decomposition process degrades or eliminates traditional toxicology
biological matrices of blood, urine, and liver tissue increasing the opportunity for insects to be used as an
alternative matrix (39, 46, 50). The study or use of insects as an alternative toxicological matrix is generally
accepted, however, the interpretation of the drugs detected is still up for debate (39, 44). With lack of
sufficient information regarding metabolism, feeding behavior, and correlation of drugs found in the
insect tissue to the human tissue, further research is necessary for conclusions on drugs detected in insect
tissue in relation to human tissue concentrations (44, 111). When drugs are deposited into the chitin
exoskeleton, this allows for the evidence to remain at the scene for months and years after all other
tissues used for toxicology analysis are no longer available (44, 163, 166). When an adult fly emerges, the
puparia cases that are left behind can be extracted to provide a qualitative observation of drugs present
in the body while the insect was feeding after soft tissues and traditional biological fluids are not present
(44, 163, 165). The larval and early stages of necrophagous flies are often investigated but the later life
stages of pupa, empty puparia, and adult flies are underrepresented in the literature (39, 44). The empty
puparia left behind when adult flies emerge are often low in mass and low in concentration compared to
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the tissue they fed on (39, 44). This requires sensitive and effective extraction techniques for the
quantitation of fentanyl and metabolites from empty puparia.
To explore the utility of analysis of empty puparia, three extraction techniques were evaluated
for the recovery of drug from authentic empty puparia specimens, ionization suppression/enhancement,
recovery, and process efficiency were compared for the three techniques. The extraction that performed
the best was selected for validation following the American Standards Board (ASB) 036 requirements
(104).
5.2.3. Methods
5.2.3.1. Adult colony
Adult colonies of L. sericata were established in May 2018 from field collected specimens from
Morgantown, West Virginia, USA. The collected insects were allowed to grow to adulthood and adults
were identified as L. sericata by physical morphological characters (62). The colony was housed in
BugDorm1 (MegaView Co., Ltd., Taiwan) screen cages (30 cm x 30 cm x 30 cm) stored in a Percival
I36LLVLC8 incubator (Percival Scientific, Inc., Perry, Iowa, USA) at 25 °C (± 0.5 °C) at 65% relative humidity
(± 10%) with a 12:12 (L:D) photoperiod. Adults were given honey and water ad libitum and raw beef liver
was provided for oviposition. New generations were separated from adults after oviposition to signal the
beginning of the next generation and were moved to a new screen cage during emergence.
5.2.3.2. Chemicals and materials
Analytical grade hydrochloric acid (HCl) was obtained from Fisher Scientific (Fair Lawn, NJ).
Analytical grade sodium hydroxide (NaOH) was purchased from Sigma-Aldrich (St. Louis, MO). Optima®
LC-MS grade 1-chlorobutane was purchased from Fisher Scientific (Fair Lawn, NJ). Other chemicals,
reagents and drugs used for this study are listed in the methods section 4.1.3. The LC-MS/MS instrument,
mass spectrometry parameters (Table 4.1), and chromatographic separation (Figure 4.2) are listed in
section 4.1.3 as well.
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Blank human liver specimens were received from the West Virginia Human Gift Registry and were
tested for the presence of fentanyl analogs before use. These liver specimens were used as the fortified
liver specimens and were homogenized with a blender. All samples were stored at -20°C prior to use for
approximately 4 to 10 months. All specimens were de-identified from personal identifying information
and this study was determined to be exempt from Institutional Review Board (IRB) review due to
postmortem specimen use and lack of human subject involvement.
5.2.3.3. Design for Authentic Insect Samples
To evaluate the three extraction techniques, authentic empty puparia were created by placing
250 eggs on 75 g of fortified human liver tissue in two treatment groups at concentrations of 250 µg/kg
and 0 µg/kg (control). After the insects completed their life cycle, the adult flies and empty puparia were
collected for analysis. Each adult fly leaves behind a single empty puparium. From the control group, 110
empty puparia and adult flies were collected and from the 250 µg/kg treatment group 100 empty puparia
and adult flies were collected. The purpose of these samples was to test the three extraction technique’s
ability to release fentanyl and metabolites from authentic empty puparia samples. The empty puparia
were randomly pooled (n=16) and allowed for each extraction technique to be run in duplicate.
To further test the chosen extraction protocol after validation, fentanyl was fortified into 10 g
aliquots of human liver homogenate to evaluate four concentrations: control (0 µg/kg), low (50 µg/kg),
medium (250 µg/kg), and high (500 µg/kg) concentrations in triplicate. To each aliquot of liver,
approximately 35-50 eggs (by mass) were placed and allowed to feed undisturbed until time of collection.
After the insects completed their life cycle (day 21), all empty puparia and adults from each replicate were
collected, rinsed with deionized water followed by methanol, and dried before being stored at -20 °C with
no liquid preservatives added (7, 40, 46). No preservative was chosen due to the insect cuticle acting as a
semipermeable membrane which can allow water or ethanol to diffuse into the body cavity and potential
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to leech out the target analytes into the preservative solution (149). The entire cohort for each replicate
was pooled and extracted so no random selection was performed.
5.2.3.4. Comparison of Extraction Techniques
Three extraction techniques were tested for the extraction of fentanyl and metabolites from the
empty puparia. The extraction that performed the best was selected for validation. To evaluate the
extraction techniques, ionization suppression/enhancement, recovery, process efficiency, and the ability
to extract from an authentic set of empty puparia collected from insects fed on liver tissue fortified with
fentanyl were compared for the three techniques.
Due to small individual insect weights, the samples were pooled of 16 insects for triplicate analysis
(n=3) with the results presented as μg/kg. Prior to the application of an extraction protocol, the pooled
insects were pulverized using the mixer mill MM200 for a minimum of five minutes or until the insects
were ground into a fine powder. This was critical to ensure the extraction protocols would be successful
for extraction of fentanyl and metabolites. The micro pulverization method was similar to published
studies for the extraction of drugs from hair (123, 127).
5.2.3.4.1. Micropulverized QuEChERS Extraction
The QuEChERS extraction slightly modified from the protocol in section 4.13 using a target sample
aliquot of 0.2 g of empty puparia or adult flies as appropriate. Insect specimens were placed into a 1.5 mL
centrifuge tube, followed by 400 μL deionized water, 100 μL internal standard mix (IS), and 700 μL
acetonitrile combined with three steel beads. The IS was comprised of three deuterated compounds:
fentanyl-D5, norfentanyl-D5, and 4-ANPP-D5 at a concentration of 1 ng/mL. Afterwards, 0.2 g of QuEChERS
original extraction salt was added to the tubes, vortexed, mixed on a mixer mill for 3 min, centrifuged for
5 min, and the resulting supernatant was transferred to a QuEChERS dispersive-SPE tube. Tubes were
vortexed then centrifuged for 5 min before the supernatant was transferred to a new 1.5 mL
microcentrifuge tube for dry down under a nitrogen stream at 50 °C to dryness. Samples were
reconstituted with 40 μL methanol and transferred to vials for LC-MS/MS analysis. This extraction protocol
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was adapted and validated for larva and pupa tissue from work published by Cox et al. for the extraction
of liver tissue (4).
5.2.3.4.2. Acidic Digestion QuEChERS Extraction
Samples of approximately 0.2 g (16 specimens) of pulverized empty puparia were placed into 1.5
mL centrifuge tubes with then 300 µL of 1M HCl and 100 µL internal standard (IS). The tubes were vortexed
and placed in a 80°C rotating heating block (500 rpm) for 3 hours to incubate (123, 167). After incubation,
the pH of the samples was alkalinized with 300 µL of 1M NaOH. To each sample, 100 μL internal standard
mix (IS), 700 μL acetonitrile, and three steel beads were added. Afterwards, 0.2 g of QuEChERS original
extraction salt was added to the tubes, vortexed, mixed on a mixer mill for 3 min, centrifuged for 5 min,
and the resulting supernatant was transferred to a QuEChERS dispersive-SPE tube. Tubes were vortexed
then centrifuged for 5 min before the supernatant was transferred to a new 1.5 mL microcentrifuge tube
for dry down under a nitrogen stream at 50 °C to dryness. Each sample was then reconstituted with 40 µL
of methanol and transferred to a LC-MS/MS vial for analysis.
5.2.3.4.3. Basic Digestion and LLE
Samples of approximately 0.2 g (16 specimens) of pulverized empty puparia were placed into 1.5
mL centrifuge tubes with then 200 µL of 1M NaOH and 100 µL internal standard (IS). The tubes were
vortexed and placed in a 80°C rotating heating block (500 rpm) for 30 mins to incubate (123, 127). Then
200 µL deionized water, 100 µL IS, and 1 mL of 1-chlorobutane were added to the tubes. 1-chlorobutane
was chosen as the organic solvent based on the successful extraction of methadone from empty puparia
and fentanyl from hair in previous published LLE work (44, 123, 127). The tubes were vortexed, rocked for
5 mins, and then centrifuged for 5 minutes. After centrifugation, the supernatant was transferred to a 1.5
mL microcentrifuge tube and the samples were evaporated under a nitrogen stream, at 50°C, to dryness.
The sample was reconstituted with 40 µL of methanol and transferred to a LC-MS/MS vial for analysis.
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5.2.3.5. Validation parameters
The QuEChERS extraction and LC-MS/MS analysis was validated following the American Standards
Board (ASB) 036 requirements (104). Evaluated parameters included calibration model, interference
studies, ionization suppression/enhancement, dilution integrity, limits of quantitation, processed sample
stability, bias, and precision.
5.2.3.5.1. Calibration model
Six different concentrations for five runs (n=15) were analyzed for both empty puparia and adult
fly tissue by linear regression lines generated using Agilent MassHunter software with a weight of (1/x).
The linear range or analytical measurement range (AMR) is displayed in Table 5.3 for each analyte in both
matrices. A calibration stock mix of fentanyl (2 ng/μL), 4-ANPP (2 ng/μL), norfentanyl (10 ng/μL), and βhydroxy fentanyl (8 ng/μL) was created for spiking tissues in the calibration curve and represents the
highest calibrator. Using this solution, a serial dilution was performed to create stock solutions at
concentrations of 0.002, 0.004, 0.008, 0.04, 0.2, 1, and 2 ng/μL (ppm) for fentanyl and 4-ANPP with
concentrations of 0.01, 0.02, 0.04, 0.2, 1, 5, and 10 ng/μL (ppm) for norfentanyl and 0.006, 0.012, 0.032,
0.16, 0.8, 4, and 8 ng/μL (ppm) for β-hydroxy fentanyl. To each 0.2 g insect calibrator sample, 5 μL of each
stock solution was added to create the calibration curve. This created the analytical measurement range
(AMR) of 0.05 to 50 µg/kg for fentanyl and 4-ANPP, 0.25 to 250 µg/kg for norfentanyl, and 0.2 to 200
µg/kg for β-hydroxyfentanyl.
5.2.3.5.2. Interference studies
To evaluate interferences a high concentration (highest calibrator) of the target analytes was
injected with no IS to show any interference of the drug standards to the IS. Conversely, an aliquot of IS
with no target analytes was injected to observe any interference caused by the IS. Matrix interferences
were evaluated by extracting blank matrix sources (n=10) for both empty puparia and adult flies with no
IS added. To evaluate potential interferences from commonly encountered compounds, a mix of common
drugs encountered in toxicology (n=31) was injected (Table 4.2).
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5.2.3.5.3. Ionization suppression/enhancement
Ionization suppression or enhancement was evaluated at two concentrations, low and high, for
ten replicates at both concentrations following the ASB Standard 036 requirements. To be deemed
acceptable, the percent ionization suppression or enhancement shall not exceed ±25% with a percent
relative standard deviation (%CV) not exceeding 20% (104). A post-extraction addition approach was
utilized by comparing neat standards (Set 1) to blank matrix samples fortified with neat standard after
extraction (Set 2). Set 1 consisted of neat standards prepared at low (2 times the LLOQ) and high (50% of
the highest calibrator) and were injected ten times to establish the mean peak area for each target
analyte. Set 2 consisted of ten individual blank matrix sources (larva and pupa) in duplicate, for low (n=10)
and high (n=10) concentration, extracted and spiked with the low and high concentration, respectively,
after extraction. The average area of each set (𝑋) was used to calculate the suppression or enhancement
effects at each concentration for each analyte is as follows:

𝐼𝑜𝑛𝑖𝑧𝑎𝑡𝑖𝑜𝑛 𝑠𝑢𝑝𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 𝑜𝑟 𝑒𝑛ℎ𝑎𝑛𝑐𝑒𝑚𝑒𝑛𝑡 (%) = (

𝑋 𝐴𝑟𝑒𝑎 𝑜𝑓 𝑠𝑒𝑡 2
𝑋 𝐴𝑟𝑒𝑎 𝑜𝑓 𝑠𝑒𝑡 1

− 1) ∗ 100

5.2.3.5.4. Bias and Precision
For bias and precision calculations, blank larval and pupal tissue samples were spiked and
analyzed at low, medium, and high concentrations for fentanyl and metabolites in triplicate over five days
(n=15). Bias was calculated as a percent deviation of the extracted mean concentration from the
theoretical concentration with an acceptable bias not exceeding ±20%. Precision was evaluated by
percent standard deviation (%CV) of the mean at each concentration with the criteria of not exceeding
20%.
5.2.3.5.5. Limits
For the evaluation of the limit of detection (LOD) and the lower limit of quantitation (LLOQ), blank
matrix sources for larval and pupal tissue were spiked with concentrations at the lowest non-zero
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calibrator. Triplicates of each blank matrix sources were spiked at the lowest non-zero calibrator and
analyzed over three days (n=9). The acceptable parameters were bias (±20%) and precision (%CV ≤ 20%).
For LOD, chromatographic acceptance was evaluated and deemed acceptable when signal to noise (s/n)
ratios were above 3.3 and qualifier ratios did not exceed ±20%.
5.2.3.5.6. Carryover and Dilution Integrity
Blank matrix samples were injected directly after injections of samples three times greater than
the highest calibrator in triplicate analysis to evaluate carryover. Carryover was not considered significant
if present below 10% of the lowest calibrator (LLOQ). For dilution integrity, blank matrix samples from
both sources were spiked at concentrations three times the highest calibrator in triplicate and extracted
simultaneously with blank matrix only spiked with internal standard in triplicate. The resulting extract was
diluted 1:5 (S:T) with the extracted blank matrix with internal standard (5, 106). The process was repeated
over a period of five runs (n=15) and the dilution integrity was deemed acceptable if bias did not exceed
±20% and the precision (%CV) did not exceed 20%.
5.2.3.5.7. Processed Sample Stability
To determine the stability of processed samples for both larval and pupal tissue in the
autosampler (25 °C), blank larva and pupa samples were spiked at low and high concentrations and
extracted. Post extraction reconstituted samples, for low and high respectively, were pooled and
aliquoted to LC-MS/MS vials. Triplicate analysis at time frames: 0, 12, 24, 36, 48, 60, and 72 hr were
performed for each concentration. Average peak area was calculated for each triplicate and compared to
time zero. An acceptable bias threshold was set at ±20%.
5.2.3.5.8. Recovery and Process Efficiency
To calculate recovery of the extraction (RE) and process efficiency (PE) two formulas were utilized.
Variables in the formulas represent the mean peak areas for the neat solution (A), the mean peak areas
for the standards spiked after extraction (B), and the mean peak areas for the standards spiked before
extraction (C) (107). Recovery and process efficiency were at low and high concentrations for ten
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replicates (n=10) for each matrix type. Ideally, a perfect recovery or process efficiency would be 100% and
±20% of this value is desired while not exceeding a %CV of 20%. The ASB Standard 036 does not have a
requirement for recovery or process efficiency and the ±20% while not exceeding a %CV of 20% is a selfimposed guideline.

𝑅𝐸(%) =

𝐶
∗ 100
𝐵

𝑃𝐸(%) =

𝐶
∗ 100
𝐴

5.2.4. Results
5.2.4.1. Comparison of Extraction Techniques
Ionization suppression or enhancement, recovery, and process efficiency for the three extraction
techniques were compared directly for the high concentration (Table 5.1). For fentanyl, norfentanyl, and
4-ANPP, the micropulverized QuEChERS extraction (MP) had an ionization suppression or enhancement
of less than ± 3.5% while the acidic digestion QuEChERS extraction and the basic digestion LLE had
percentages of less than ± 6.3% and ± 5.2%, respectively. For β-hydroxyfentanyl, the acidic digestion
produced a slightly better ionization suppression of -15.0% compared to -17.7% and -16.0% for the
micropulverized QuEChERS and basic digestion LLE, respectively. The recovery for the micropulverized
QuEChERS extraction ranged from 95.3% to 97.9%, the recovery for acidic digestion QuEChERS extraction
ranged from 96.9% to 137.0 %, and the recovery for the basic digestion LLE ranged from 94.8% to 270.8%.
The overall process efficiency for the micropulverized QuEChERS extraction ranged from 78.4% to 100.9%,
the process efficiency for acidic digestion QuEChERS extraction ranged from 82.3% to 145.6 %, and the
recovery for the basic digestion LLE ranged from 99.0% to 227.3%.
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Table 5.1: Ionization suppression/enhancement, recovery, and process efficiency for the empty puparium tissue (n=10).
Ionization Suppression/Enhancementa

Recoverya

Process Efficiencya

High

High

High

Compound
Mean

CV

Mean

CV

Mean

CV

Micropulverized QuEChERS
4-ANPP

3.5

8.7

97.5

9.2

100.9

8.7

β-Hydroxyfentanyl

-17.7

11.4

95.3

9.2

78.4

11.4

Fentanyl

2.9

8.3

96.5

8.8

99.3

8.3

Norfentanyl

3.2

8.2

97.9

8.3

100.9

8.2

Acidic Digestion QuEChERS
4-ANPPb

6.3

7.4

137.0

7.0

145.6

7.4

β-Hydroxyfentanyl

-15.0

8.7

96.9

3.5

82.3

8.7

Fentanyl

5.2

5.2

99.1

3.8

104.2

5.2

Norfentanyl

4.9

5.6

100.3

4.3

105.3

5.6

Basic Digestion and LLE
4-ANPP

4.4

6.7

94.8

6.9

99.0

6.7

β-Hydroxyfentanyl

-16.0

64.4

270.8

64.1

227.3

64.4

Fentanyl

4.8

5.5

95.3

5.7

99.8

5.5

Norfentanyl

5.2

5.5

101.5

5.2

106.8

5.5

a

Data in %
b
D5-Norfentanyl used as IS as D5-ANPP reduced response in Acidic digestion extraction

In comparison of the three extraction techniques in the ability to extract fentanyl from authentic
empty puparia specimens, the micropulverized QuEChERS extraction quantitated an average (n=2) of 5.2
± 0.9 µg/kg, the acidic digestion QuEChERS produced an average of 4.9 ± 1.2 µg/kg, and the basic digestion
LLE an average of 3.7 ± 0.05 µg/kg (Table 5.2). Each of the three extraction techniques were effective at
extracting the three metabolites with none of the techniques being efficient at extracting all three
metabolites. The MP extraction was successful in extracting β-hydroxyfentanyl and norfentanyl with
averages of 4.1 ± 1.5 µg/kg and 2.2 ± 0.3 µg/kg, respectively. The acidic digestion QuEChERS was successful
at extracting 4-ANPP with an average of 1.1 ± 0.4 µg/kg; however only detected β-hydroxyfentanyl in one
of the replicates and did not detect norfentanyl. The basic digestion LLE technique detected norfentanyl
at an average of 1.3 ± 0.04 µg/kg; however, did not detect 4-ANPP or β-hydroxyfentanyl. For the L5 quality
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control, the MP technique performed the best with the bias ranging from -7.6% to -13.6% while the acidic
digestion technique bias ranged from -3.7% to -21.0% and the basic digestion LLE bias ranged from -3.5%
to -22.4%.
Table 5.2: Comparison for the three extraction techniques micropulverized QuEChERS extraction (MP), acidic digestion
QuEChERS (acidic), and basic digestion LLE for the ability to extract fentanyl and metabolites from pooled (n=16) authentic
empty puparia specimens.
Compound

β-Hydroxyfentanyl

Fentanyl

Extraction Technique

MP

Acidic

Basic

MP

Acidic

Basic

Replicate A

4.5

5.8

3.7

3.0

ND

ND

Replicate B

5.8

4.1

3.8

5.2

3.8

ND

Average

5.2 ± 0.9

4.9 ± 1.2

3.7 ± 0.05

4.1 ± 1.5

-

-

L5 QC

4.6

4.8

4.3

18.5

15.8

15.5

Bias

-7.8

-3.7

-14.1

-7.6

-21.0

-22.4

Control

ND

ND

ND

ND

ND

ND

Compound

4-ANPP

Norfentanyl

Extraction Technique

MP

Acidic

Basic

MP

Acidic

Basic

Replicate A

ND

1.3

ND

2.0

ND

1.3

Replicate B

ND

0.8

ND

2.4

ND

1.3

Average

-

1.1 ± 0.4

-

2.2 ± 0.3

-

1.3 ± 0.04

L5 QC

4.5

4.3

4.8

21.6

21.7

21.0

Bias

-9.5

-15.0

-3.5

-13.6

-13.2

-16.0

Control

ND

ND

ND

ND

ND

ND

5.2.4.2. Validation
The linear range or analytical measurement range (AMR) is displayed in Table 5.3 for each analyte
in both matrices. As part of the evaluation of the calibration model, the R2 values for the calibration curves
exceeded 0.99 and the residuals for each set of five replicates were plotted with no discernable pattern
being identified indicating a random dispersion. This allows for linear analysis of the analytes presented
using a weight of (1/x).
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Table 5.3: LOD, LLOQ, and AMR for empty puparia and adult fly extractions.
Empty Puparia
LLOQ (n=9)

LOD/LLOQ
(µg/kg)

Bias

%CV

AMR
(µg/kg)

4-ANPP

0.05

3.1

12.7

0.05-50

β-Hydroxyfentanyl

0.2

-2.8

10.3

0.2-200

Fentanyl

0.05

13.0

4.7

0.05-50

Norfentanyl

0.25

19.8

3.4

0.25-250

LLOQ (n=9)

Compound

Adult
LOD/LLOQ
(µg/kg)

Bias

%CV

AMR
(µg/kg)

4-ANPP

0.05

10.4

11.7

0.05-50

β-Hydroxyfentanyl

0.2

-1.9

14.2

0.2-200

Fentanyl

0.05

12.5

7.9

0.05-50

Norfentanyl

0.25

19.4

2.4

0.25-250

Compound

Blank matrix samples from 10 individual insect sources for both larval and pupal tissue were
extracted without addition of standards or internal standards to determine any matrix interferences.
Chromatographic analysis of these injections was performed using Agilent MassHunter Qualitative
Analysis software version B.08.00 and no interference peaks from the blank matrices were observed.
No interfering peaks were observed from the high standards to the internal standards or from the
internal standards to the target analytes. A neat mix of 31 commonly encountered analytes, encompassing
other opioids, stimulants, depressants, synthetic cannabinoids, synthetic cathinones, and dietary
supplements, was injected and no interferences were observed.
5.2.4.3. Ionization suppression/enhancement
Ionization suppression or enhancement was evaluated at low and high concentrations (n=10) for
both empty puparia and adult fly tissue following the ASB Standard 036 requirements (168). The percent
ionization suppression or enhancement and %CV for all four target analytes is presented in Table 5.4. The
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four target analytes were within the criteria for acceptance at both high and low concentrations for both
insect tissue types. For the empty puparia tissue, the percent ionization suppression or enhancement for
the four analytes ranged from -9.1% to 5.6% for the low and ranged from -17.7% to 3.5 % for the high
while not exceeding a %CV of 11.4%. For the adult fly tissue, the percent ionization suppression or
enhancement ranged from 4.5% to 9.2% at the low concentration and ranged from 3.6% to 11.8% for the
high while not exceeding a %CV of 10.9%.
Table 5. 4: Ionization suppression/enhancement, recovery, and process efficiency for the adults and empty puparium tissue
(n=10).
Ionization
Suppression/Enhancementa
Compound

Low
Mean

High
CV

Mean

Recoverya
Low

CV

Mean

Process Efficiencya
High

CV

Low

High

Mean

CV

Mean

CV

Mean

CV

Adults
4-ANPP

8.9

10.6

9.2

9.9

90.9

9.6

91.7

6.2

99.1

12.0

100.1

10.6

βHydroxyfentanyl

4.5

6.6

3.6

8.9

93.9

10.6

96.5

5.5

98.1

10.0

100.0

9.7

Fentanyl

6.1

9.9

11.8

9.8

95.3

8.2

91.7

5.6

101.1

10.1

102.5

10.3

Norfentanyl

9.2

10.9

8.0

9.8

95.1

9.9

91.9

5.5

103.9

12.2

99.3

10.7

Empty Puparium
4-ANPP

-9.1

11.4

3.5

8.7

104.1

8.9

97.5

9.2

94.5

10.0

100.9

8.7

βHydroxyfentanyl

-10.0

11.3

-17.7

11.4

107.6

9.0

95.3

9.2

96.8

9.7

78.4

11.4

Fentanyl

-10.4

9.3

2.9

8.3

109.0

8.5

96.5

8.8

97.6

7.2

99.3

8.3

Norfentanyl

5.6

10.2

3.2

8.2

98.1

12.0

97.9

8.3

103.6

10.9

100.9

8.2

a

Data in %
The criteria for acceptance was ±25% ionization suppression or enhancement with a percent relative standard
deviation (%CV) not exceeding 20%.

5.2.4.4. Bias and precision
The bias for all four analytes in both insect matrices were within ±20% and the %CV did not exceed
20%, meeting the ASB Standard 036 requirements (Table 5.5). For the empty puparia tissue, the bias for
the low ranged from 0.6% to 5.4%, the medium ranged from -9.7% to -1.5%, and the high ranged from 7.1% to -1.5%. For the adult fly tissue, the bias for the low ranged from 0.6% to 4.3%, for the medium
ranged from -11.5% to -5.0%, and for the high ranged from -7.3% to -5.1%. Of the four analytes and two
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matrices, only norfentanyl and 4-ANPP experienced a bias greater than ±10% at -10.1% bias for the
medium norfentanyl in the adult fly matrix and -11.5% bias for the medium 4-ANPP in the adult fly matrix.
These elevated percent bias values are still well within the criteria for acceptance.

Table 5.5: The bias and precision validation data for adults and empty puparium extractions (n=15).
Adults
Bias (%)

Between Run (%CV)

Within Run (%CV)

Compound
LOW

MED

HIGH

LOW

MED

HIGH

LOW

MED

HIGH

4-ANPP

0.6

-11.5

-6.3

9.1

6.1

3.6

4.6

3.7

4.0

β-Hydroxyfentanylb

2.4

-5.0

-7.1

11.9

7.4

3.9

6.3

3.7

3.4

Fentanyla

1.8

-8.7

-7.3

6.8

6.2

3.4

5.9

4.0

3.7

Norfentanylc

4.3

-10.1

-5.1

4.9

4.5

4.3

2.8

3.1

4.7

a

Empty Puparium
Bias (%)

Between Run (%CV)

Within Run (%CV)

Compound
LOW

MED

HIGH

LOW

MED

HIGH

LOW

MED

HIGH

4-ANPPa

0.7

-5.6

-6.1

5.6

5.8

3.2

5.2

4.8

3.2

β-Hydroxyfentanylb

0.6

-1.5

-6.3

7.0

4.1

3.4

6.3

4.4

3.1

Fentanyla

5.4

-5.3

-7.1

5.8

4.7

3.3

5.3

4.9

3.3

5.2

3.2

Norfentanylc

6.0
-9.7
-1.8
9.3
6.5
5.0
6.2
Low concentration at 0.2 µg/kg, medium concentration at 5 µg/kg, and high concentration at 40 µg/kg
b Low concentration at 0.8 µg/kg, medium concentration at 20 µg/kg, and high concentration at 160 µg/kg
c Low concentration at 1.0 µg/kg, medium concentration at 25 µg/kg, and high concentration at 200 µg/kg
a

5.2.4.5. Limits
Bias and precision for the LLOQ (Table 5.3) were considered acceptable within ±20% for bias and
the %CV not exceeding 20% (104). The bias for the LLOQ for the empty puparia tissue ranged from -2.8%
to 19.8% and for the adult fly tissue ranged from -1.9% to 19.4%. The LOD was evaluated as the lowest
calibrator which is also the LLOQ and the requirements for the LOD and LLOQ by the ASB Standard 036
were met for both matrices (104).
5.2.4.6. Carryover and dilution integrity
To determine any carryover, extracted blank matrix samples were injected directly after injections
of samples with concentrations three times greater than the highest calibrator in triplicate analysis. This
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was performed for both the empty puparia and adult fly matrices. No significant carryover of the target
analytes was detected in the blank matrix injections for either matrix.
For the dilution integrity evaluation, bias and precision was calculated for each analyte and is
shown in Table 5.6. For the four target analytes in the empty puparia tissue the dilution integrity did not
exceed ± 8.4% for bias and did not exceed 10.5% for %CV. For the adult fly tissue, the dilution integrity
did not exceed ± 4.4% for bias and did not exceed 17.2% for %CV. For the empty puparia extractions, the
bias of the dilution integrity ranged from -8.4% to -4.3% indicating a tendency for the dilution to have a
lower than anticipated value. In contrast, the dilution integrity bias for the adult fly extracts ranged from
-0.7% to 4.4% indicating a slightly inflated value than expected. This could be attributed to matrix effect
at the high concentration for the adult fly extraction as they experience a slight high-end ionization
enhancement.
Table 5.6: Dilution integrity for the adult and empty puparium extractions at a 1:5 dilution.
Adult
Compound

Target Concentration (µg/kg)

Dilution Integrity (% Bias)

% CV

4-ANPP
β-Hydroxyfentanyl
Fentanyl
Norfentanyl

150
600
150
750

4.4
1.8
-0.7
3.0

13.3
17.2
14.0
14.7

Empty Puparium
Compound

Target Concentration (µg/kg)

Dilution Integrity (% Bias)

% CV

4-ANPP
β-Hydroxyfentanyl
Fentanyl
Norfentanyl

150
600
150
750

-4.9
-7.4
-8.4
-4.3

10.5
9.2
9.9
8.3

5.2.4.7. Processed sample stability
Processed sample stability in the autosampler was evaluated for both insect matrices in triplicate
at low and high concentrations over time intervals up to 72 hours (Table 5.7). For the empty puparia
extractions, all four analytes were stable up to 72 h at the high concentrations but the β-hydroxyfentanyl
stability exceeded ±20% with 38.4% at the 72 h for the low concentration stability. It was determined that
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stability was maintained up to 60 h for that analyte for the low concentration. All the analytes at the low
concentration were increasing and approaching the limit at 72 h for the empty puparia. For the adult fly
extractions, all the analytes were stable up to 72 h for the high concentrations. For the low concentrations
of the adult fly stability extractions, norfentanyl reached instability at 48 h and continued to exceed 20%
in the next two time segments. Norfentanyl in the adult fly extractions was deemed stable only up to 36
h in the low concentrations.

Table 5. 7: Stability at a low and high concentration for the adult and empty puparium extractions for processed samples stored
in the autosampler (25 °C).
Adults
Low (% d)

High (% d)

Compound
12 h

24 h

36 h

48 h

60 h

72 h

12 h

24 h

36 h

48 h

60 h

72 h

4-ANPPa

0.3

-3.7

-0.7

-2.0

-2.7

-2.6

0.4

-1.7

-0.4

-1.7

-3.5

-4.7

β-Hydroxyfentanylb

-3.8

-4.5

4.7

-2.4

-1.6

-1.1

-1.6

-1.9

0.0

-1.4

-1.6

-1.6

Fentanyla

-3.9

-1.6

-2.6

-1.6

-3.7

-2.3

-0.7

-1.8

-0.8

-2.6

-3.4

-4.4

Norfentanylc

6.7

9.3

16.5

20.7

24.4

24.8

-0.7

-2.1

-3.1

-3.3

-5.5

-6.3

Empty Puparium
Low (% d)

Compound

High (% d)

12 h

24 h

36 h

48 h

60 h

72 h

12 h

24 h

36 h

48 h

60 h

72 h

4-ANPPa

-1.4

-1.0

-1.5

-1.5

-5.3

-12.9

-0.8

-2.9

-0.8

-2.2

-3.9

-4.9

β-Hydroxyfentanylb

-3.3

-2.7

0.7

0.7

2.2

38.4

-0.3

-0.3

0.0

0.1

0.6

-0.7

Fentanyla

-2.0

-4.2

-2.9

-2.9

-5.1

18.1

-1.0

-1.3

-1.3

-3.0

-3.0

-4.8

Norfentanylc

5.3

9.7

12.7

12.7

12.3

-15.6

-1.6

-1.9

-3.2

-2.9

-4.7

-6.6

Low concentration at 0.2 µg/kg, and high concentration at 25 µg/kg
Low concentration at 0.8 µg/kg, and high concentration at 100 µg/kg
c Low concentration at 1 µg/kg, and high concentration at 125 µg/kg
d %  indicates the percent change for the time interval response compared to time zero response
a

b

5.2.4.8. Recovery and process efficiency
Recovery and process efficiency was evaluated simultaneously with ionization suppression or
enhancement and the results are displayed in Table 5.4. The recoveries and process efficiencies for both
matrices at the low and high concentrations were deemed acceptable within ±20% of the target recoveries
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(100%) and the %CV not exceeding 20%. Overall, the empty puparia extractions recovered more efficiently
compared to the adult fly extractions at both concentrations. Conversely, the adult extractions obtain
higher process efficiencies compared to the empty puparia extractions at both concentrations. The
precision for the recovery and process efficiency did not exceed 12.0% with the majority being below 11%.
5.2.4.9. Entomotoxicology Results
After fortifying liver tissue with varying fentanyl concentrations (0, 50, 250, and 500 ug/kg) in
triplicate analysis, the insects were allowed to finish their life cycle and the end of end stages of empty
puparia and adult flies were collected. The empty puparia and adult flies collected from each collection
day were treated as individual cohorts and all the insects were pooled for QuEChERS extraction of fentanyl
and metabolites (Table 5.8). The average number of insects in a collected cohort was 26 insects. Each
adult when emerging leaves behind an empty puparium, therefore each insect provides an adult fly and
an empty puparium specimen. From the empty puparia specimens collected, fentanyl and norfentanyl
was detected in all the treatments except for the control liver tissue spike. The average fentanyl
concentrations (n=3) for the pooled cohort of empty puparia collected were 0.1 ± 0.1 µg/kg in the low
treatment, 0.5 ± 0.2 µg/kg in the medium treatment, and 1.1 ± 0.4 µg/kg in the high treatment. The
average norfentanyl concentrations (n=3) for the pooled cohort of empty puparia collected were 0.4 ± 0.1
µg/kg in the low treatment, 0.5 ± 0.1 µg/kg in the medium treatment, and 0.9 ± 0.2 µg/kg in the high
treatment. From the adult fly specimens collected, fentanyl was detected in all the treatments except for
the control liver tissue spike. The average fentanyl concentrations (n=3) for the pooled cohort of adult
flies collected were 0.1 ± 0.04 µg/kg in the low treatment, 3.0 ± 3.6 µg/kg in the medium treatment, and
1.8 ± 1.6 µg/kg in the high treatment. From the adult flies collected, norfentanyl was only detected in the
medium and high treatment groups. Average fentanyl concentrations (n=3) for the adult flies collected
from the medium treatment were 0.6 ± 0.2 ug/kg and from the high treatment group 0.5 ± 0.2 µg/kg.
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Table 5.8: Concentrations of fentanyl and norfentanyl detected in the empty puparia and adult flies.
Empty Puparia

Adult Flies

Compound

Fentanyl

Norfentanyl

Fentanyl

Norfentanyl

Control

ND

ND

ND

ND

Low

0.1 ± 0.09

0.4 ± 0.1

0.1 ± 0.04

ND

Medium

0.5 ± 0.2

0.5 ± 0.1

3.0 ± 3.6

0.6 ± 0.2

High

1.1 ± 0.4

0.9 ± 0.2

1.8 ± 1.6

0.5 ± 0.2

n=3

Figure 5.1: Regression plot data for the liver to empty puparia fentanyl concentrations (left) and for liver to adult

fentanyl concentrations (right).

Regression plots for the fentanyl concentrations for the insect tissues (empty puparia and adult
fly) were created versus the fentanyl concentration of the liver tissue (Figure 5.1). For the empty puparia,
the correlation plot generated an R 2 value of 0.832 which indicates a moderately strong correlation. For
the adult flies the correlation plot generated a lower R2 value of 0.623 which is a much weaker correlation.
A possible reason for the lower correlation could be created by continued metabolism of fentanyl by the
adult insect. The fentanyl concentration for the empty puparia is from only the fentanyl trapped in the
chitin of the puparia but the adult concentrations are from the entire insect.
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5.2.5. Conclusion
Three extraction techniques were explored for the quantitation of fentanyl and metabolites from
empty puparia. The selected extraction technique was the micropulverized QuEChERS extraction and was
validated following the ASB 036 (104). Liberation of the drugs from chitin is vital for quantitation when
dealing with the low concentrations encountered in insect tissue. Metabolites of norfentanyl and βhydroxyfentanyl were quantitated from the insect tissue when the presence of those metabolites were
not detected in the liver at the time of egg placement nor at the time of collection which is indicative of
insect metabolism. The ability to extract fentanyl and metabolites from late stages of the insect life cycle
allows for the insect to be an alternative matrix that persists longer than biological fluids and soft tissues.
Overall, the QuEChERS extraction was successful at extracting fentanyl from empty puparia and
adult flies collected from feeding on human liver tissue that contained fentanyl. This provides a method
for detecting and quantifying fentanyl and metabolites in an alternate matrix, liver to empty puparia
concentrations, liver to adult fly concentrations, and shows the persistence of fentanyl and metabolites
through the insect life cycle to adult emergence.

5.3. Section 2: Morphometric Comparisons of Adult Flies
5.3.1. Overview
This section presents the morphometric comparisons for the adult flies reared in task 2.a. To
determine the effects of fentanyl on the growth and development of the blow flies, the mass, length of
the wing vein, and length of the tibia of the adult flies were statistically compared using nested ANOVA
(task 2.c). Tukey-HSD test will determine which treatments are significantly different to determine if the
drug treatments have any significant effects on the insect’s development.
Since entomological techniques utilize the growth and development of insects to estimate the
minimum time since death, it is crucial to understand the role of fentanyl in the development of Lucilia
sericata blow flies. Insects follow a predictable life cycle that xenobiotics can influence. While several
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drugs have been explored in entomotoxicological studies, little is known about the direct effects that
fentanyl may pose on the growth and development of blow fly adults.
5.3.2. Morphometrics
Much like the larva, the adult flies have physical characteristics that can be measured to evaluate
the impact that fentanyl has on the insect’s growth. Unfortunately, due to the nature of the fly emerging
from the puparia, the empty puparia do not have relevant physical characteristics to record. For the adult
fly, mass, the costa wing vein, and tibia of the leg were selected to be measured to explore the impact of
the drug on the insect’s growth based on literature review (46). Unlike larva, age estimation for adult flies
is not a common practice and only morphometrics were used to evaluate the impact of the fentanyl on
the adult insects.
5.3.3. Methods
5.3.3.1. Design
The insects used in this chapter was the last day of collection (day 21) from the design presented
in Methods 4.2.3. Fentanyl was spiked into 200 g aliquots of human liver homogenate to evaluate four
concentrations: control (0 µg/kg), low (10 µg/kg), medium (100 µg/kg), and high (350 µg/kg)
concentrations. For replicate # 3, an authentic postmortem liver specimen with a fentanyl concentration
of 111 µg/kg, norfentanyl concentration of 8.1 µg/kg, and a 4-ANPP concentration of 5.8 µg/kg was
homogenized to be treated as a fifth treatment group. The 200 g treatment portions were aliquoted into
seven 25 g foil containers (Figure 4.6) with sand as a substrate for pupation. To each aliquot of liver,
approximately 70-90 eggs (by mass) were placed and allowed to feed undisturbed until time of collection
(Figure 4.6). Empty puparia and adult flies were collected after emergence (day 21) (Figure 4.7). Empty
puparia were collected and rinsed in deionized water to remove excess sand substrate followed by a
methanol rinse to remove any excess drug from the feeding media. The empty puparia were then allowed
to dry before being stored at -20 °C with no liquid preservatives added (7, 40, 46). Collected adult flies
were rinsed with deionized water and then methanol before being stored at -20 °C with no addition of
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any liquid preservative. No preservative was chosen due to the insect cuticle acting as a semipermeable
membrane which can allow water or ethanol to diffuse into the body cavity and potential to leech out the
target analytes into the preservative solution (149). Liver samples were collected at the time of egg
placement (day 0) and at the day of collection to establish the initial tissue concentrations and to evaluate
any metabolism of the drugs by the feeding media. This protocol was repeated for three replicates
approximately 6-8 weeks apart. The colony was described in section 1 of chapter 4 (4.1.3). For replicate
#1, the colony was at generation 24, for replicate #2 the generation was 26, and for replicate #3 the
generation was 28.
To evaluate developmental effects, the mass (mg), costa vein length (mm) from wing, and tibia
length (mm) of the collected insects were documented (Figure 5.2). Statistical analysis for the physical
characteristics including nested ANOVA and Tukey-Kramer HSD were performed using JMP Pro 15.1.0.

Figure 5.2: Measurements for the costa vein in the fly wing and the tibia length.
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5.3.4. Results
For the statistical analysis of the groups, mean was selected as the measure for length, width, and
mass of the insects. In the figures below, Tukey-HSD or Steel-Dwase statistical tests were performed with
the letters A, B, C, and D representing significant difference. Treatments not connected by a letter are
considered significantly different from each other.
5.3.4.1. Day 21
5.3.4.1.1. Wing Vein
For day 21 replicate #1, the medium treatment wing vein was significantly longer than the other
three treatment groups (t7.9, 9.5 = 3.19, p = 0.0102) (Figure 5.3). For replicate #2 and #3 in terms of wing
vein length, there was no significant difference observed between the treatment groups.

Figure 5.3: Comparison of mean wing vein length for insects collected on day 21 for replicates #1-3.

5.3.4.1.2. Tibia Length
For replicate #1 tibia length, the medium treatment group was significantly longer than the
control and low groups (t9.6, 11.5 = 3.42, p = 0.0054) (Figure 5.4). For replicate #2 and #3 in terms of tibia
length, there was no significant difference observed between the treatment groups.
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Figure 5.4: Comparison of mean tibia length (mm) for insects collected on day 21 for replicates #1-3.

5.3.4.1.3. Mass
For replicate #1 in terms of mean mass, the medium treatment group was significantly greater
than the control and low groups (t9.5, 10.6 = 3.28, p = 0.0076) (Figure 5.4). For replicate #2 and #3 in terms
of mass, there was no significant difference observed between the treatment groups.

Figure 5.5: Comparison of mean mass for insects collected on day 21 for replicates #1-3.

5.3.4.2. Estimated Survivor Rates
The estimated survivor rates for the entire study were calculated after the last collection on day
21 (Table 5.9). No significance was observed for the treatment survivor rates but for between the
replicates (F9, 72 = 0.948, p = 0.4894), there was a significant decrease in survivor rates in replicate #2 (F2, 9
= 4.38, p = 0.0468).
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Table 5.9: Percent estimated survivor rates for all the treatments and replicates combined.

Estimated Survivor Rates
Treatment

% Survived

St Dev

Control

87.4

24.9

Low

92.3

26.4

Medium

79.7

22.1

High

86.6

17.7

Replicate

% Survived

St Dev

Replicate #1

93.2

25.3

Replicate #2

77.1

23.7

Replicate #3

84.2

14.9

Table 5.10: Gender distribution for the adult flies.

Number of Gender
Treatment Male

% Gender

Females

% Male

% Female

Control

97

96

50.3

49.7

Low

81

93

46.6

53.4

Medium

56

59

48.7

51.3

High

58

76

43.3

56.7

Authentic

29

26

52.7

47.3

5.3.5. Discussion
For comparison of adult fly sizes, wing veins have been selected in previously published results
(46, 47, 169, 170). Adult Calliphora vomitoria flies were compared by Ireland et al. using the posterior
cross vein for the evaluation of overcrowding impacts on insect growth (169). Clark et al. compared the
length of the posterior cross vein in adult L. sericata flies for the effects of the insects feeding on different
body tissues (170). The costa wing vein was chosen for the comparison of adult flies to evaluate the effect
of drugs on insect growth (46, 47). George et al. compared the length of the costa vein of adult Calliphora
stygia for the effects of morphine on the insects (47). Mullany et al used the length of the costa vein of
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adult Calliphora stygia to evaluate the effects of methamphetamine and metabolites (46). George et al.
and Mullany et al. also used the tibia length as a metric for the effects of drugs on Calliphora stygia (46,
47).
For the costa wing vein length, only the medium treatment experienced a significant different and
no pattern among the treatments was observed. The results for the tibia length were similar to the vein
length. Fentanyl did not have a discernable effect on the size of the adults across the treatment groups
for the length of the wing vein and tibia. For comparison to previous studies, George et al. did not observe
any significant differences in wing vein and tibia length when larva fed on media fortified with morphine
(47). Mullany et al. observed increases in the treatment groups for methamphetamine in terms of mass,
wing vein, and tibia length (46). The mass of the treatment groups were significantly lower than the
control group for all replicates. Even though the length metrics did not decrease the mass of the flies did
decrease in the treatment groups with the greatest decrease in the high treatment group. The decrease
in mass is similar to the decrease in size of the high treatment for the pupa measurements. The
continuation of the effects to the adult flies is reasonable.
5.3.6. Conclusion
For the physical characteristics of the adult flies measured to evaluate the impact that fentanyl
has on the insect’s growth, the only significant difference was a decrease in mass for the treatment groups
compared to the control group. There was a significant increase of wing vein and tibia length for the
medium treatment group compared to the control but with no significant difference observed in the high
treatment a pattern cannot be determined. Unlike larva, age estimation for adult flies is not a common
practice and only morphometrics were used to evaluate the impact of the fentanyl on the adult insects.
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5.4. Section 3: Application of QuEChERS Extraction to Empty Puparia and Adult Flies
5.4.1. Overview
This section presents the toxicological findings for the empty puparia and adult flies for task 1.e.
The validated QuEChERS extraction presented in section 1 of this chapter was used for extraction of the
feeding media liver and the insect tissue. Presented is the survey of fentanyl and metabolites detected in
the empty puparia and adult flies. The later stages of the insect life cycle have advantages over traditional
biological matrices as a toxicological matrix due to persistence of the insect during the decomposition
process. Due to their slow chemical degradation and proximity to the corpse, pupa and empty puparia
can be collected from a cadaver months and even years after death, long after the decomposition process
has advanced to skeletonization (34, 163, 166). The goal of this section is to evaluate the toxicological
value of the insect life stages, quantify any metabolites detected for evidence of metabolism by the insect,
and to draw any conclusions of the liver tissue concentration to insect tissue concentrations.
5.4.2. Toxicology Matrix and Correlations
Detection of drugs in later stages of blowfly development has a benefit over larva because they
persist on the cadaver after other suitable toxicology specimens are unavailable (111). When feeding on
tissue with drugs present, the drugs are deposited in fat bodies of larva and the chitinized exoskeleton of
the pupa (154). The function of the hardened, chitin cuticle of the pupa is to protect the insect from
environment during metamorphosis and is resistant to chemical attack, microorganisms, and weathering
(44). Due to the structure of chitin, the drugs are often locked in and remain for an extended period of
time (34). When pupa emerge to adult flies, the empty puparia remains behind with the drugs trapped in
the chitin (44). Pupa and empty puparia, due to the strength of the chitin protected exoskeleton, can
persist in the remains long after the soft tissue of the corpse have disappeared (34). This allows for
toxicological analysis to take place on the pupa and empty puparia even in advanced decomposition or
skeletonized remains when traditional toxicology specimens like blood, urine and organ tissue are not
available for testing. The use of empty puparium for toxicological analysis has utility due to their ability to
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exist for extend periods on remains, even after skeletonization of the corpse (171). Miller et al. were able
to isolate amitriptyline and nortriptyline from empty fly puparia and beetle exuvia recovered from
mummified human remains in an indoor decomposition case (163). From stomach contents and analysis
of the desiccated brain, multiple drug intoxication, including amitriptyline, was identified as the cause of
death (163). Puparia have been discovered in Egyptian and pre-Columbia Peruvian mummies which
displays the ability of this type of evidence to remain in the environment for hundreds of years (172).The
ability of empty puparia to remain in soil surrounding the remains for hundreds of years, makes empty
puparia a prime target specimen for toxicology analysis in cadavers discovered in the late stage of
decomposition (163).
5.4.3. Methods
The samples from the design in methods 4.2.3 were used for the toxicology analysis of the
collected insects. Insects from collection day 21 were selected for toxicology analysis after the imaging
and morphometric characteristic measurements (Figure 4.7). The insects were pooled (n=16) as empty
puparia or as adult flies and extracted using the validated QuEChERS extraction. Liver samples were
collected at the time of egg placement (day 0) and at the day of collection to establish the initial tissue
concentrations and to evaluate any metabolism of the drugs by the feeding media. A survey of the
persistence and prevalence of fentanyl and metabolites was created.
5.4.4. Results
The previously discussed validated QuEChERS extraction was applied to the empty puparia and
adult flies collected on day 21 for all four treatments over three replicates with one additional treatment
set of an authentic postmortem liver specimen containing fentanyl (Table 5.11). The insects were analyzed
as pooled samples (n=16) in duplicate for all three replicates (n=6).
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Table 5.11: Empty puparia and adult drug concentrations from day 21 collections for all three replicates.
Empty Puparia
Pooled Empty Puparia (µg/kg)
Compound
Control

Low

Medium

High

Authentic

4-ANPP

ND

ND

ND

ND

ND

β-Hydroxyfentanyl

ND

2.0 ± 0.4

9.0 ± 0.1

5.1 ± 2.2

ND

Fentanyl

ND

<LLOQ

0.4 ± 0.2

2.4 ± 1.6

3.4 ± 1.1

Norfentanyl

ND

ND

1.2 ± 0.6

2.5 ± 0.7

1.6 ± 0.2

Adult Flies
Pooled Adult Flies (µg/kg)
Compound
Control

Low

Medium

High

Authentic

4-ANPP

ND

ND

ND

ND

ND

β-Hydroxyfentanyl

ND

ND

ND

ND

ND

Fentanyl

ND

1.1 ± 0.7

1.8 ± 1.7

3.5 ± 3.5

0.2 ± 0.2

Norfentanyl

ND

1.1 ± 0.4

2.4 ± 1.5

2.2 ± 0.9

<LLOQ

For the empty puparia and adult flies collected on day 21, fentanyl was detected in all treatments
across all three replicates but was below the LLOQ for the low treatment in the empty puparia (Table 5.9).
For the adult flies a trend emerged. As the concentration of the fortified liver treatment increased, the
concentration of fentanyl observed in the adult fly extractions also increased. For the empty puparia
collected from the low treatment, the average β-hydroxyfentanyl concentration (n=4) across the three
replicates was 2.0 ± 0.4 µg/kg, fentanyl was detected but below LLOQ, norfentanyl, and 4-ANPP were not
detected. For the empty puparia collected from the medium treatment, the average β-hydroxyfentanyl
concentration (n=2) across the three replicates was 9.0 ± 0.1 µg/kg, fentanyl (n=6) was 0.4 ± 0.2 µg/kg,
norfentanyl (n=4) 1.2 ± 0.6 µg/kg, and 4-ANPP was not detected. For the high treatment, the average βhydroxyfentanyl concentration (n=4) across the three replicates was 5.1 ± 2.2 µg/kg, fentanyl (n=6) was
2.4 ± 1.6 µg/kg, norfentanyl (n=4) 2.5 ± 0.7 µg/kg, and 4-ANPP was not detected. For the authentic
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treatment, the fentanyl average concentration (n=2) was 3.4 ± 1.1 µg/kg, norfentanyl (n=2) 1.6 ± 0.2
µg/kg, β-hydroxyfentanyl, and 4-ANPP was not detected. Box plots were created for these averages from
fentanyl (Figure 5.6), norfentanyl (Figure 5.7), and β-hydroxyfentanyl (Figure 5.8).

Figure 5.6: Box plot for the concentration of fentanyl quantitated for the pooled empty puparia specimens collected from the
authentic, medium, and high treatments on day 21 for all three replicates (n=6).
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Figure 5.7: Box plot for the concentration of norfentanyl quantitated for the pooled empty puparia specimens collected from
the authentic, medium, and high treatments on day 21 for all three replicates (n=6).

Figure 5.8: Box plot for the concentration of β-hydroxyfentanyl quantitated for the pooled empty puparia specimens collected
from the low, medium, and high treatments on day 21 for all three replicates (n=6).
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For the adult flies collected from the low treatment, the average norfentanyl concentration (n=2)
across the three replicates was 1.1 ± 0.4 µg/kg, fentanyl (n=2) was 1.1 ± 0.7 µg/kg, β-hydroxyfentanyl, and
4-ANPP were not detected. For the adult flies collected from the medium treatment, the average fentanyl
concentration (n=4) was 1.8 ± 1.7 µg/kg and norfentanyl (n=4) was 2.4 ± 1.5 µg/kg. For the high treatment,
the average fentanyl concentration (n=4) across the three replicates was 3.5 ± 3.3 µg/kg and norfentanyl
(n=4) 2.2 ± 0.9 µg/kg. For the authentic treatment, the fentanyl average concentration (n=3) was 0.2 ± 0.2
µg/kg, norfentanyl (n=3) was detected below the LLOQ, β-hydroxyfentanyl, and 4-ANPP were not
detected. Box plots were created for these averages from fentanyl (Figure 5.9) and norfentanyl (Figure
5.10). The metabolites β-hydroxyfentanyl and 4-ANPP were not detected in the adults flies in any of the
extracted specimens across all treatments.

Figure 5.9: Box plot for the concentration of fentanyl quantitated for the pooled adult fly specimens collected from the low,
medium, and high treatments on day 21 for all three replicates (n=6).
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Figure 5.10: Box plot for the concentration of norfentanyl quantitated for the pooled adult fly specimens collected from the
low, medium, and high treatments on day 21 for all three replicates (n=6).

5.4.5. Conclusion
Fentanyl and metabolites were extracted from the empty puparia and adult flies feeding on liver
tissue fortified with fentanyl. β-hydroxyfentanyl was detected in the empty puparia but not in the adult
flies. β-hydroxyfentanyl was detected in the later larval and pupal stages therefore the persistence of the
metabolite to the empty puparia is expected but the lack of detected it the adult flies indicates either the
compound is sequestered by the chitin of the pupa and left behind in the exuviate or the adult flies could
be continuing to excrete and clear the compound from their system. The detection of fentanyl and
norfentanyl from the empty puparia and the adult flies exemplify the utility of this matrix as a biomarker
for the presence of fentanyl in the tissues the insects fed on which can be a proxy to postmortem tissue
drug presence. The detection of fentanyl and norfentanyl from the empty puparia and the adult flies also
indicates that a portion of the drug is left behind in the fly exuviate but also persists to the adult fly.
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These findings strengthen the utility of empty puparia for the detection of fentanyl and
metabolites collected from tissues fortified with fentanyl. This is promising for the use of late stage insect
tissue for the detection of postmortem tissue drug presence.
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Chapter 6: General Conclusions
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6.1. Chapter 3: Development and Application of QuEChERS Extraction Method for the
Quantitation of Fentanyl and Metabolites from Liver Tissue
The ability to extract a drug or toxin from a matrix and the instrumental analysis are the main
components of toxicology analysis. For the analysis of complex biological matrices, three extractions were
evaluated: liquid-liquid extraction (LLE), solid-phase extraction (SPE), and a QuEChERS extraction. For each
extraction technique, matrix effects, recovery, and process efficiency were evaluated. The QuEChERS
extraction outperformed the SPE and LLE techniques and was selected for validation and evaluation of
authentic specimens. The QuEChERS technique had recoveries higher than 90.2%, matrix effects greater
than 80.4%, and process efficiencies greater than 76.7% with %CV values below 12.8% for fentanyl,
norfentanyl, and 4-ANPP. The bias for all three target analytes at all three concentrations did not exceed
±20% with repeatability and reproducibility within the ±20% threshold and the analytical measurable
range (AMR) of 0.4-80 µg/kg for 4-ANPP and 0.5-100 µg/kg for fentanyl and norfentanyl. The fentanyl
concentrations reported ranged from 56.6 to 462.3 µg/kg with a mean of 149.2 µg/kg (n=10) for authentic
postmortem liver specimens. Overall, the QuEChERS technique met all the acceptable criteria and was
shown to be effective at extracting and quantitating fentanyl, norfentanyl, and 4-ANPP. The advantages
of the QuEChERS extraction include the direct extraction of the tissues, a cleaner sample to reduce
ionization enhancement or suppression, elimination of cross contamination by eliminating the need for
bladed homogenizers, and provided a reduction of extraction mass.
The QuEChERS extraction was expanded to 34 analytes including fentanyl, metabolites, and
fentanyl analogs, validated following the American Academy of Forensic Sciences Standards Board (ASB)
standard 036 requirements, and the protocol was applied to 22 authentic postmortem liver specimens.
The bias for all 34 target analytes at low, medium, and high concentrations did not exceed ±20% with
repeatability and reproducibility within the 20% threshold. The QuEChERS technique had recoveries
greater than 93.3%, matrix effects greater than 76.8%, and process efficiencies greater than 81.5% for all
34 target analytes. Of the 22 authentic postmortem samples, 17 were multidrug positive with at least one
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fentanyl analog and fentanyl present indicating a prevalence of multiple fentanyl types in use. Nine of the
22 samples contained at least two fentanyl analogs plus fentanyl and metabolites. Three of the 22 samples
contained three fentanyl analogs plus fentanyl and metabolites.
Overall, the QuEChERS extractions met all the acceptable criteria set by the ASB Standard 036
requirements for liver extraction and proved to be effective at extracting and quantitating fentanyl as well
as fentanyl analogs.

6.2. Chapter 4: Evaluation of the Effects of Fentanyl on Blowfly Larva and Application of
QuEChERS Extraction Method for the Quantitation of Fentanyl and Metabolites from Larva and
Pupa (Lucilia sericata)
The overarching goals of this study was to evaluate the developmental effects of fentanyl on
immature stages of the blow fly Lucilia sericata (Meigen) and to monitor the prevalence of fentanyl and
metabolites from larval and pupal tissue after feeding on liver tissue with the presence of fentanyl. The
QuEChERS extraction method developed for postmortem liver was adapted for extraction of larval and
pupal tissue. The extraction protocol met all the criteria mapped out by the ASB and was applied to
authentic insect samples that were reared on human tissue containing fentanyl.
This study presented morphometric measures of length, width, and mass for the insects collected;
however, larval length was the most significant physical characteristic. In comparison of individual
collection days, at least one of the treatment groups (low, medium, or high) was significantly different
(nested ANOVA, p < 0.05) from the control group over all three replicates. The low, medium, and high
treatment groups reached a greater maximum length compared to the control group in most of the
replicates indicating fentanyl had some effect on the length of the insects. Using a polynomial equation
on the growth curve of the control group, the estimation of age of the insects showed that there was
often an increase in growth at the early life stages, followed by a decrease in the later larval stages. The
age estimation for the high treatment group was as high as 1.4 d younger than the actual age and for the
authentic set as high as -2.9 d younger than the actual age. Every treatment group had an underestimation
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in age of 1 d in at least one day of collection among the three replicates. With the impact of fentanyl on
the length of the larval length, it can be concluded that fentanyl can reduce the larval growth by at least
1 day and up to 3 days. This indicates age estimation based on length can be impacted by the presence of
fentanyl in the feeding media and needs to be taken into consideration when estimating minPMI.
The validated QuEChERS extraction was applied to the larva and pupa collected on days 3, 6, and
10 for all four treatments over three replicates with one additional treatment set of an authentic
postmortem liver specimen containing fentanyl. Fentanyl was detected in the larvae and pupae that were
collected from the human liver tissue. Fentanyl was quantitated in all larva collected on day three from
all three treatments of low, medium, and high across the three replicates. By quantitating fentanyl in all
three treatments, a correlation plot and simple linear regression was performed using the known
concentrations of the fortified liver feeding substrate. Strong correlation of larva concentration to liver
tissue concentration was observed for all replicates in the single and pooled larva specimens. The single
larva to liver correlations observed an R2 value ranging from 0.908 to 0.937 and the pooled larva to liver
correlations observed an R2 value ranging from 0.959 to 0.988. To further investigate the utility of the
correlation, the larva collected from the authentic treatment group was used to test the ability of the
linear regression to estimate the liver fentanyl concentration using the larva fentanyl concentration. After
estimation, the single larva fentanyl extractions had an average bias (n=5) of -21.7 and the pooled
specimens had an average bias (n=5) of -32.1. After dropping an outlier, the average bias (n=4) for the
single larva was -11.8. It is not known what created the outlier, but this highlights why it is important to
analyze multiple replicates for insect toxicology analysis or to sample a pooled specimen. Metabolites of
norfentanyl and β-hydroxyfentanyl were quantitated from the insect tissue when the presence of those
metabolites were not detected in the liver at the time of egg placement nor at the time of collection. It
can be derived that the most likely creation of these metabolites was metabolism of fentanyl by the insect
to these compounds. Also, the metabolite 4-ANPP was quantitated from the feeding larva insects

202

collected from the authentic liver specimen; however, this liver had a quantified 4-ANPP prior to egg
placement and with no other insect containing a quantifiable concentration of 4-ANPP, no metabolism of
fentanyl to 4-ANPP by the insects can be determined.
Overall, the QuEChERS extraction was successful at extracting fentanyl from larvae and pupae
collected from feeding on human liver tissue that contained fentanyl. This provides a method for detecting
and quantifying fentanyl in an alternate matrix, liver to larvae concentrations, and shows the persistence
of fentanyl through the insect life cycle to pupation.

6.3. Chapter 5: Evaluation of the Effects of Fentanyl on Blowfly Adults and Application of
QuEChERS Extraction Method for the Quantitation of Fentanyl and Metabolites from Empty
Puparium and Adult Flies (Lucilia sericata)
Three extraction techniques, micropulverized QuEChERS extraction, acidic digestion QuEChERS
extraction and the basic digestion LLE were tested for the extraction of fentanyl and metabolites from the
empty puparia. The extraction that performed the best was selected for validation. To evaluate the
extraction techniques, ionization suppression/enhancement, recovery, process efficiency, and the ability
to extract from an authentic set of empty puparia collected from insects fed on liver tissue fortified with
fentanyl were compared for the three techniques. The micropulverization QuEChERS extraction method
was selected and validated for the analysis of fentanyl and metabolites from empty puparia and adult fly
tissue.
Much like the larva, the adult flies have physical characteristics that can be measured to evaluate
the impact that fentanyl has on the insect’s growth. Unfortunately, due to the nature of the fly emerging
from the puparia, the empty puparia do not have relevant physical characteristics to record.
Morphometric comparisons for the collected adult flies were recorded to evaluate the effects each
treatment had on growth. To determine the effects of fentanyl on the growth and development of the
blow flies, the mass, costa wing vein, and tibia length were statistically compared. Unlike larva, age
estimation for adult flies is not a common practice and only morphometrics were used to evaluate the
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impact of the fentanyl on the adult insects. For the physical characteristics of the adult flies measured to
evaluate the impact that fentanyl has on the insect’s growth, the only significant difference was a decrease
in mass for the treatment groups compared to the control group. There was a significant increase of wing
vein and tibia length for the medium treatment group compared to the control but with no significant
difference observed in the high treatment a pattern cannot be determined.
Detection of drugs in later stages of blowfly development has a benefit over larva because they
persist on the cadaver after other suitable toxicology specimens are unavailable. Fentanyl and metabolites
were extracted from the empty puparia and adult flies feeding on liver tissue fortified with fentanyl. The
survey of fentanyl and metabolites detected in the empty puparia and adult flies included the detection
of fentanyl, β-hydroxyfentanyl, and norfentanyl. The metabolite 4-ANPP was not detected in any empty
puparia or adult fly specimens after being detected in the authentic larva specimens. β-hydroxyfentanyl
was detected in the empty puparia but not in the adult flies. β-hydroxyfentanyl was detected in the later
larval and pupal stages therefore the persistence of the metabolite to the empty puparia is expected but
the lack of detected it the adult flies indicates either the compound is sequestered by the chitin of the
pupa and left behind in the exuviate or the adult flies could be continuing to excrete and clear the
compound from their system. The detection of fentanyl and norfentanyl from the empty puparia and the
adult flies exemplify the utility of this matrix as a biomarker for the presence of fentanyl in the tissues the
insects fed on which can be a proxy to postmortem tissue drug presence. The detection of fentanyl and
norfentanyl from the empty puparia and the adult flies also indicates that a portion of the drug is left
behind in the fly exuviate but also persists to the adult fly.
These findings strengthen the utility of empty puparia for the detection of fentanyl and
metabolites collected from tissues fortified with fentanyl. This is promising for the use of later stage insect
tissue for the detection of postmortem tissue drug presence.
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Overall, the goals of detecting fentanyl and metabolites from all life stages of the insects and the
observation of any effects of fentanyl on the growth of the insects was accomplished. For the growth and
developmental impacts of fentanyl on the insects, even though a statistical trend for the impact of the
drug was not observed, the variations in the insect growth should be taken into consideration when
estimating minPMI when fentanyl is present in the cadaver. Fentanyl was observed in all insect life stages
(feeding larva, wandering larva, pupa, empty puparia, and adult flies) for the insects feeding on tissue with
fentanyl present. This indicates the insects do incorporate the drugs into their tissues to some degree and
fentanyl can be detected in the insect tissue collected from cadavers that contain fentanyl. From the later
stages of wandering larva, pupa, and empty puparia, fentanyl concentrations decreased and fentanyl
metabolites were observed more frequently. This is evidence of the insect’s (Lucilia sericata) ability to
metabolize and eliminate fentanyl from their bodies and with greater success in the later or non-feeding
life stages. In regard to the metabolites observed, norfentanyl was the only metabolite detected in the
early life stages (feeding larva) while β-hydroxyfentanyl in combination with norfentanyl was detected in
the later life stages (wandering larva, pupa, and empty puparia). The significance of these findings could
be a change in the metabolic pathways or of the later life stage insects or more likely the accumulation of
β-hydroxyfentanyl in the insect tissue as the insect metabolizes fentanyl without the insect being able to
eliminate the metabolite from their tissue. The increase in the frequency of the detection of βhydroxyfentanyl could be an indication of the metabolite being trapped in the insect tissue and
accumulating in the later insect life stages. Another unique observation is the absence of βhydroxyfentanyl in the adult flies while the metabolite was detected in the empty puparia that the adult
flies emerged from. These findings could be indicative of sequestering of β-hydroxyfentanyl into the
exoskeleton of the pupa and therefore trapped in the empty puparia that is left behind when the adult
insect emerges. Another possible explanation could be the elimination of β-hydroxyfentanyl by the adult
fly in the meconium that is defecated after emergence. Detection of fentanyl and metabolites in the
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empty puparia is of great importance as the rugged chitinized exoskeleton can persist in the environment
for hundreds of years and depending on the stability of the drug, this evidence can be utilized long after
soft tissues or fluids are no longer available.
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Future Work
This work consisted of large data set and provides valuable information for the impact of
fentanyl on the growth of Lucília sericata. The focus of this study was to observe the effects of
fentanyl on the insects and to evaluate the ability to extract fentanyl and metabolites from all
the insect life stages. Even though the work presented is valuable, there are still limitations to
the study. One limitation was the days collected, due to limited resources the number of
collection days were chosen to optimize the amount of toxicology data gathered. Days there
were selected in the late stage of the life cycle were not sensitive to changes in the development
time of the flies in order to ensure the toxicology specimens were available however this reduced
the value of data for development impact. In order to have toxicology samples and maximize
resources, later life stages were chosen for collection at days that had a higher chance of having
the majority of the insects in the desired life stage. This reduced the efficacy of detecting subtle
impacts that fentanyl could have on the insects while still being able to observe if the drug had
major effects on the insects. More data collected at the later life stages could provide a better
look at the percent stage of insects in the later life cycle. A related limitation is no information
was collected between day 6 and day 10 for the life cycle of the insects. Larva were still observed
with the pupa at day 10 collection times, while more larva were collected in the treatment groups
but the difference was not significant. More replicates and/or the addition of collection days
between day 6 and day 10 could identify if there are significant impacts on the insect as they
transition to pupa. Based on the larval growth patterns, the treatment groups either grew to their
maximum length or grew to a length longer than the treatment groups at some stage of their life
cycle however, the as the larval stage continue the slopes of the growth curves slowed. This could
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be an indication of a slowdown to pupation and the collection days between 7 and 9 could
provide more insight to this effect.
Some future work that I would recommend to enhance the data collected would be to
expand and separate the experimental design. The design I used in this study was focused on
maximizing the current resources on hand while gathering the most observable data for both the
effects of the drug on the insects and to provide a toxicological analysis on the collected samples.
With the conclusions discussed above, further study with experimental designs focused entirely
on either the developmental effects of fentanyl on the insect and the toxicological analysis can
be implemented.
For the toxicology future work, this study provided regression plots that displayed high
correlation of the liver tissue fentanyl concentration to feeding larvae fentanyl concentrations.
This is an important step in discovering correlation of insect and tissue concentrations, but this
does not mean the concentrations will correlate in authentic case work. Future work should
include more replication and additional tissues for fortification like muscle and heart tissue. This
work and previous literature have shown that the later life stages of insect varies as metabolism
and ability of the insect to excrete the drug creates variations. This would be the next step to
correlating real world scenarios.
For developmental effects, an increase in replicates and an increase in collection days
would be my recommendation. Growth rates of insects can vary, and more replicates can be
useful in identifying variation created by genetics compared to treatment. Also increasing the
collection days to include up to pupation and beyond. For this study there was a gap in between
day 6 and day 10 due to resources but collection days 7 through 9 could have valuable insight to
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the stage development of the insects. Also, days 7 through 9 should be more discriminatory to
the transition of larva to pupa as day 10 was chosen in this study to improve the likelihood of
observing enough pupa for toxicology analysis but sacrificed observations of percent stage. The
same is true for emergence, more studies can be applied to see the effect the fentanyl has on
the emergence of the adult flies by collecting at more days between day 10 and day 21.
This study provided insight into the effect of fentanyl on Lucilia sericata and the detection
of fentanyl and metabolites from all of the insect’s life stages to lay the groundwork for future
studies.
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“Quantitation of Fentanyl and Metabolites from Lucilia Sericata Larvae and Liver Tissue Using a Modified Quick,
Easy, Cheap, Effective, Rugged, and Safe (QuEChERS) Extraction with Analysis by Liquid
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Presented research projects at 2015 SOFT meeting
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Full Member in the Toxicology Section
Presented at 2014, 2016, 2019, and 2020 meetings

Society of Forensic Toxicologists
Student Member

2015- present

Presented at the 2015, 2018, and 2019 conferences

232

AWARDS
National Institute of Justice’s (NIJ) Graduate Research Fellowship

2019-2021

in Science, Technology, Engineering, and Mathematics
Project entitled: Extraction and quantitation of fentanyl and metabolites from complex biological matrices to
support medicolegal death investigations
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